[
    {
        "pmid": "40823237",
        "title": "Perceptions of coastal dwellers about the effects of extreme temperature and saline water on human health: evidence from Bangladesh.",
        "abstract": "Climate change disproportionately affect coastal community worldwide increasing exposure extreme temperature saline water intrusion Understanding impact critical public health planning intervention study aim examine perception effect climate changeinduced phenomena specifically extreme temperature water salinity overall human health coastal community residing Ramgati Lakshmipur Bangladesh study adopted quantitative research approach utilized crosssectional survey design gather data sample consisted 391 participant iNi  391 residing coastal region Ramgati structured questionnaire employed collect data gathered data subjected several bivariate analyses including independentsample ititests Pearson correlation analysis hierarchical regression analysis using IBM SPSS version 240 Participants exposed higher extreme temperature reported perception various health effects heat stroke dengue epidemic migraine headache Additionally participant experiencing elevated water salinity reported different health effects including hair loss high blood pressure diarrhea maternal health problems child development hindered child mental health development Linear regression analysis revealed participants age iβi  033 ipi  0001 gender iβi  016 ipi  0001 perceived risk health disease iβi  017 ipi  0001 high salinity water iβi  015 ipi  0002 high temperature iβi  025 ipi  0001 significantly associated perception health effects study highlight importance addressing key issue regarding effect extreme temperature saline water human health Specifically study report access clean drinking water climate change adaptation strategies health education awareness integrated public health approach need vulnerable populations order mitigate effect climate change human health living coastal areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823237/"
    },
    {
        "pmid": "40791273",
        "title": "Childhood diarrhoeal disease in South Asian countries: a population-based analysis.",
        "abstract": "Despite advancement water sanitation vaccination childhood diarrhoeal disease CDDs continue pose significant public health challenges especially South Asia study aim estimate pooled prevalence CDDs South Asia identify key factor contributing persistence providing crucial insight future policy intervention strategies study utilised data recent Demographic Health Surveys conducted 2015 2022 Afghanistan Bangladesh India Nepal Maldives Pakistan focusing child 5 year old Descriptive statistic used measure prevalence CDDs multivariable logistic regression performed identify significant factors p value 005 considered level significance overall pooled prevalence CDDs 1013 95 CI 983 1045 Afghanistan highest rate childhood diarrhoea South Asian region prevalence 2915 95 CI 2801 3031 Maldives lowest prevalence 417 95 CI 320 542 Higher odds CDDs associated younger children male sex younger mothers mother little education larger households unimproved drinking water type toilet facilities lack access antimicrobial agent handwashing limited electronic medium access However factor varied country country study highlight persistently high prevalence childhood diarrhoea South Asia Countryspecific finding underscore urgency focused interventions particularly Afghanistan Pakistan effectively reduce CDDs region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791273/"
    },
    {
        "pmid": "40774609",
        "title": "Evaluation of colonization factors of ETEC isolated from diarrheal patients in Bangladesh: A comparative approach using multiplex PCR and dot blot immunoassay.",
        "abstract": "Enterotoxigenic Escherichia coli ETEC harbor colonization factor CFs colonize small intestine study part routine systematic ETEC surveillance Bangladesh evaluated CFs ETEC isolated hospitalized diarrheal patient using multiplex PCR assay first time availability monoclonal antibody dot blot assay became limited total 5914 diarrheal patient enrolled study period 20232024 PCR assay targeting heatlabile toxin LT heatstable toxin ST found 531 ETECinfected patients findings 40  ETEC isolates positive ST followed 38  LT  ST 22  LT overall CF detection rate using newly established multiplex PCR 51  among ETECpositive cases CFAI  CS21 CS6 ± CS21 CS5  CS6 CS1  CS3  CS21 prevalent CFs period validation purposes multiplex PCR assay compared conventional dot blot method considered gold standard assay used parallel assess frequency CFs detected subset ETEC strain n  157 observed significant consistency dot blot PCR method Additionally compared dot blot method PCR assay identified CS21 11  ETEC strain harboring CFAI CS6 Overall finding suggest multiplex PCR method advantageous well timeefficient detection ETEC CFs compared dot blot assay",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774609/"
    },
    {
        "pmid": "40763727",
        "title": "An O-Specific Polysaccharide Shigella flexneri 3a Conjugate Vaccine is Immunogenic and Protective against Virulent Keratoconjunctival Challenge in Guinea Pigs.",
        "abstract": "Shigella infection major cause diarrhea cognitive physical stunting death young child resourcelimited settings vaccine protective shigellosis needed Immune response target Ospecific polysaccharide OSP Shigella spp protective shigellosis previously reported development evaluation conjugate vaccine targeting Shigella flexneri S flexneri 3a mice Here report evaluation vaccine Shigella conjugate vaccine S flexneri 3a OSP conjugated 52 kiloDalton recombinant fragment tetanus toxin heavy chain SCVSf3a OSPrTTHc second animal model guinea pig vaccine induced prominent OSP lipopolysaccharide rTTHcspecific Immunoglobulin IgG IgA IgM response serum vaccinated animals Shigella conjugate vaccine S flexneri 3a also induced serum bactericidal functional antibody responses vaccinated guinea pig protected virulent strain keratoconjunctival challenge standard Shigella Sereny assay result support development SCVSf3a OSPrTTHc",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763727/"
    },
    {
        "pmid": "40746426",
        "title": "Neuropharmacological, Antidiarrheal, and Antimicrobial Effects of <i>Chaetomorpha aerea</i> Acetone Extract: GC-MS Profiling and In Silico Analysis.",
        "abstract": "iChaetomorpha aereai distributed temperate tropical coastal regions traditionally consumed nutrientrich food source coastal community believed possess medicinal properties study evaluated sedative anxiolytic antidiarrheal antimicrobial activity acetone extract iC aereai AECA Furthermore GCMS performed quantitative phytochemical analysis AECA Sedative activity evaluated mouse using open field test OFT hole cross test HCT anxiolytic activity assessed using elevated plus maze EPM hole board test HBT lightdark box test LDBT antidiarrheal activity determined castor oilinduced diarrhea gastrointestinal motility test discdiffusion method employed evaluate antibacterial activity OFT HCT models AECA 400 mgkg demonstrated significant reduction square crossed hole crossed compared diazepam respectively case EPM HBT 400 mgkg dose AECA demonstrated significant dosedependent activity castor oilinduced diarrhea gastrointestinal motility test 400 mgkg AECA demonstrated moderate inhibition diarrhea compared standard loperamide Antimicrobial assay AECA showed considerable inhibition iEscherichia colii iSalmonella typhii measuring inhibition zone 14 mm 13 mm Bioactive metabolite GCMS analysis investigated molecular docking Docking performed GABAsubAsub receptor 6X3T MAOA 2Z5X M3 muscarinic receptor 5ZHP iE colii FabI 1LX6 GyrA 5ZTJ AECA showed notable sedative anxiolytic antidiarrheal antimicrobial activities evaluate molecular pathway involved isolate bioactive ingredients research required",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746426/"
    },
    {
        "pmid": "40743111",
        "title": "Water, sanitation, and hygiene (WASH) factors and the incidence of communicable diseases in Urban Bangladesh: Evidence from municipal areas.",
        "abstract": "Safe drinking water sanitation hygiene WASH crucial health development especially low middleincome country LMICs WASHrelated disease prevalent Bangladesh high poverty rate large population face significant WASH challenges study examines association hygienerelated factor communicable disease two Bangladeshi municipalities descriptive crosssectional study conducted June 1 July 30 2021 Savar Satkhira municipalities chosen diverse socioeconomic geographic characteristics stratified random sampling method targeted poor marginalised socially excluded populations total 607 interview conducted using structured questionnaire collecting data sociodemographics hygiene practices disease history Participants included adult aged 18 older resided municipality least one year provided informed consent participate Data analysed using SPSS employing chisquare test logistic regression assess association variables study revealed 241 participant communicable disease diarrhoea common Significant predictor communicable disease included gender female likely affected OR 321 95 CI 119 866 p  0003 source drinking water tube well user higher risk OR 281 95 CI 113 702 p  0015 Poor hand hygiene significantly increased disease risk OR 1231 95 CI 286 5303 p  0001 Communicable disease prevalent Bangladeshi municipalities primarily driven poor WASH conditions Enhancing access safe drinking water implementing communitybased WASH interventions hygiene education campaigns improved sanitation infrastructure schoolbased awareness programs vital reducing disease burden research explore effectiveness scalability targeted strategies",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Sanitation",
            "Male",
            "Adult",
            "Hygiene",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Young Adult",
            "Communicable Diseases",
            "Adolescent",
            "Drinking Water",
            "Incidence",
            "Cities",
            "Urban Population",
            "Water Supply",
            "Surveys and Questionnaires",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40743111/"
    },
    {
        "pmid": "40738050",
        "title": "Associations between floor material and E. coli contamination in rural Bangladeshi households.",
        "abstract": "Soil floor common lowincome country harbor contamination fecal waste Soildust ingestion floor indirectly via hands water food contribute childrens ingestion fecal organisms assessed finished eg concrete floor associated lower E coli contamination domestic environment rural Bangladesh collected sample 1864 household 35 years including stored drinking water child caregiver hand rinses courtyard soil food fly n  24118 samples enumerated E coli using IDEXX QuantiTray2000 Controlling sociodemographics watersanitation status animal ownership household finished floor slightly lower log10transformed E coli count Δlog10  010 020 000 prevalence prevalence ratio PR  090 083 098 child hand household soil floors floor material associated contamination level sample types subgroup analyses finished floor associated lower E coli child hand following heavy rainfall Δlog10  023 039 007 abovemedian temperature Δlog10  018 030 006 household domestic animal Δlog10  016 032 001 Finished floor also associated slightly lower contamination stored water following heavy rainfall PR  089 081 099 abovemedian temperature PR  091 084 098 lower contamination stored food following higher rainfall temperature association food statistically significant Measures control enteric infection lowincome country test flooring improvement reduce exposure fecal contamination",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40738050/"
    },
    {
        "pmid": "40716798",
        "title": "Is rotavirus aetiology in young children with acute diarrhoea associated with sociodemographic and clinical factors, including rotavirus vaccination status? A secondary cross-sectional analysis of the ABCD trial.",
        "abstract": "One leading cause global child mortality continues diarrhoea rotavirus contributed 24 death among diarrhoeal deaths mostly lowincome middleincome countries Rotavirus vaccination programme contributed reduction mortality 24 19 rotavirus infection among hospitalised children burden rotaviral diarrhoea remains high especially setting undernutrition aimed determine association rotaviral diarrhoea aetiology prior vaccination socioeconomic status clinical factor child see utility clinical settings analysed secondary data multicentre clinical trial antibiotic impact child diarrhoea increased risk mortality used stored stool sample 6697 child aged 223 month old presenting health facility diarrhoea increased risk mortality determined rotavirus aetiology prevalence using quantitative PCR qPCR looked association patients rotaviral vaccination status clinical symptom sociodemographic characteristics Prevalence ratio PR calculated logbinomial regression models converge logPoisson model used Rotavirus prevalence 211 observed weak statistically nonsignificant inverse association rotavirus vaccination rotaviral diarrhoea aetiology adjusted PR 071 95 CI 049 103 five tested clinical symptoms shorter diarrhoea duration associated rotaviral aetiology PR 265 95 CI 129 545 seven tested socioeconomic characteristics maternal paternal secondary education compared formal education associated rotaviral aetiology PR 086 95 CI 074 100 PR 087 95 CI 075 100 respectively Rotaviral diarrhoea aetiology cannot accurately determined prior receipt rotavirus vaccination among child presenting facility diarrhoea increased risk mortality Short diarrhoea duration parental secondary education associated increased prevalence rotaviral aetiology however utility clinical care remains unclear",
        "mesh_terms": [
            "Humans",
            "Rotavirus Infections",
            "Infant",
            "Male",
            "Female",
            "Rotavirus Vaccines",
            "Cross-Sectional Studies",
            "Diarrhea",
            "Vaccination",
            "Prevalence",
            "Rotavirus",
            "Socioeconomic Factors",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40716798/"
    },
    {
        "pmid": "40701374",
        "title": "Childhood diarrheal infections among the multi hazard disaster risk zones in Bangladesh: A household level analysis.",
        "abstract": "Bangladeshs geographic climatic condition make highly disasterprone increasing vulnerability underfive child diarrheal infections study analyzed MICS Bangladesh 2019 dataset using multivariable logistic regression model assess diarrhea prevalence low moderate high multihazard risk zones focusing floods tornadoes cyclones earthquakes Diarrhea prevalence highest highrisk zone 771  followed moderate 598  lowrisk zone 467  Socioeconomic factor male gender urban residence extreme poverty lack handwashing facility associated higher risk diarrhea highrisk zones though link weaker moderate lowrisk zones Public health official aid organization must mitigate increased diarrheal disease risk following extreme events Interventions prioritize highrisk area awareness campaigns early warning systems improved water sanitation hygiene moderate highrisk zones vaccination particularly impoverished household disasterprone regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40701374/"
    },
    {
        "pmid": "40689249",
        "title": "Epidemiological and Clinical Features of Enterotoxigenic <i>Escherichia coli</i> (ETEC) Diarrhea in an Urban Slum in Dhaka, Bangladesh.",
        "abstract": "Enterotoxigenic iEscherichia colii ETEC major cause diarrheal illness populationbased data incidence clinically significant ETEC diarrhea developing country limited provide insight ETEC epidemiology followed populationbased cohort vaccine trial analyzed data clusterrandomized controlled trial oral cholera vaccine conducted urban slum Dhaka Bangladesh study cover 90 geographical cluster average population 2988 householdscluster baseline population 268 896 Two cohort analysis conducted 1 dynamic cohort included subject vaccination inmigrants birth 4 year closed cohort included individual present baseline evaluated individual placed treatment centerbased diarrheal surveillance 2011 2015 dynamic cohort ETEC incidence 150100 000 personyears PY 95 CI 141159 seasonal peak warmer months closed cohort incidence 153100 000 PY 95 CI 140 166 highest rate seen child aged 1 year 2007 95 CI 16642402 aged 14 year 314 95 CI 252386 rate rose aged 45 year 219100 000 PY 95 CI 177267 rate severe ETEC ≤35100 000 PY person aged ≤45 year 95 CI 2744 rose 82 adult aged 45 year 95 CI 58113 ETEC diarrhea major health problem young child older adults prevention vaccination improved water sanitation hygiene target age groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689249/"
    },
    {
        "pmid": "40685382",
        "title": "Healthcare seeking behavior and antibiotic use for diarrhea among children in rural Bangladesh before seeking care at a healthcare facility.",
        "abstract": "Appropriate healthcare utilization compliance treatment guideline significantly reduce diarrhearelated childhood mortality morbidity overuse antibiotic notably increase antibiotic resistance studied careseeking behavior antibiotic use childhood diarrhea analyzing data 8294 diarrheal episode 159monthold child visiting tertiarycare hospital rural Bangladesh Overall 55 study child received antibiotics 6 dysentery Notably 77 antibiotic obtained local pharmacy without prescription Antibiotics alone without zinc ORS used child dysentery watery diarrhea 15 vs 9 p  0001 85 child received ORS 7 received zinc ORS without antibiotics Children received antibiotic seeking care hospital significantly higher rate hospitalization antibiotic 20 vs 13 p  0001 factor influenced caregivers decision seek care pharmacy desire early recovery traditional practices faith seeking care pharmacies distance healthcare facility finding warrant reducing unnecessary antibiotic consumption requires increasing public awareness strengthening law sale overthecounter antibiotics",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Child, Preschool",
            "Anti-Bacterial Agents",
            "Male",
            "Female",
            "Infant",
            "Patient Acceptance of Health Care",
            "Diarrhea",
            "Rural Population"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685382/"
    },
    {
        "pmid": "40684137",
        "title": "Determinants of inequalities in health care seeking behavior for childhood illness in Bangladesh: a trend analysis.",
        "abstract": "Worldwide pneumonia diarrhea leading public health problems kill child five year age infectious disease Approximately twothirds death occur 15 developing countries including Bangladesh achieve target childhood mortality essential reduce current rate under5 mortality Bangladesh healthcare utilization childhood illness increased recent years desirable level disparity among different group remain matter concern study explores determinant contributing unequal access healthcareseeking behavior childhood illnesses namely diarrhea acute respiratory infection ARI last decade half study extracted data latest three Bangladesh Multiple Indicator Cluster Surveys 2006 201213 2019 Children younger five year diarrhea andor ARI 2 week prior survey included study prevalence association careseeking investigated chisquare test multivariate logistic model applied identify determinant unequal access healthcare services Care seeking diarrhea symptom acute respiratory infection showed downward trend 2006 201213 30 vs 185 upward trend 2012 13 2019 185 vs 746 Several socioeconomic demographic factor gender administrative division childrens age mothers education household heads education wealth ethnicity found significant association careseeking behavior child 5 Gender division age significant predictor across three study periods study identified possible determinant careseeking behavior childhood illnesses Based finding research policymakers revise existing policy increase utilization rate reduce inequality health care seeking child age 5 Specifically counseling slum resident provide provision subsidizing providing free health care benefit poorest household enhancing parents counseling remove gender bias",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Patient Acceptance of Health Care",
            "Female",
            "Male",
            "Child, Preschool",
            "Infant",
            "Respiratory Tract Infections",
            "Diarrhea",
            "Healthcare Disparities",
            "Socioeconomic Factors",
            "Health Services Accessibility",
            "Infant, Newborn",
            "Pattern Analysis, Machine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684137/"
    },
    {
        "pmid": "40673689",
        "title": "Rapid tests as a practical alternative to slide agglutination for the confirmation of <i>V. cholerae</i> O1.",
        "abstract": "Slide agglutination serogroup andor serotype identification crucial step confirming cholera culture Rapid diagnostic test RDTs typically used directly stool considered sufficient cholera confirmation However may provide practical alternative slide agglutination step cultureii easy use store require minimal training study evaluates concordance iVibrio choleraei O1O139 detection presumptive colony slide agglutination RDTs Patients ≥1 year acute watery diarrhea icddrb Dhaka hospital enrolled Stool sample cultured thiosulfatecitratebile saltssucrose medium presumptive colony subcultured Gelatin Agar medium Isolates tested slide agglutination four commercial cholera RDTs 4 February 2024 24 May 2025 1638 patient acute watery diarrhea enrolled 1140 70 presumptive iV choleraei colonies 482 29 cultureconfirmed iV choleraei O1 tested suspected iV choleraei colony using Cholkit n1140 SD Bioline n693 Crystal VC O1O139 n693 Crystal VC O1 n655 RDT kits RDTs showed nearperfect concordance slide agglutination Using slide agglutination reference sensitivity RDT kit ranged 993 996 specificity 993 997 RDTs offer practical potentially easier alternative slide agglutination presumptive iV choleraei colony within typical cholera culture protocols may help provide pathway quick confirmation outbreak setting lab facility reagent may limitedIMPORTANCEThis study demonstrated rapid diagnostic test RDTs effectively replace traditional slide agglutination method confirm suspected iVibrio choleraei colony belonging O1 serogroup responsible current seventh cholera pandemic Comparing four RDTs slide agglutination found almost perfect agreement sensitivity specificity exceeding 99 Since RDTs cheaper easier use store require less technical training adopting could significantly speed cholera outbreak confirmation especially area limited laboratory resources practical shift could lead faster response cholera outbreaks ultimately improving public health surveillance disease control globally",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40673689/"
    },
    {
        "pmid": "40670046",
        "title": "Cost of diarrhoea: a household perspective from seven countries in the Global Enteric Multicentre Study (GEMS).",
        "abstract": "burden diarrhoeal disease considerable South Asia well subSaharan Africa economic impact profound resourcelimited setting like lowincome middleincome country LMICs study aimed estimate direct indirect cost reported caregiver participant seven LMICs current study secondary analysis using data multicentre Global Enteric Multicentre Study enrolled under5 children prospective casecontrol study conducted seven sites LMICs adjustment inflation cost data collected caregiver converted international dollar I Quantile regression model developed adjusting age sex country study analysed data 4592 participants median IQR total direct cost TDC total indirect cost TIC I84 I110 I102 I143 respectively Statistically significant difference found across continent multiple variables highest median TDC TIC Bangladesh I136 I232 respectively mozambique reported lowest I04 I49 respectively medication accounting 609 TDC Quantile regression analysis showed TDC positively associated factor like family size urban residence moderatetosevere disease caregiver education use rehydration methods treated drinking water overweight status negatively associated TIC significantly associated seeking prior care indirect cost diarrhoea higher indicates impact lost productivity due disease Bolstering healthcare financing systems ensuring affordable medication using pricing regulation subsidising treatment packages promoting water sanitation hygiene WASH initiative promoting practising standard case management timely healthcareseeking reduce economic burden",
        "mesh_terms": [
            "Humans",
            "Diarrhea",
            "Male",
            "Female",
            "Case-Control Studies",
            "Prospective Studies",
            "Cost of Illness",
            "Child, Preschool",
            "Infant",
            "Caregivers",
            "Developing Countries",
            "Family Characteristics",
            "Health Care Costs"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670046/"
    },
    {
        "pmid": "40661265",
        "title": "Factors influencing post-diarrhea growth patterns among children under two years old in rural Bangladesh.",
        "abstract": "Undernutrition child major global health issue Diarrhea exacerbates undernutrition creating vicious cycle infection malnutrition longitudinal study examined growth pattern influencing factor among 138 child following diarrhea Children two seeking care watery diarrhea rural hospital Bangladesh enrolled followed three month homebased visits Anthropometric measurementslengthforage zscore LAZ weight forage zscore WAZ weightforlength zscore WLZ midupper arm circumference MUAC taken enrollment followups Linear mixedeffects model assessed association clinical sociodemographic sanitation hygiene food security factor growth outcomes Overall LAZ declined three month 0260 SD 0408 WAZ WLZ MUAC improved 0100 SD 0484 0249 SD 0725 0672 cm SD 0476 Children malnutrition enrollment strongly predicted persistent malnutrition LAZ  2 WAZ  2 WLZ   2 MUAC  125 cm followup compared new incidence malnutrition RR 38 p  0001 95 CI 180 635 Poor growth outcome linked longer diarrhea duration vomiting hospitalization Hospitalization associated decline LAZ 0095 p  0009 MUAC 0098 p  0030 Children aged 712 month greater decline WAZ  0109 p  0096 WLZ 0181 p  0113 Improved sanitation hygiene supported growth household hunger linked declines study highlight multifactorial nature postdiarrhea growth outcome emphasizes need integrated intervention addressing clinical care sanitation hygiene food security Children two year age low middleincome country highly vulnerable undernutrition especially following diarrheal illness study show growth recovery diarrhea guaranteed shaped multiple factors including childs age severity illness household sanitation hygiene practices food security Children already malnourished time illness much likely remain month later Poor hygiene practice limited access proteinrich food reduced likelihood recovery finding critical highlight need targeted followup integrated intervention support child diarrhea identifying child highest risk environmental clinical condition hinder growth study provides essential evidence guide strategy improving child nutrition health similar lowresource settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40661265/"
    },
    {
        "pmid": "40654922",
        "title": "Associations between floor material and <i>E. coli</i> contamination in rural Bangladeshi households.",
        "abstract": "Soil floor common lowincome country harbor contamination unsafely managed human animal fecal waste Soildust ingestion directly floor indirectly via hands drinking water food significantly contribute childrens ingestion fecal organisms assessed finished eg concrete floor associated lower iE colii contamination domestic environment rural Bangladesh collected sample 1864 household 35 years including stored drinking water child caregiver hand rinses courtyard soil food fly n24118 samples enumerated iE colii using IDEXX QuantiTray2000 Controlling potential confounders sociodemographics watersanitation status animal ownership household finished floor slightly lower log10transformed iE colii count Δlog10 010 020 000 prevalence prevalence ratio090 083 098 child hand household soil floors floor material associated contamination level sample types Finished floor associated lower iE colii contamination child hands food stored drinking water following period higher rainfall temperature lower iE colii contamination child hand household domestic animals Measures control enteric infection lowincome country test flooring improvement reduce exposure fecal contamination",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40654922/"
    },
    {
        "pmid": "40642564",
        "title": "Addressing the Health Risks Posed by Adenovirus: A Perspective on Strategies for Prevention and Management.",
        "abstract": "Adenovirus AdV nonenveloped virus doublestranded DNA genome infect respiratory gastrointestinal tracts well cause conjunctivitis infection influenced patients age environment temperature immunocompromised individuals Due wide range symptom diarrhea fever cough eye redness AdV virus present substantial health risk particularly child vulnerable due frequent touching mouth face Investigation epidemiology economic impact infection vital public health However lack comprehensive data underscoring importance shedding light subject HAdV Human adenovirus infection child healthy individual tend resolve without medical intervention Therefore possible prevent virus triggering severe epidemic maintaining social individual hygiene practices Considering COVID19 situation emergence another viral epidemic potential present substantial challenge healthcare system would lead increased burden general community causing distress healthrelated difficulties imperative establish enhance healthcare systems infrastructure capacity effectively manage future outbreaks Neonates immunecompromised individuals infant particularly vulnerable severe outcome virus summarize resolving issue posed viral infection necessitates comprehensive preventative method mitigate social economic consequences",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40642564/"
    },
    {
        "pmid": "40592849",
        "title": "Personalized azithromycin treatment rules for children with watery diarrhea using machine learning.",
        "abstract": "use machine learning identify innovative strategy target azithromycin child watery diarrhea likely benefit Using data randomized trial azithromycin watery diarrhea NCT03130114 develop personalized treatment rule given set diagnostic child clinical characteristics employing robust ensemble machine learningbased procedure procedure estimate childlevel expected benefit given set covariates combining prediction library statistical models rule estimate proportion treated rule average benefit treatment Among 6692 children treatment comprehensive rule recommended average one third children risk diarrhea day 3 101 lower 95 CI 54 149 azithromycin compared placebo among child recommended treatment NNT 10 day 90 rehospitalization death risk 24 lower 95 CI 06 41 NNT 42 pathogen diagnostics strong determinant azithromycin effect diarrhea duration host characteristic may better predict benefit rehospitalization death suggests targeting antibiotic treatment severe outcome among child watery diarrhea may possible without access pathogen diagnostics",
        "mesh_terms": [
            "Humans",
            "Azithromycin",
            "Machine Learning",
            "Diarrhea",
            "Anti-Bacterial Agents",
            "Child, Preschool",
            "Female",
            "Male",
            "Infant",
            "Child",
            "Precision Medicine",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40592849/"
    },
    {
        "pmid": "40589484",
        "title": "Sustainable Utilization of Agricultural By-Products: <i>in vivo</i> investigation of the antidiarrheal potential of <i>Litchi chinensis</i> seed extract.",
        "abstract": "Diarrheal disease remain significant global health concern rising resistance traditional pharmaceutical treatments iLitchi chinensisi tropical fruit known medicinal properties seed often discarded waste extensively studied potential health benefits study investigates antidiarrheal effect iL chinensisi seed extract LCSE Ethanolic extract prepared dried powdered iL chinensisi seeds Acute oral toxicity conducted administering single 2000 mgkg dose female Swiss albino mice Mice divided five group control positive control Loperamide test group receiving 100 200 400 mgkg LCSE antidiarrheal assay Diarrhea induced castor oil parameter onset diarrhea fecal output gastrointestinal motility enteropooling measured statistical analysis conducted GraphPad Prism version 1012 using oneway ANOVA followed Dunnett multiple comparison test iL chinensisi seed extract LCSE significantly p  0001 delayed onset diarrhea reduced frequency defecation decreased fecal weight castor oilinduced diarrhea model dos 100 200 400 mgkg Additionally LCSE significantly p  0001 reduced total wet fecal output inhibited gastrointestinal motility p  0001 charcoal meal test notably p  0001 decreased volume weight intestinal content enteropooling assay iin vivoi antidiarrheal index ADI showed dosedependent increase highest ADI recorded 400 mgkg 18942 slightly surpassing standard drug loperamide 16014 finding support antidiarrheal potential LCSE hold potent antidiarrheal properties positioning promising sustainable alternative modern medications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40589484/"
    },
    {
        "pmid": "40585145",
        "title": "Using machine learning to identify subgroups with the highest expected benefit in a population-based water, sanitation, handwashing, and nutrition intervention.",
        "abstract": "Understanding benefit investment water sanitation hygiene WaSH intervention elucidate causal pathways uncover complex interaction population characteristic interventions inform targeted implementation applied machine learning identify describe household child benefited WaSH nutrition interventions used causal forest baseline characteristic pregnant woman enroled trial Bangladesh 20132015 test heterogenous treatment effect primary trial outcome two year lengthforage Zscore LAZscore diarrhoea prevalence one secondary outcome child development EASQ Zscore treatmentoutcome combination split household three group based predicted treatment effect magnitude compared characteristic benefitted Tercile 3 versus least Tercile 1 Heterogeneity detected effect Sanitation EASQ Zscore compared Control child Tercile 3 estimated gain 051 SD 95 CI 035 067 whereas child Tercile 1 estimated benefit baseline household child Tercile 3 likely report chicken always entered house 85 vs 4 animal feces observed childs play area 84 vs 18 compared Tercile 1 Tercile 3 household also owned less land asset lived Dhaka population center market detect heterogeneity treatmentoutcome comparison detect heterogeneity treatment arm outcome diarrhoea LAZscore showing child background benefit effective intervention equally based household characteristics found heterogeneity effect receiving sanitation improvement child development poorer household located remote area potentially higher level animal fecal contamination highest expected benefit",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40585145/"
    },
    {
        "pmid": "40585104",
        "title": "Ranked placement of phage predation as a determinant of dehydration severity among cholera patients in Bangladesh.",
        "abstract": "Phage predation inversely associated severe cholera yet importance determinant dehydration severity unknown relative factors used machine learning assess rank potential host microbial environmental factor determinant severe dehydration among cohort cholera patient enrolled hospital admission across Bangladesh found phage pathogen ratio ranked among top classifying features placing behind patient age admission location advocate phage predation key factor include characterization cholera scientific clinical epidemiological applications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40585104/"
    },
    {
        "pmid": "40583669",
        "title": "Role of Resistive Index to Differentiate between Prerenal Acute Kidney Injury and Acute Tubular Necrosis.",
        "abstract": "Acute kidney injury AKI life threatening condition one dreadful disease broad etiological profile challenging problem community specially critically ill patient also associated high morbidity mortality Accurate rapid diagnosis cause AKI particularly important selecting appropriate therapy Measurement renal index commonly used differentiate prerenal AKI ATN often cannot used also may accurate many conditions renal biopsy gold standard invasive procedure may feasible critically ill patients Therefore cross sectional study conducted among patient AKI Department Nephrology Dhaka Medical College Hospital Bangladesh November 2017 June 2019 assess ability Resistive index RI differentiate prerenal AKI ATN Mean age 3945±1096 years male 650 Among all 190 AKI patient found sepsis followed acute watery diarrhea 175 cause hypovolemia combined hypovolemia constituted prevalent cause According renal index 470 patient prerenal AKI 530 ATN basis RI 450 patient case prerenal AKI mean RI 063±007 550 ATN Mean RI 077±071 But type AKI based clinical diagnosis considered standard 460 prerenal AKI 540 patient ATN compared clinical diagnosis RI found correlated clinical diagnosis p0001 renal indices RI 9189 sensitivity 9535 specificity differentiate prerenal AKI ATN hand renal index low sensitivity 6216 specificity 6512 Moreover statistically significant difference noted type AKI diagnosed RI renal index p005 So RI derived Doppler ultrasound superior renal index used useful differentiating tool",
        "mesh_terms": [
            "Humans",
            "Male",
            "Acute Kidney Injury",
            "Female",
            "Adult",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Kidney Tubular Necrosis, Acute",
            "Diagnosis, Differential",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583669/"
    },
    {
        "pmid": "40576353",
        "title": "The cAMP responsive element modulator (CREM) transcription factor influences susceptibility to undernutrition and infection.",
        "abstract": "previously identified genetic polymorphism associated iEntamoeba histolyticaipositive diarrhea locus containing transcription factor cAMP responsive element modulator iCREMi Genetic association testing birth cohort Bangladeshi child showed previously described single nucleotide polymorphism SNPs iCREMi locus associated iE histolyticaipositive diarrhea independently associated undernutrition 1 year age reference allele tested SNPs associated lower weightforage zscores WAZ 1 year age rs2148483 0161 reduction WAZ per allele iPi  0007 rs58000832 0203 reduction WAZ iPi  0001 Small intestinal transcriptome data Bangladeshi American child revealed differentially expressed gene DEGs enriched cAMP response elementbinding sites DEGs related mitochondrial function upregulated small intestine child rs2148483 reference allele adaptive immune response process enriched among downregulated genes Upregulation mitochondrial function mirrored plasma metabolomics profile concordant shift toward mitochondrial respiration mice global conditional deletion iCremi resulted reduced body weight downregulation gene related innate immune function upregulation metabolic gene expression intestine Tissuespecific deletion iCremi intestinal epithelial cell sufficient reduce overall body weight alter intestinal expression mitochondrialrelated metabolic gene immune gene transcription data indicate intestinal epithelial expression iCremi linked body weight plausibly regulation mitochondrial gene expression iCremi expression cell type influence immune response iE histolyticaiIMPORTANCEUndernutrition diarrheal disease leading cause global childhood morbidity mortality Undernutrition present cause consequence diarrheal diseases leading u hypothesize phenotype share common genetic basis identification cAMP responsive element modulator iCREMi transcriptional regulator influence susceptibility undernutrition diarrheal disease child growing impoverished Bangladeshi community advance understanding interaction two major cause childhood illness offer potential therapy targeted cAMPregulated transcription factor iCREMi",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40576353/"
    },
    {
        "pmid": "40576116",
        "title": "Determinants of post-discharge stunting among diarrhoeal children aged 2-23 months in Bangladesh: findings from Antibiotics for Children with Severe Diarrhea (ABCD) trial.",
        "abstract": "Despite global burden stunting data regarding determinant stunting observed followup discharge health care facility among child treated severe diarrhoea limited investigated factor influencing stunting postdischarge followup among under2 child treated severe diarrhoea developed predictive model estimate stunting prevalence identify risk factor without postdischarge anthropometry analysed data two site Bangladesh participating multicountry doubleblind randomised clinical trial Antibiotics Children Severe Diarrhoea among child aged 223 months 2017 2019 Severe diarrhoea defined child acute diarrhoea severesome dehydration moderate wasting severe stunting admission Multiple linear regression constructed predict independent factor associated stunting among enrolled child followed 180 day hospital discharge developed predictive model stunting using 75 available data training remaining 25 reserved test set evaluate model performance applied predictive model child enrolled trial admitted hospital diarrhoea estimate predictive prevalence determinant postdischarge stunting 180 days 1431 enrolled children 589 412 stunted enrolment day 180 stunting increased 698 493 Linear growth diarrhoeal child followup period positively associated enrolment lengthforage z score LAZ maternal body mass index BMI maternal education duration diarrhoea breastfeeding applied predictive model developed enrolled patients data 33 341 child admitted diarrhoea enrolled trial model estimated 6142 child 184 nonfollowup group would stunted 180 days Persistent stunting 180 day notfollowed child predicted positively associated dehydration admission higher number child household negative association predicted formal parental education increased maternal BMI study highlight need targeted intervention mitigate persistent stunting vulnerable group recovering diarrhoea",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Infant",
            "Growth Disorders",
            "Female",
            "Male",
            "Anti-Bacterial Agents",
            "Diarrhea",
            "Risk Factors",
            "Prevalence",
            "Double-Blind Method",
            "Patient Discharge"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40576116/"
    },
    {
        "pmid": "40561131",
        "title": "Use of minimally invasive tissue sampling to determine the contribution of diarrheal diseases to under-five mortality and associated co-morbidities and co-infections in children with fatal diarrheal diseases in Africa and Bangladesh.",
        "abstract": "Achieving Sustainable Development Goal reducing child mortality 25 death per 1000 live birth 2030 requires strategy prevent diarrheal diseaserelated morbidity mortality Accurate etiological diagnosis essential study used postmortem diagnostics investigate contribution diarrhea under5 mortality examine comorbidities coinfections Africa South Asia Child Health Mortality Prevention Surveillance CHAMPS generates data child death minimally invasive tissue sampling clinical record review verbal autopsies Multidisciplinary panel assign causes death using International Classification Diseases analysis included death among child aged 159 month enrolled 18 December 201631 December 2023 across six African site Ethiopia Mali Kenya Sierra Leone Mozambique South Africa Bangladesh 1517 death assessed diarrhea causal pathway 240 158 proportion diarrhearelated death highest Ethiopia 410 3483 followed Bangladesh 300 310 Mozambique 217 56258 Mali 175 18103 Kenya 139 51366 Sierra Leone 128 46358 South Africa 94 32339 Diarrhea underlying cause 442 106240 case immediateantecedent cause 583 140240 death involving multiple role causal chain diarrhea underlying cause sepsis 330 lower respiratory infection 255 common downstream conditions antecedentimmediate cause leading underlying cause malnutrition 643 HIV 136 pathogen identified 496 119240 diarrhearelated deaths among these diarrhea underlying cause 429 Among 121 pathogenattributed deaths frequent EAEC 347 typical EPEC 157 ShigellaEIEC 140 STETEC 124 rotavirus 264 adenovirus non4041 190 4041 50 pathogen frequently identified coinfections Diarrheal disease accounted substantial share child death across CHAMPS sites Reducing mortality require preventing diarrhea addressing key contributor malnutrition HIV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40561131/"
    },
    {
        "pmid": "40505670",
        "title": "Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.",
        "abstract": "Replacing oral polio vaccine inactivated polio vaccine IPVs necessary stop potential transmission vaccinederived polio viruses aimed compare safety immunogenicity dosesparing IPV dsIPV fulldose IPV infant Bangladesh doubleblind randomised controlled phase 3 study done two field site Bangladesh Kamlapur Matlab Eligible participant healthy infant aged 68 weeks parent intended reside area study period Participants randomly assigned 1111 receive either dsIPV one three lot lot A B C Serum Institute India Pune India IPV Serum Institute India Three intramuscular dos 0·5 mL administered age 6 10 14 week addition standard vaccines study staff involved safety evaluation study procedures parent participants laboratory personnel masked treatment allocations primary endpoint seroconversion poliovirus type 1 2 3 28 day third dose assessed perprotocol full analysis populations Solicited adverse event collected 4 day vaccine dose unsolicited adverse event serious adverse event collected 28 day third dose study registered ClinicalTrialsgov NCT05163561 complete Jan 9 2022 April 29 2023 1072 eligible participant randomly assigned receive dsIPV n801 IPV n267 1052 completed study 755 96 95 CI 94 97 786 participant dsIPV group versus 256 97 94 98 265 participant IPV group seroconversion poliovirus type 1 difference 0·55 95 CI 3·05 1·95 744 95 93 96 786 participant dsIPV group versus 261 98 96 100 265 participant IPV group seroconversion poliovirus type 2 difference 3·83 6·48 1·19 765 97 96 98 786 participant dsIPV group versus 260 98 96 99 265 participant IPV group seroconversion poliovirus type 3 difference 0·78 2·73 1·16 Solicited event observed 446 56 801 participant dsIPV group 143 54 267 participant IPV group Unsolicited event observed 746 93 801 participant dsIPV group 250 94 267 participant IPV group Serious adverse event observed 23 3 801 participant dsIPV group five 2 267 participant IPV group common serious adverse event pneumonia n10 dsIPV group n3 IPV group bronchiolitis n3 dsIPV group n1 IPV group diarrhoea n3 dsIPV group n1 IPV group None unsolicited event serious adverse event causally related study vaccines Delivery three intramuscular dos novel dsIPV vaccine safe immunologically noninferior delivery three intramuscular dos IPV dose sparing formulation might therefore become attractive option national immunisation programme due lower expected vaccine costs Serum Institute India",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40505670/"
    },
    {
        "pmid": "40504602",
        "title": "Deep Tubewell Use and Child Diarrhea in Rural Bangladesh: Results from a Prospective Community Surveillance Study.",
        "abstract": "Diarrheal disease remain leading cause mortality morbidity among underfive child South Asia rural Bangladesh deep tubewells tap lowarsenic deep aquifer installed provide microbially safe arsenicfree drinkingwater source However unlike widely used shallow tubewells deep tubwells sparsely distributed household often travel farther drinkingwater consumption wells Hence benefit deep tubewells may abated higher level microbial contamination water handling storage could increase risk diarrheal diseases examined association deep tubewell use diarrheal disease risk underfive child investigated role social environmental factor modifying association implemented community diarrheal disease surveillance across household underfive child using deep shallow tubewells Matlab Bangladesh March 2018 October 2019 used Generalized Estimating Equations GEE measure association deep tubewell use compared shallow tubewell use diarrheal disease prevalence Children household using deep tubewells diarrheal disease prevalence 083 time child household using shallow tubewells 95 Confidence interval CI 071096 Protective effect deep tubewell use diarrhea risk observed among child household drank well within household compound Risk ratio RR 070 95 CI 054091 floodprone area RR083 95 CI 075092 used unimproved latrine RR062 95 CI 043089 Deep tubewell use protective diarrhea shallow tubewell use dry season RR  071 95 CI 052097 Despite concerns using deep tubewells may translate higher diarrhea risk among underfive children may reduce diarrhea especially social environmental context associated higher groundwater microbial contamination httpsdoiorg101289EHP15725",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40504602/"
    },
    {
        "pmid": "40488529",
        "title": "Decrease in Incidence of Diarrhea Due to Cryptosporidium in Bangladeshi Children Is Associated With an Increase in Anti-Cryptosporidium Antibody Avidity.",
        "abstract": "Cryptosporidium cause diarrhea morbidity mortality infant low middleincome countries cohort child followed longitudinally hightransmissionintensity community Bangladesh Diarrhea attributed Cryptosporidium cryptosporidiosis decreased peak 019 episode per child 12 year 005 episode per child 34 year age P  0064 Notably decrease cryptosporidiosis accompanied decline subclinical infections Using episodebased analysis confirmed parasite burden declined repeated infection P  0001 mixedeffects model included data infection frequencies Cq value first fourth infection last reinfection 10 cases Cq 2865 ± 5533 versus 3242 ± 4046 also decrease time required clear parasitic infection longer infection 1 month occurred 43 first infection compared 24 fourth infection P  00017 mixedeffects model avidity antiCp23 antiCp17 plasma IgG increased older child fewer diarrheal infection ratio avidity index first infection versus older repeatedly infected children 181 ± 102 antiCp23 IgG P  0001 114 ± 035 antiCp17 IgG P  0056 result consistent development antiCryptosporidium adaptive immune response repeated infection average number previous infection 4 years 242 ± 124 characterized increase antiCryptosporidium antibody avidity associated decrease cryptosporidiosis subclinical Cryptosporidium infections Clinical Trials Registration NCT02764918",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40488529/"
    },
    {
        "pmid": "40487607",
        "title": "Effect of beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review and meta-analysis.",
        "abstract": "Beinaglutide shortacting glucagonlike polypeptide1 receptor agonist shown variable efficacy weight reduction metabolic control randomized controlled trial RCTs summarize therapeutic effect beinaglutide patient overweightobesity withwithout type 2 diabetes RCTs involving patient receiving beinaglutide intervention arm placebo active comparator control arm searched multiple electronic databases change baseline body weight primary outcome secondary outcome included change body mass index BMI waist circumference WC blood pressure glycemic parameters lipids adverse event AEs RevMan web used conduct metaanalysis using randomeffects models Outcomes presented mean difference MDs odds ratio ORs risk ratio RRs 95 confidence interval 95CIs Six RCTs ini  800 mostly concern risk bias included 1224 weeks beinaglutide 0102 mg thrice daily superior control group reducing total MD  325 kg 95CI 452 198 iIi sup2sup  84 iPi  000001 percent MD  413 95CI 487 339 iIi sup2sup  54 iPi  000001 body weight reduction Beinaglutide also outperformed control group achieving weight loss 5 OR 461 10 OR  534 superiority beinaglutide ivsi control group also found reducing BMI MD  122 kgmsup2sup 95CI 167 077 WC MD  247 cm 95CI 374 119 Beinaglutide control group comparable impact blood pressure glycemic parameters insulin resistance hepatic transaminases lipid profile Beinaglutide posed higher risk treatment discontinuation due AEs RR  315 nausea RR  451 vomiting RR  819 palpitation RR  395 headache RR  287 dizziness RR  607 control However two group identical risk total serious AEs diarrhea fatigue hypoglycemia Shortterm data RCTs suggested beinaglutide cause modest benefit reducing body weight BMI WC significant difference glycemic metabolic endpoint compared control arm Safety data consistent drug glucagonlike polypeptide1 receptor agonist class Larger RCTs warranted prove longerterm metabolic benefit beinaglutide",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40487607/"
    },
    {
        "pmid": "40484924",
        "title": "Assessment of water, sanitation and hygiene services within nineteen Rohingya camps in Cox's Bazar, Bangladesh in 2022.",
        "abstract": "Since August 2017 approximately 960000 Rohingya refugee settled Coxs Bazar Bangladesh Water sanitation hygiene WASH infrastructure program implemented across camp address need population reduce burden linked infectious diseases However monitoring maintenance infrastructure inconsistent study aimed assess progress WASH camp Coxs Bazar since early emergency phase 2018 update priority intervention January March 2022 lot quality assurance sampling LQAS survey conducted across 19 camps Nineteen household randomly selected per camp Data access quality WASH services household practices health outcome including skin infection among child five year age collected Crude weighted average 95 confidence interval calculated indicator compared target predefined based Sphere guideline Médecins Sans Frontières WASH experts Chisquared test used compare result 2018 LQAS survey half indicator 59 1627 meet predetermined targets Performance adequate three five water quality supply indicators less half household 44 95 CI 3949 reporting water continuously available past week Regarding water storage performance three indicator considered adequate proportion household keep water less one day 27 95 CI 2332 six hygiene indicators adequate performance identified one Performance sanitation indicator inadequate 11 95 CI 815 household using improved sanitation facility solid waste management two four indicator suggested adequate performance health outcomes proportion child shown skin infection inadequate 69 95 CI 6473 Improvements WASH situation Coxs Bazar observed 2022 compared 2018 However significant gap remain water supply sanitation facilities hygiene services LQAS effective monitoring tool support longterm multisectoral intervention protracted emergencies",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Sanitation",
            "Hygiene",
            "Water Supply",
            "Refugee Camps",
            "Refugees",
            "Child, Preschool",
            "Female",
            "Infant",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40484924/"
    },
    {
        "pmid": "40481472",
        "title": "High indoor temperatures increase reporting of acute symptoms: finding mitigating solutions for the climate-vulnerable of Bangladesh.",
        "abstract": "Bangladesh already prone extreme weather event like heatwaves leaving million vulnerable High ambient temperature associated increased morbidity mortality infectious diseases effect high temperature indoors remains studied study investigated effect high indoor temperature feeling illness heat coping mechanism vulnerable population without heat mitigation crosssectional survey conducted 490 house rural village coastal area Chakaria Bangladesh chosen stratified cluster sampling assessed feeling illness adaptative behaviour high temperatures 49 temperature humidity monitor placed indoors obtain accurate measurement parameter different area different house materials information used determine effect high indoor temperature symptom vulnerable population reported People living hotter house reported overall symptoms notably diarrhoea local site infection sore throat Temperatures higher house made bamboo compared cement shade significantly decreased indoor temperature woman study reported performing adequate heat coping mechanisms However show protective effect illness paper showed high indoor temperature could associated increase symptoms Housing characteristic material environment decreased indoor temperature shading house made cement protective reporting symptoms study compliance coping behaviour needed assess potential protective effect",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Cross-Sectional Studies",
            "Male",
            "Adult",
            "Hot Temperature",
            "Housing",
            "Middle Aged",
            "Young Adult",
            "Vulnerable Populations",
            "Adolescent",
            "Rural Population",
            "Humidity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40481472/"
    },
    {
        "pmid": "40463539",
        "title": "Cholera rapid diagnostic tests at the host-microbe interface: Key Considerations for Global Deployments.",
        "abstract": "Effective cholera outbreak response requires accurate bedside rapid diagnostic test RDTs access laboratory often limited Formative study suggest cholera diagnostics multiple vulnerabilities including antibiotic predation bacteriophage phage specific iVibrio choleraei iVci conducted prospective nationwide study Bangladesh among 2000 patient diarrhoeal disease characterize vulnerability impact RDT performance Assays included culture qPCR mass spectrometry current gold standard culture qPCR iVci positivity found effect phage RDT performance diagnostic criterion expanded include phage small decrease RDT sensitivity contrast large increase sensitivity specificity observed among patient moderate severe dehydration Using expanded definition odds RDT positivity decreased among cholera patient phage exposure effect robust among patient severe dehydration Antibiotic detected 80 sample LCMSMS limited testing effect RDTs Applying findings estimated restricting RDT use severe patient reported antibiotic exposure increase sensitivity 50 compared unrestricted use phage diagnostic proxy iVci estimate RDT would miss additional 17 cholera cases Cholera RDTs critical limitation require consideration global deployments Inclusion phage detection diagnostic criterion may improve case detection requires study impact finding likely extends disease diagnostics share similar vulnerabilities",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463539/"
    },
    {
        "pmid": "40463439",
        "title": "Azithromycin treatment response as a probe to attribute bacterial etiologies of diarrhea using molecular diagnostics: a reanalysis of the Antibiotics for Children with Severe Diarrhea (ABCD) trial.",
        "abstract": "Multipathogen molecular diagnostics enhance understanding pathogenspecific burden diarrhea However attributing etiology remains challenging highburden setting coinfections common Antibiotics Children severe Diarrhea ABCD trial provides unique opportunity leverage azithromycin treatment response identify bacterial diarrhea analyzed data 6692 child watery diarrhea enrolled ABCD 2017 2019 randomized receive azithromycin placebo modelled heterogeneity azithromycin treatment response enteric pathogen quantity detected quantitative PCR using logbinomial regression Azithromycin treatment response varied pathogen quantity strongest effect observed iShigellai log₁₀ increase iShigellai quantity associated 13 reduction 95 CI 323 diarrhea risk day 3 azithromycin group compared placebo observed similar though nonsignificant trend iVibrio choleraei STETEC tEPEC contrast association found pathogen quantity azithromycin response iCampylobacteri LTETEC EAEC pattern remained consistent evaluating hospitalization death risk within 90 days observed association azithromycin treatment response pathogen quantity iShigellai iVibrio choleraei STETEC tEPEC support prior evidence pathogen likely cause diarrhea present high quantities Conversely absence similar response pattern iCampylobacteri LTETEC EAEC consistent largescale study showing limited association quantity diarrhea",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463439/"
    },
    {
        "pmid": "40460157",
        "title": "Maternal perception, barriers, and facilitators regarding oral rehydration salt solution in diarrhoeal disease: A qualitative study in Bangladesh.",
        "abstract": "Although oral rehydration salt ORS solution lifesaving management diarrhoea exertion still surprisingly low among caregivers mother considered primary caregivers bear responsibility administering medication children aimed evaluate maternal perception along barrier facilitator play affecting ORS administration among child Bangladesh study conducted Dhaka Hospital International Centre Diarrhoeal Diseases Research Bangladesh qualitative approach Indepth Interviews IDIs conducted thirtyone mother under5 child reporting hospital February April 2024 Qualitative content analysis method used describe analyse transcribed data mother held several misconception regarding administration ORS Majority participant thought child could receive ORS breastmilk interesting finding Along this mother also lacked proper understanding regarding ORS preparation storage use key barrier lack proper knowledge motivation compliance along misdirection elder pharmacy drug sellers Additional key facilitator ORS use trust towards doctors positive attitude towards learning ORS community education instruction written packet support healthcare providers focused approach implemented educate mother correct preparation administration ORS children also addressing dispelling misconceptions",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Mothers",
            "Female",
            "Diarrhea",
            "Fluid Therapy",
            "Health Knowledge, Attitudes, Practice",
            "Adult",
            "Rehydration Solutions",
            "Qualitative Research",
            "Infant",
            "Child, Preschool",
            "Male",
            "Caregivers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40460157/"
    },
    {
        "pmid": "40424267",
        "title": "Methanolic crude extract of Litsea Monopetala leaves combats oxidative stress, clot formation, inflammation and stool frequency in animal model.",
        "abstract": "Litsea monopetala LM leaf used traditional medicine system South Asian region treating ailment digestive issues respiratory problem skin disorders study investigated possible antioxidant thrombolytic analgesic antidiarrheal property methanolic extract LM leaves assessed antioxidant activity using DPPH 22diphenyl1picrylhydrazyl free radical scavenging total phenolic content tests thrombolytic activity evaluated clot lysis assays invivo analgesic antidiarrheal activity tested two standard methods eg acetic acidinduced castor oilinduced animal model respectively Prior vivo vitro evaluation pharmacological activity phytochemical screening also performed estimate bioactive compound eg phenol carbohydrates reducing sugars tannins alkaloids flavonoids saponin steroids present Among tested phytochemicals result reveal carbohydrates alkaloids flavonoid tannin major phytocompounds present extract Within different solvent extractives methanolic extract exhibited DPPH free radical scavenging feature IC50 899 µgml compared ascorbic acid IC50 1338 µgml 500 mgkg dose extract produced 6705 decrease frequency acetic acidinduced writhing diclofenac sodium showed decrease 7425 extract also significantly P  001 decreased frequency castor oilinduced diarrhea compared standard drug loperamide Finally clot lysis assay methanolic extract demonstrated increase thrombolytic activity 4079 compared streptokinase increased 6952 Overall study show promise methanolic crude extract LM leaf may contribute alternative additive strategy modulate condition oxidative stress thrombolytic inflammation diarrhea comprehensive investigation necessary clarify exact mechanism action phytochemical composition LM leaves",
        "mesh_terms": [
            "Animals",
            "Plant Extracts",
            "Plant Leaves",
            "Methanol",
            "Oxidative Stress",
            "Litsea",
            "Antioxidants",
            "Male",
            "Mice",
            "Inflammation",
            "Disease Models, Animal",
            "Rats",
            "Blood Coagulation",
            "Antidiarrheals",
            "Analgesics",
            "Phenols"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40424267/"
    },
    {
        "pmid": "40404808",
        "title": "Spatial variations and determinants of vitamin A and iron rich food consumption among Bangladeshi children aged 6-23 months.",
        "abstract": "Consuming food high vitamin iron crucial childrens growth wellbeing However deficiency remain public health problem Bangladesh study explores spatial variation determinant vitamin ironrich food consumption among child aged 623 months study data 2528 child Bangladesh Demographic Health Survey BDHS 2022 used BDHS 2022 employed crosssectional study design collect data outcome measured vitamin ironrich food consumption within 24 h preceding survey including factor mothers age education occupation child age sex Antenatal care ANC visits medical illness diarrhea fever cough use deworming drugs wealth index place residence division etc Spatial pattern analyzed ArcGIS version 108 associated factor assessed using multilevel mixed effect logistic regression model prevalence vitamin ironrich food consumption 72 95 CI 070074 618 95 CI 060064 respectively Clustering vitamin Morans I 0055 p  0001 ironrich food I 0101 p  0001 consumption observed hot spot Rangpur Rajshahi Khulna mixed effect logistic regression analysis maternal employment aOR  16 95 CI 1220 maternal education aOR  20 95 CI 1135 paternal education aOR  20 95 CI 1430 ≥ 4 ANC visit aOR  17 95 CI 1126 older child aged 1823 month aOR  40 95 CI 3053 deworming drug aOR  16 95 CI 1222 residing Khulna aOR  23 95 CI 1535 Rajshahi aOR  19 95 CI 1229 shown statistically significant association increased consumption vitamin ironrich foods Furthermore lower likelihood ironrich food consumption observed among child diarrhea aOR  07 95 CI 0509 compared child diarrhea Poor consumption vitamin Arich food found Chittagong aOR  06 95 CI 04098 Sylhet aOR  06 95 CI 0409 finding revealed significant disparity region protective factor associated vitamin ironrich food intake among child Bangladesh Understanding spatial variation key determinant guide targeted interventions particularly cold spot regions improve child nutrition Bangladesh",
        "mesh_terms": [
            "Humans",
            "Vitamin A",
            "Infant",
            "Bangladesh",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Iron",
            "Diet",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40404808/"
    },
    {
        "pmid": "40403455",
        "title": "Integrating wastewater surveillance and meteorological data to monitor seasonal variability of enteric and respiratory pathogens for infectious disease control in Dhaka city.",
        "abstract": "Seasonal meteorological variation influence spread infectious diseases Wastewater surveillance help understanding pathogen transmission dynamics particularly urban area climatevulnerable country like Bangladesh analysed 54 week wastewater surveillance clinical surveillance meteorological data Dhaka Bangladesh Samples 11 site tested Vibrio cholerae V cholerae SARSCoV2 Salmonella enterica subspecies enterica serovar Typhi S Typhi Group rotavirus Diarrhoeal Disease Surveillance data sourced icddrb meteorological data Bangladesh Meteorological Department Regression model adjusted site time variation used statistical analysis Proportion confirmed cholera case among diarrhoeal disease surveillance recruit highest postmonsoon coef 253 95  CI 041 467 p  0029 V cholerae log10 concentration wastewater positively associated premonsoon coef 093 95  CI 026 158 p  0010 SARSCoV2 peaked monsoon coef 185 95  CI 096 273 p  0001 S Typhi rotavirus log10 concentration showed negative association premonsoon coef 096 95  CI 168 027 p  0011 084 95  CI 117 050 p  0001 respectively Temperature positively influenced log10 concentration V cholerae adj coef 009 95  CI 002 015 p  0014 SARSCoV2 adj coef 019 95  CI 010 027 p  0001 negatively associated rotavirus adj coef 006 95  CI 010 003 p  0001 Similar association found pathogenpositive sample temperature study show seasonal meteorological factor particularly temperature influence pattern abundance pathogen wastewater help understanding disease transmission across different weather patterns",
        "mesh_terms": [
            "Bangladesh",
            "Seasons",
            "Wastewater",
            "Humans",
            "SARS-CoV-2",
            "Vibrio cholerae",
            "COVID-19",
            "Rotavirus",
            "Salmonella typhi",
            "Cholera",
            "Cities",
            "Communicable Disease Control",
            "Diarrhea",
            "Meteorological Concepts"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40403455/"
    },
    {
        "pmid": "40388464",
        "title": "Dysmagnesemia in critically ill diarrheal patients in Bangladesh.",
        "abstract": "Despite pivotal role numerous physiologic functions magnesium disorder rarely considered clinical practice study aimed explore burden predictors outcome associated magnesium imbalance among critically ill patient admitted critical care setting diarrheal disease retrospective chart analysis done among critically ill patient diarrhea aged 18 year admitted Intensive Care Unit ICU specialized hospital serum magnesium measured Data extracted electronic health record system Serum magnesium level measured upon ICU admission Multivariate multinomial logistic regression analysis done find association clinical variables higher incidence hypomagnesemia 34 hypermagnesia 59 multivariate analysis independent association hypomagnesemia sepsis mOR625 95 CI 361 1081 p  0001 HO regular medicine intake prior admission mOR194 95 CI 118 318 p  001 hand hypermagnesemia independently associated dehydration mOR478 p  0003 95 CI 16 143 Comparing electrolyte disorders hypocalcemia p  0001 associated hypomagnesemia Hypermagnesemia associated hypochloremia p  0017 metabolic acidosis p  0014 hypercalcemia p  0002 high occurrence dysmagnesemia study highlight need closely monitor magnesium critically ill ICU patients particularly resource limited settings could help prevent serious complication related magnesium imbalances Intensivists remain alert magnesium disturbance conduct thorough patient evaluations",
        "mesh_terms": [
            "Humans",
            "Critical Illness",
            "Male",
            "Female",
            "Magnesium",
            "Diarrhea",
            "Middle Aged",
            "Retrospective Studies",
            "Bangladesh",
            "Adult",
            "Intensive Care Units",
            "Aged",
            "Sepsis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40388464/"
    },
    {
        "pmid": "40359931",
        "title": "Clinico-Epidemiological Characteristics of Symptomatic and Asymptomatic Enterotoxigenic and Enteropathogenic Escherichia Coli Diarrhea and Impact on Child Growth.",
        "abstract": "Enterotoxigenic Escherichia E coli ETEC enteropathogenic E coli EPEC major bacterial cause childhood diarrhea explored clinicoepidemiological characteristic child aged 5 year associated moderatetosevere diarrhea MSD asymptomatic ETEC EPEC infections subsequent impact growth reflected zscore Data 9439 MSD 13128 asymptomatic child extracted Global Enteric Multicenter Study conducted 2007 2011 Epidemiological risk factor clinical characteristic ETEC EPEC infection explored using multivariable logistic regression paired ttest used investigate impact infection nutritional status Children aged 1223 month affected ETECpositive MSD compared 011 months whereas child aged 011 month vulnerable EPECpositive MSD ETEC EPECpositive MSD child showed characteristic clinical dehydration like sunken eye loss skin turgor preservation needed intravenous rehydration ETEC EPECnegative MSD children Among identified copathogen presence Campylobacter analyzed stool sample higher likelihood associated symptomatic MSD adjusted odds ratio aOR 142 95 CI 117171 asymptomatic child ETEC infection aOR 142 95 CI 116173 asymptomatic EPEC infection aOR 122 95 CI 104143 Significant growth faltering noted MSD child ETEC mean difference 022 95 CI 010034 EPEC mean difference 015 95 CI 003027 baseline ∼60 day 5090 days finding highlight need implement preventative strategy reduce risk diarrheal illnesses",
        "mesh_terms": [
            "Child, Preschool",
            "Female",
            "Humans",
            "Infant",
            "Infant, Newborn",
            "Male",
            "Diarrhea",
            "Enteropathogenic Escherichia coli",
            "Enterotoxigenic Escherichia coli",
            "Escherichia coli Infections",
            "Risk Factors",
            "Asymptomatic Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40359931/"
    },
    {
        "pmid": "40327713",
        "title": "Comparing the predictive discrimination of machine learning models for ordinal outcomes: A case study of dehydration prediction in patients with acute diarrhea.",
        "abstract": "Many comparison statistical regression machine learning algorithm build clinical predictive model use inadequate method build regression model proper independent test set externally validate models Proper comparison model ordinal categorical outcome exist set compare model discrimination four regression machine learning method case study predicting ordinal outcome severe some dehydration among patient acute diarrhea presenting large medical center Bangladesh using data NIRUDAK study derivation validation cohorts Proportional Odds Logistic Regression POLR penalized ordinal regression RIDGE classification tree CART random forest RF model built predict dehydration severity compared using three ordinal discrimination indices ordinal cindex ORC generalized cindex GC average dichotomous cindex ADC Performance evaluated model developed training data model applied external test set internal validation three bootstrap algorithm correct overoptimism RF superior discrimination original training data set performance similar three method internal validation using bootstrap Performance model lower prospective test dataset particularly large reduction RF RIDGE POLR best performance test dataset also efficient smallest final model size Clinical prediction model ordinal outcomes like binary continuous outcomes need prospectively validated external test set possible internal validation may give optimistic picture model performance Regression method perform well automated machine learning method constructed attention potential nonlinear associations regression model often interpretable clinically use encouraged",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40327713/"
    },
    {
        "pmid": "40321784",
        "title": "Healthcare seeking behavior and antibiotic use for diarrhea among children in rural Bangladesh before seeking care at a healthcare facility.",
        "abstract": "Appropriate healthcare utilization compliance treatment guideline significantly reduce diarrhearelated childhood mortality morbidity overuse antibiotic notably increase antibiotic resistance studied careseeking behavior antibiotic use childhood diarrhea analyzing data 8294 diarrheal episode 159monthold child visiting tertiarycare hospital rural Bangladesh Overall 55 study child received antibiotics 6 dysentery Notably 77 antibiotic obtained local pharmacy without prescription Antibiotics alone without zinc ORS used child dysentery watery diarrhea 15 vs 9 p0001 85 child received ORS 7 received zinc ORS without antibiotics Children received antibiotic seeking care hospital significantly higher rate hospitalization antibiotic 20 v 13 p0001 factor influenced caregivers decision seek care pharmacy desire early recovery traditional practices faith seeking care pharmacies distance healthcare facility finding warrant reducing unnecessary antibiotic consumption requires increasing public awareness strengthening law sale overthecounter antibiotics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40321784/"
    },
    {
        "pmid": "40303190",
        "title": "Isolation and Genomic Characterization of the G6P[1]-Type Sheep Rotavirus in China.",
        "abstract": "Rotavirus RVA prevalent cause enteric diarrhea infants bovine pigs sheep globally Currently G6P1type rotavirus prevalent sheep goat Bangladesh Turkey Uganda However genotype reported Chinese sheep goat Therefore 12 anal swab collected diarrheal sheep Gansu Province China 2023 tested rotavirus using reverse transcriptionpolymerase chain reaction RTPCR Pathological section immunohistochemistry used observe pathological change rotavirus antigen duodenum respectively sheep rotavirus isolated MA104 cell characterized indirect immunofluorescence transmission electron microscopy gene strain obtained using nextgeneration sequencing technology analyzed phylogenetically One sheep positive rotavirus RTPCR immunohistochemistry revealed numerous rotavirus antigen apical portion duodenal villi Transmission electron microscopy revealed strain characterized virus particle wheelshaped measured 7080 nm size gene constellation strain G6P1I2R2C2M2A11N2T6E2H3 BLASTn phylogenetic tree analysis suggest strain likely recombinant human rotavirus goat rotavirus bovine rotavirus comparison amino acid similarity revealed three difference key antigenic epitope VP7 VP4 protein GO34 strain study strain despite identical gene constellation two strains date first report constellation RVA found sheep",
        "mesh_terms": [
            "Animals",
            "Rotavirus",
            "Sheep",
            "Rotavirus Infections",
            "China",
            "Sheep Diseases",
            "Phylogeny",
            "Genome, Viral",
            "Genotype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303190/"
    },
    {
        "pmid": "40300760",
        "title": "Uncovering the Efficacy of Cinnamomum tamala Leaf Extract Against Paracetamol-Induced Hepatotoxicity in Swiss Albino Mice.",
        "abstract": "Cinnamomum tamala belongs Lauraceae family diverse traditional pharmacological role treating toothache diarrhea gastrointestinal disorders vomiting fever diabetes hyperlipidemia others research aim evaluate protective effect paracetamolinduced hepatotoxicity mice this ethanolic leaf extract C tamala ECT different dos administered via oral gavage without standard hepatoprotective drug silymarin liver biochemical histopathological profile checked Gas chromatographymass spectrometry GCMS analysis molecular docking study performed check possible molecular mechanism behind hepatoprotective effect Results suggest ECT significantly enhances antioxidant capability lower animal Nacetylpbenzoquinone imine metabolites histopathological slide showed minimum inflammation inflammatory cell infiltrations vascular edematous congestion ECT individual coadministration groups Computational drug discovery approach validated results identified compound GCMS study subjected molecular docking top docking score found CYP2E1 protein molecular dynamic simulation 13dioxolane 2pentadecyl butyl 14methylhexadecanoate showed root mean square deviation rootmeansquare fluctuation value silymarin conclusion ECT key compounds butyl 14methylhexadecanoate CID 91693030 13dioxolane 2pentadecyl CID 552019 may potentially act paracetamolinduced hepatotoxicity animals",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40300760/"
    },
    {
        "pmid": "40297736",
        "title": "Phytochemical Isolation and Antimicrobial, Thrombolytic, Anti-inflammatory, Analgesic, and Antidiarrheal Activities from the Shell of Commonly Available <i>Citrus reticulata</i> Blanco: Multifaceted Role of Polymethoxyflavones.",
        "abstract": "Fruit waste becoming popular treasure drug discovery different class therapeutics research aimed investigate phytochemical potential bioactivities antimicrobial thrombolytic antiinflammatory analgesic antidiarrheal property commonly available mandarin orange iCitrus reticulatai Blanco peel experimental computational techniques Extensive chromatographic sup1supHNMR spectroscopic analysis employed isolate four purified compounds characterized tangeretin A nobiletin B limonin C βsitosterol D Furthermore GCMSMS analysis detected 90 compound notable number polymethoxyflavones including nobiletin 2904 tangeretin 1555 artemetin 81 6demethoxytangeretin 128 sinensetin 095 demethylnobiletin 014 pebrellin 010 salvigenin 004 Dichloromethane soluble fraction DCMSF exerted highest antimicrobial potency iCandia albicansi 20 mm zone inhibition disk diffusion assay method aqueous soluble fraction AQSF exhibited 3471 4814 inhibition hypotonic solutioninduced heatinduced hemolysis membrane stabilizing assay Similarly AQSF exhibited highest antithrombotic property 3257 clot lysis investigated 3 dos methanolic extract 100 200 400 mgkg body weight exerted statistically significant iin vivoi central analgesic effect tailflicking method timedependent manner Moreover dos exhibited significant efficacy inhibiting acetic acidinduced abdominal writhing castor oilinduced diarrheal episode mouse models molecular docking study corroborated existing vitro vivo finding demonstrating better comparable binding affinity toward respective receptor favorable pharmacokinetic property toxicological profiles present finding indicate iC reticulatai rich source polymethoxyflavones demonstrating potential efficacy microbial infections thrombosis inflammation pain diarrhea Nonetheless comprehensive phytochemical screening imperative identify additional bioactive compound evaluate pharmacological effect several chronic health conditions grounded traditional us current evidence",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40297736/"
    },
    {
        "pmid": "40292056",
        "title": "Anticancer effect of <i>Phyllanthus reticulatus</i> methanolic leaf extract on HCT-116 colon cancer cell line using GC-MS and FTIR analysis.",
        "abstract": "iPhyllanthus reticulatusi plant specie belonging family Euphorbiaceae plant native tropical area India Bangladesh China Malay Islands plant known medicinal property traditionally used diuretic cooling medicine remedy spongy bleeding gums Literature revealed plants hepatoprotective hypolipidemic antinociceptive analgesic antiinflammatory antimalarial cytotoxic antimicrobial anticancer properties plant specie significant medicinal potential leaf studied potential therapeutic application managing diabetes diarrhea study highlight chemical profile iP reticulatusi methanolic leaf extract phytochemical GCMS analysis revealing nine major peak active chemical components FTIR analysis showed presence six biologically active functional groups methanolic leaf extract showed existence 9344 mgg significant amount phenolic content 5535 mgg flavonoid content elemental concentration plant leaf revealed presence 12 elements DPPH PM assay showed antioxidant property leaf extract evidenced anticancer property leaf extract 2856  cell growth inhibition HCT116 colon cancer cell line 24 h dosedependent manner first report iPhyllanthus reticulatusi report spectroscopic anticancer property leaf extract colon cancer study open avenue investigation bioactive constituent iPhyllanthus reticulatusi leaf mechanism action paving way future study potential drug development",
        "mesh_terms": [
            "Phyllanthus",
            "Humans",
            "Plant Extracts",
            "Plant Leaves",
            "Gas Chromatography-Mass Spectrometry",
            "HCT116 Cells",
            "Antineoplastic Agents, Phytogenic",
            "Spectroscopy, Fourier Transform Infrared",
            "Colonic Neoplasms",
            "Methanol"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40292056/"
    },
    {
        "pmid": "40276386",
        "title": "Association of <i>Escherichia coli</i> pathotypes with fecal markers of enteropathy and nutritional status among underweight adults in Bangladesh.",
        "abstract": "Environmental enteric dysfunction EED subclinical intestinal disorder characterized chronic fecaloral exposure enteropathogens could diagnosed measuring noninvasive biomarkers iEscherichia colii one key bacterial enteric pathogen drive EED lack information iE colii pathotypes relation biomarkers EED malnourished adults Here intended measure possible association pathotypes EED biomarkers nutritional status adult residing slum Bangladesh Fecal sample collected 524 malnourished adult BMI ≤185 kgmsup2sup living slumsetting Dhaka March 2016 September 2019 analyzed TaqMan Array Card assay evaluate presence E coli pathotypes enteropathogens multivariable linear regression model used assess association malnourished adults prevalent pathotype E coli EAEC 617 least prevalent STEC 67 prevalence atypical EPEC ETEC ShigellaEIEC 52 489 451 respectively infection atypical EPEC significant positive association level Myeloperoxidase b  038 95 CI  011 065 pvalue  0006 Similarly significantly higher concentration alpha1antitrypsin b  013 95 CI  003 022 pvalue  0011 found STECinfected adults However notable association found iE colii pathotypes nutritional status adult participants Moreover iPlesiomonasi infected adult likely infected EAEC pvalue  0017 ETEC pvalue 0001 STEC pvalue  0002 Significant coinfection also detected among pathotypes enteropathogens iGiardiai iAscarisi iCampylobacteri iSalmonellai iEnterocytozoon bieneusii iAdenovirusi study result imply influence particular iE colii pathotypes EPEC STEC intestinal inflammation gut permeability malnourished Bangladeshi adults association nutritional status found Potential pathogenicity E coli pathotypes also observed coinfection pathogen exists adults",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Feces",
            "Adult",
            "Nutritional Status",
            "Male",
            "Biomarkers",
            "Female",
            "Escherichia coli Infections",
            "Escherichia coli",
            "Thinness",
            "Intestinal Diseases",
            "Middle Aged",
            "Young Adult",
            "Malnutrition",
            "Prevalence",
            "Shigella"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40276386/"
    },
    {
        "pmid": "40226208",
        "title": "A case of typhoid fever with neurological presentation.",
        "abstract": "Typhoid fever leading systemic disease due Salmonella enterica serotype Typhi typically gastrointestinal manifestation however neurologic complicationsalthough uncommon arise Aseptic meningitis optic neuritis rare manifestation challenging diagnose patient 31year male presented fever 18 day associated headache rash vomiting diarrhea progressive neurological symptom form disorientation blurred vision examination bilateral sixth cranial nerve palsy Investigations positive typhoid fever aseptic meningitis optic neuritis successfully treated intravenous ceftriaxone corticosteroids Atypical neurological symptom typhoid fever must recognized prevent complications early diagnosis treatment important Typhoid fever considered febrile patient unexplainable neurological symptoms especially endemic region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40226208/"
    },
    {
        "pmid": "40210138",
        "title": "Harnessing Enterococcus faecium WFD-128 from yogurt fermentation: Unveiling probiotic attributes and targeted inhibition of Shigella sonnei diarrheal pathogenesis.",
        "abstract": "Diarrhea leading cause mortality among child five effective intervention beyond oral rehydration antibiotics zinc supplementation study aimed identify evaluate probiotic antidiarrheal potential Enterococcus faecium WFD128 isolated fermented yogurt vitro silico vivo approaches bacterium showed notable antibacterial activity inhibition zone measuring 21 mm 19 mm Shigella flexneri Shigella sonnei respectively Additionally exhibited antibiofilm effectiveness 82  80  pathogens exhibited resistance Amoxicillin intermediate sensitivity Ampicillin Chloramphenicol tolerance bile salt 348h acidic pH level ranging 2 8 Gas ChromatographyMass Spectrometry GCMS identified 68 volatile compounds 11Bicyclohexyl4carboxylic acid 4propyl 4fluorophenyl ester 85 Cholest4en26oic acid 3oxo methyl ester 79 showed strong binding affinity diarrheal protein T3SS Shigella sonnei PDB 6WRY molecular docking studies compound exhibited favorable pharmaceutical property ADMET analysis supported molecular dynamic simulations vivo experiment albino mouse validated bacteriums therapeutic potential Histopathological analysis revealed significant recovery diarrheaaffected organs including kidney liver intestine spleen following treatment E faecium aligns vitro silico findings demonstrating bacteriums therapeutic effectiveness study highlight promise E faecium probioticbased treatment bacteriainduced diarrhea offering strong foundation development innovative antidiarrheal therapeutics",
        "mesh_terms": [
            "Enterococcus faecium",
            "Shigella sonnei",
            "Probiotics",
            "Yogurt",
            "Animals",
            "Diarrhea",
            "Fermentation",
            "Anti-Bacterial Agents",
            "Molecular Docking Simulation",
            "Dysentery, Bacillary",
            "Mice",
            "Biofilms",
            "Humans",
            "Microbial Sensitivity Tests",
            "Shigella flexneri",
            "Disease Models, Animal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40210138/"
    },
    {
        "pmid": "40204339",
        "title": "Trends in preventive practices against diarrhoeal disease among under-five children: experience from the largest diarrhoeal disease hospital in Bangladesh.",
        "abstract": "burden childhood diarrhoea remains one important public health problem country like Bangladesh reduced effective preventive measures aimed investigate trend preventive measure practised among five child diarrhoea last 12 years Data extracted Diarrhoeal Disease Surveillance System Dhaka Hospital period 20122023 STATA 15 used analysis used JoncheereTerpstra trend test examine trend preventive measure diarrhoea slope index inequality SII determine association wealth index Among 20 373 participants 610 male median IQR age 11 month 80160 883 access sanitary latrines 403 household consumed boiled filtered water found 503 child aged 659 month received vitamin A 884 child 9 month measles vaccination Breastfeeding practice observed 178 children Significant upward trend observed sanitary latrine use measles vaccination p0001 Receiving vitamin supplementation boiledfiltered water consumption showed declining trend p0001 Parental education maternal medium exposure found significantly associated preventive measure p005 wealth index showed significant association vitamin supplementation p001 However SII indicate inequality groups found child wealthier quintile family significantly higher rate measles immunisation indicated SII p value0039 Improving practice preventive measure significantly reduce diarrhoeal disease among child five Emphasis placed vitamin supplementation consumption boiled filtered water targeted approach essential including promoting health education enhancing health awareness increasing medium exposure mothers",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Male",
            "Infant",
            "Child, Preschool",
            "Diarrhea",
            "Breast Feeding",
            "Toilet Facilities",
            "Vitamin A",
            "Socioeconomic Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40204339/"
    },
    {
        "pmid": "40190944",
        "title": "Duodenal Amyloidosis Inducing Malabsorption in Hepatitis B-Related Liver Cirrhosis: A Rare Case Presentation.",
        "abstract": "Chronic hepatitis B virus HBV infection major cause liver cirrhosis worldwide hepatic complication welldocumented extrahepatic manifestation secondary amyloidosis less common lead diverse complex clinical outcomes Here present case 60yearold male history chronic hepatitis B progressed liver cirrhosis presented chronic unexplained intractable diarrhea unresponsive standard treatments also experienced significant unintentional weight loss generalized weakness investigation revealed amyloid deposition duodenum confirming secondary amyloidosis affecting gastrointestinal tract cause malabsorption Persistent diarrhea malabsorption necessitated nutritional support symptomatic management case highlight rare association chronic liver disease CLD secondary amyloidosis malabsorption syndrome emphasizing importance clinical suspicion timely diagnosis Early recognition prompt intervention crucial managing complex cases improving outcomes preventing complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40190944/"
    },
    {
        "pmid": "40189546",
        "title": "Clinical spectrum and risk factors of severe dengue infection: findings from the 2023 dengue outbreak in Bangladesh.",
        "abstract": "Since first detection dengue 2000 Bangladesh facing increasing number dengue patient related death every year situation warrant importance quickly identifying severe dengue patient expedite necessary medical intervention could potentially reduce adverse consequences aim study identify clinical feature laboratory parameter severe dengue patient 2023 dengue outbreak Bangladesh hospital based crosssectional study included demographic clinical laboratory data 1313 Dengue patient several secondary tertiary hospital across Bangladesh August 2023 December 2023 According 2009 classification dengue case classified severe dengue nonsevere dengue with without warning signs Chisquare test Fischers exact test multiple logistic regression analysis conducted identify potential risk factor associated severe dengue cases 1313 patient included study nearly 20 severe dengue 3671 1625 year age bracket nearly twothirds male Fever 9954 common clinical symptom followed anorexia 6954 severe headache 6603 whereas common warning sign severe lethargy 4364 persistent vomiting 2757 severe abdominal pain tenderness 2003 across patients Gastrointestinal symptom nausea vomiting diarrhea significantly common severe dengue case compared nonsevere ones Among laboratory parameters decrease platelet level increased ALT level prominent severe patients Multiple logistic regression analysis found severe abdominal pain severe lethargy respiratory distress altered mental status decreased urine output pleural effusion ascites positively associated development severe dengue study present warning signs clinical symptom trend laboratory parameter associated severe case dengue Bangladesh used improving patient management future",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Male",
            "Female",
            "Risk Factors",
            "Adult",
            "Cross-Sectional Studies",
            "Young Adult",
            "Adolescent",
            "Severe Dengue",
            "Disease Outbreaks",
            "Middle Aged",
            "Child",
            "Dengue",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40189546/"
    },
    {
        "pmid": "40181850",
        "title": "Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.",
        "abstract": "exponential increase obesity responsible increased prevalence obstructive sleep apnoea OSA Weight loss critical improvement OSA Glucagonlike peptide1 receptor GLP1R agonismbased therapy GLP1RABT associated significant weight loss Several randomized controlled trial published evaluating use GLP1RABT OSA However literature review revealed systematic review metaanalysis SRM published evaluating efficacy safety GLP1RABT OSA Electronic database searched study documenting use GLP1RABT OSA primary outcome evaluate impact apneahypopnea index AHI Secondary outcome evaluate impact percent change AHI Epworth Sleepiness Score body weight blood pressure sideeffect profile initially screened 59 articles data 4 article 5 different randomized cohort 937 patients analysed SRM Use GLP1RABT associated significant reduction AHI MD1250 events hour 95 CI1733  767 iPi  0001 Isup2sup95 percentreduction AHI MD5217 95 CI 6449  3985 iPi  0001 Isup2sup  0 percentreduction bodyweight MD1246 95 CI2254  239 iPi  0001 Isup2sup  99 systolic bloodpressure MD 459 mm Hg 95 CI661  258 P  0001 Isup2sup  67 considerable heterogeneity greater improvement outcome withtirzepatide compared liraglutide occurrence nausea RR423 95 CI 273655 iPi  0001 Isup2sup  0 vomiting RR422 95 CI 212841 iPi  0001 Isup2sup  0 diarrhoea RR281 95 CI 184431 iPi  0001 Isup2sup  0 constipation RR451 95 CI 247826 iPi  0001 Isup2sup  0 significantly higher GLP1RABT compared placebo SRM provides encouraging data use GLP1RABT improving different respiratory aspect OSA reducing body weight blood pressure",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40181850/"
    },
    {
        "pmid": "40179512",
        "title": "Understanding the factors impacting dengue rapid diagnosis in Bangladesh.",
        "abstract": "Dengue affect 70  population tropical subtropical regions including Bangladesh posing significant health burden sensitivity widely used rapid diagnostic test RDTs varies due factor like viral load serotypes secondary infections disease severity study evaluated diagnostic performance RDTs compared RTPCR identifying key factor affecting sensitivity study Dhaka Medical College DMC involved 683 suspected dengue cases Blood sample metadata collected RDTs NS1 IgG IgM performed onsite Samples analyzed icddrb using RTPCR viral RNA detection serotyping Diagnostic performance assessed using MedCalc metadata sensitivity difference analyzed SPSS found vomiting common symptom followed by diarrhea restlessness abdominal tenderness RDT sensitivity highest case high viral loads reaching 94  within 13 day symptom onset 82  beyond three days Moderate viral load showed sensitivity 70  NS1IgM 84  NS1IgMIgG within three days decreasing thereafter Sensitivity low low viral load case improved three day IgG incorporation DENV3 secondary infection showed higher falsenegative rates study emphasizes importance early testing suspected dengue case symptom like fever vomiting diarrhea abdominal tenderness offering critical insight enhance diagnostics patient care disease control",
        "mesh_terms": [
            "Humans",
            "Dengue",
            "Bangladesh",
            "Dengue Virus",
            "Sensitivity and Specificity",
            "Viral Load",
            "Male",
            "Female",
            "Adult",
            "Young Adult",
            "Adolescent",
            "Child",
            "Antibodies, Viral",
            "Diagnostic Tests, Routine",
            "RNA, Viral",
            "Immunoglobulin M",
            "Child, Preschool",
            "Immunoglobulin G",
            "Middle Aged",
            "Infant"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40179512/"
    },
    {
        "pmid": "40176929",
        "title": "Health Challenges Among Waste Collectors in Bangladesh: Exploring Risk Factors Using Multi-level Modeling.",
        "abstract": "Waste collector face multifaceted health risk including exposure musculoskeletal disorders respiratory diseases workplace injury hazardous work environment purpose study determine risk factor affect health waste collector across Bangladesh Data crosssectional survey obtained information 481 waste collector demographics housing conditions hygiene practices security measures disease prevalence Descriptive analysis multilevel model used per univariate analysis 813 access clean water 584 access sanitation 659 people lived unhealthy housing According bivariate analysis association unhealthy working condition ie respiratory illness 191 asthma 297 cough gastrointestinal issue 593 discomfort 241 diarrhea musculoskeletal disorders dermatological diseases unsafe working condition ie 60 masks 71 gloves 75 boots Considering geographic clustering multilevel modeling examined different factor affected particular illnesses following significant protective factors better housing 80 lower odds acute irritation security measure 50 lower odds gastrointestinal diseases good hygiene 62 lower odds dermatological diseases younger age 2 higher odds respiratory disease per year summary unsafe living working condition greatly push risk illness waste collectors risk occupational health reduced targeted intervention enhance housing hygiene security protocols working conditions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40176929/"
    },
    {
        "pmid": "40172221",
        "title": "<i>Vibrio cholerae</i> O47 associated with a cholera-like diarrheal outbreak concurrent with seasonal cholera in Bangladesh.",
        "abstract": "Ganges delta Bay Bengal recognized hotspot emergence spread novel variant iVibrio choleraei Despite diverse species little information available concerning environmental humanassociated aspect iV choleraei serogroups two major epidemicrelated serogroups O1 O139 represents crucial gap understanding spectrum diversity ecology epidemiology specie influencing dynamic global cholera study describe emerging variant iV choleraei displaying antigenic property serogroup O47 associated choleralike outbreak coastal Bangladesh cholera endemic centuries outbreak coincides rise case cholera caused iV choleraei O1 well frequency isolation serogroups O47 O1 environment iV choleraei O47 isolates proved clonal nature genome biology revealed distinct features respect multidrug resistance MDR serogroupspecific genes genomic island combinations overall phylogenetic properties Genome comparison confirmed absence canonical virulence factor iV choleraei O1 O139 namely cholera toxin CTX toxincoregulated pili TCP presence putative virulence factor including type 3 secretion system T3SS MDR pseudocompound transposon carrying gene macrolide resistance extended spectrum betalactamase Results study suggest iV choleraei O47 could represent emerging iVibrioi pathogen potential spread virulence antimicrobial resistance trait impacting management choleralike diseasesIMPORTANCEDespite global insurgence human disease caused Vibrios recent years research focus O1 serogroup iV choleraei leaving significant gap concerning environmental humanassociated aspect serogroups found nature Although serogroups often found associated sporadic diarrhea cases 19921993 massive choleralike diarrhea epidemic initiated nonO1 serogroup namely O139 temporally displaced O1 endemic cholera Bay Bengal village Bangladesh India highlighting potential threat might pose study describes yet another emerging variant iV choleraei displaying antigenic property serogroup O47 associated choleralike outbreak coastal locality Bangladesh Findings study offer critical insight genome biology iV choleraei O47 potential implication understanding ecology epidemiology choleralike diseases",
        "mesh_terms": [
            "Bangladesh",
            "Cholera",
            "Humans",
            "Disease Outbreaks",
            "Serogroup",
            "Vibrio cholerae",
            "Phylogeny",
            "Virulence Factors",
            "Diarrhea",
            "Seasons",
            "Drug Resistance, Multiple, Bacterial",
            "Vibrio cholerae O1",
            "Genome, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40172221/"
    },
    {
        "pmid": "40168517",
        "title": "Health service readiness and quality for sick child care: an effective coverage analysis in eight low- and middle-income countries.",
        "abstract": "child death averted prompt appropriate treatment child illness pneumonia diarrhoea malaria However research suggested increase care seeking necessarily mean quality care received assessed service readiness process quality curative healthcare childhood determined whether child receiving health service sufficient quality across countries linked data household survey including standard Demographic Health Survey Multiple Indicator Cluster Survey data facility survey including Service Provision Assessment Health Facility Assessment Bangladesh Democratic Republic Congo Haiti Kenya Malawi Nepal Senegal Tanzania estimate effective coverage child illness treatment assessed gap service availability coverage lack service readiness missed care opportunities inadequate service process service readiness process quality defined according global standard countryspecific adaptations analysed service readiness quality care effective coverage individual illness combined illness accounting equity dimensions Seven 42 child experienced least one illness integrated management child illness IMCI service available 5885 facilities found 5566 health facility country ready deliver treatment sick children However readinessadjusted contact suggested child healthcare mostly sought facility low readiness score ranging 15 Nepal 460 Malawi Health facility low diagnostics supervision trained personnel capacity manage child illnesses Concerning quality care 5160 procedure clinical encounter line standards Counselling caretaker lowest score treatment component highest process quality score Hospitals higher readiness process quality score compared primary facility private sector were however large gap service readiness significant inadequate service process countries 35 Haiti 79 Bangladesh sick child sought care health facility 7 Nepal 29 Malawi actually receiving appropriate treatment found large inequality care seeking quality care effective coverage across level education poverty place residence large proportion facility meet required capacity provide IMCI services provision health service major quality gaps highlighting need strengthening health service access capacity quality care reach universal child health coverage",
        "mesh_terms": [
            "Humans",
            "Quality of Health Care",
            "Child Health Services",
            "Developing Countries",
            "Child, Preschool",
            "Infant",
            "Health Services Accessibility",
            "Child",
            "Female",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40168517/"
    },
    {
        "pmid": "40160064",
        "title": "Relationship between Functional Dyspepsia and Gastric Eosinophilia: A Single Centre Cross-Sectional Study.",
        "abstract": "Functional dyspepsia one common gastrointestinal disorders Immune activation eosinophil thought one important mechanism behind pathogenesis functional dyspepsia study aimed evaluate association gastric eosinophilia functional dyspepsia crosssectional study conducted Department Gastroenterology Sir Salimullah Medical College Mitford Hospital Dhaka Bangladesh July 2019 June 2020 Fortysix 46 adult patient functional dyspepsia diagnosed RomeIII criterion enrolled Forty patient fulfilling criterion functional dyspepsia also patient attending department endoscopy evaluation anemia preERCP screening evaluation chronic diarrhea etc normal endoscopic feature subsequently taken comparison group endoscopy biopsy taken gastric body antrum participant Counting eosinophil histopathology done expert senior histopathologist expressed per HPF Statistical analysis done SPSS 220 p005 set statistically significant Mean±SD age 4034±1622 4015±1396 functional dyspepsia patient patient taken comparison respectively Females slightly predominant femalemale ratio 121 Lower middleclass family found vulnerable group suffering functional dyspepsia mean eosinophil count gastric body antrum functional dyspepsia patient higher comparison group difference two group statistically significant p0001 statistically significant relation found gastric eosinophilia p0015 0016 functional dyspepsia p0001 Eosinophil count gastric mucosa significantly higher functional dyspepsia patient association it However study large sample size could explain precisely",
        "mesh_terms": [
            "Humans",
            "Female",
            "Dyspepsia",
            "Cross-Sectional Studies",
            "Male",
            "Adult",
            "Middle Aged",
            "Eosinophilia",
            "Gastritis",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40160064/"
    },
    {
        "pmid": "40157382",
        "title": "Epidemiology of Shigella species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study.",
        "abstract": "Shigellosis leading cause diarrhoea child globally aimed assess burden specific Shigella specie Shigella flexneri serotypes characterise clinical syndrome natural immunity evaluate relevance cause diarrhoea linear growth faltering MALED birth cohort study child younger 17 day enrolled Nov 3 2009 Feb 29 2012 Bangladesh Brazil India Nepal Pakistan Peru Tanzania South Africa followed 2 years retrospective substudy retested Shigella quantitative PCRpositive diarrhoeal nondiarrhoeal stool sample molecular subtyping assays estimated prevalence specific Shigella specie serotypes estimated association diarrhoea clinical characteristic using generalised linear mixed models estimated association linear growth using linear regression used longitudinal infection data estimate protection due previous infection using Andersen Gill extension Cox model 1715 child 874 51·0 male 841 49·0 female complete followup 2 year provided 45 835 stool sample collected age 0 2 years 1294 75·5 child least one Shigella detection nondiarrhoeal asymptomatic stool 507 29·6 least one Shigellaattributed diarrhoea episode substudy able type 1202 samples common specie serotypes Shigella sonnei 366 30·4 1202 flexneri 2a 250 20·8 flexneri 6 296 24·6 association flexneri sonnei detection diarrhoea versus asymptomatic control stool similar Compared diarrhoea episode attributable flexneri attributable sonnei less likely bloody prevalence ratio 0·36 95 CI 0·23 0·56 severe prevalence ratio 0·58 0·35 0·96 association asymptomatic Shigella infection impaired linear growth age 2 year stronger flexneri sonnei S flexneri lengthforage Z score difference 0·18 95 CI 0·29 0·07 sonnei lengthforage Z score difference 0·07 0·21 0·07 Examination longitudinal infection showed previous sonnei infection associated lower hazard subsequent sonnei diarrhoea calibrated hazard ratio 0·41 95 CI 0·19 0·90 Otherwise evidence homotypic heterotypic natural immunity apparent study provides data prevailing Shigella specie serotypes setting high burden disease underscoring importance asymptomatic flexneri infection growth impairment severity flexneri diarrhoea Upcoming Shigella vaccine might need induce immune response improve upon produced natural infection Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Dysentery, Bacillary",
            "Male",
            "Female",
            "Infant",
            "Retrospective Studies",
            "Diarrhea",
            "Shigella",
            "Serogroup",
            "Feces",
            "Child, Preschool",
            "Infant, Newborn",
            "Prevalence",
            "Birth Cohort",
            "South Africa",
            "Brazil",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40157382/"
    },
    {
        "pmid": "40123738",
        "title": "Pathways through which water, sanitation, hygiene, and nutrition interventions reduce antibiotic use in young children: a mediation analysis of a cohort nested within a cluster-randomized trial.",
        "abstract": "Lowcost householdlevel water sanitation hygiene WASH nutrition intervention reduce pediatric antibiotic use mechanism intervention reduce antibiotic use investigated conducted causal mediation analysis using data collected September 2013 October 2015 cohort nested within WASH Benefits Bangladesh clusterrandomized trial NCT01590095 Among subsample child within WASH nutrition nutrition  WASH control arm N  1409 children 267 clusters recorded caregiverreported antibiotic use age 14 28 month collected stool age 14 months primary outcome caregiverreported antibiotic use index child within past 30 90 day measured age 14 28 months Mediators included caregiverreported child diarrhea acute respiratory infection ARI fever enteric pathogen carriage stool measured qPCR interventionmediator mediatoroutcome model controlled mediatoroutcome confounders receipt WASH nutrition intervention reduced caregiverreported antibiotic use pathway past month 55 percentage point 95 CI 12 99 495 95 CI 459 530 control group 450 95 CI 427 472 pooled intervention group separating effect different pathways found intervention reduced antibiotic use 06 percentage point 95 CI 01 13 reduced diarrhea 07 percentage point 95 CI 01 15 reduced ARI fever 15 percentage point 95 CI 04 30 reduced prevalence enteric viruses Interventions reduced antibiotic use measured mediator 21 percentage point 95 CI 03 45 WASH nutrition intervention reduced pediatric antibiotic use prevention enteric respiratory infection rural lowincome population Given many infection caused virus parasites WASH nutrition intervention may help reduce inappropriate antibiotic use similar settings Bill  Melinda Gates Foundation National Institute Allergy Infectious Diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40123738/"
    },
    {
        "pmid": "40115172",
        "title": "Letter to the editor in response to a letter by Fuchs and Santosham regarding; assessing safety and efficacy of a novel glucose-free amino acid oral rehydration solution for watery diarrhea management in children: a randomized, controlled, phase III trial.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40115172/"
    },
    {
        "pmid": "40106483",
        "title": "Understanding climate-sensitive diseases in Bangladesh using systematic review and government data repository.",
        "abstract": "Understanding effect climate change health outcome crucial effective policy formulation intervention strategies However Low MiddleIncome Countries like Bangladesh true extent effect remains unexplored due data scarcity study aim assess available evidence climate changerelated health outcome Bangladesh compare actual national occurrences explore challenge related climate change health data first conducted systematic review summarize climatesensitive disease examined existing literature Bangladesh review result compared 28 million sample governments data repository representing reported case climatesensitive disease 20172022 comparison aimed identify discrepancy disease currently occurring Bangladesh related climate change available knowledge existing research Additionally also explored limitation data recorded government data repository available literature Bangladesh report specific climatesensitive diseases including Diarrhea Dengue Cholera Malaria Pneumonia Cardiovascular Diseases Hypertension UrinaryTract Infections Malnutrition also considered studies represents segment total 510 reported climatesensitive disease Bangladesh 143 disease responsible 9066 total occurrences common form disease diarrhea gastroenteritis presumed infectious 2851 pneumonia 1888 anxiety disorders panic disorders generalized anxiety disorder 132 others 1315 Additionally UrinaryTract infection 787 cholera 303 typhoid fever 327 frequently reported climatesensitive diseases also explored several challenge related available data government repository include inadequate collection patients comprehensive sociodemographic information absence unique patient identifier finding underscore urgent need tackle data challenge understanding climatesensitive disease Bangladesh Policies program required prioritize digitalization healthcare system implement unique patient identification number facilitate accurate tracking analysis health data Climate Change including rising temperature extreme weather event like cyclone floods pose significant global health threat 1 World Health Organization estimate climate change already cause least 150000 death annually global level number projected double 2030 Beside impact climate change farreaching leading forced displacement malnutrition increased incidence disease dengue diarrhea pneumonia 2 Additionally climate change established link mental health issues like anxiety depression 3 effect particularly severe Low MiddleIncome Countries LMICs due limited resource inadequate infrastructure coping erratic weather disaster 4 undertook comprehensive mixedmethod study incorporating systematic review existing study conducted Bangladesh along analysis government data repository detailed description component presented below",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Climate Change",
            "Diarrhea",
            "Government"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40106483/"
    },
    {
        "pmid": "40075809",
        "title": "Enhancing Typhoid Fever Diagnosis Based on Clinical Data Using a Lightweight Machine Learning Metamodel.",
        "abstract": "bBackgroundb Typhoid fever remains significant public health challenge especially developing country diagnostic resource limited Accurate timely diagnosis crucial effective treatment disease containment Traditional diagnostic methods effective timeconsuming resourceintensive study aim develop lightweight machine learningbased diagnostic tool early efficient detection typhoid fever using clinical data bMethodsb custom dataset comprising 14 clinical demographic parametersincluding age gender headache muscle pain nausea diarrhea cough fever range °F hemoglobin gdL platelet count urine culture bacteria calcium mgdL potassium mgdLwas analyzed machine learning metamodel integrating Support Vector Machine SVM Gaussian Naive Bayes GNB Decision Tree classifier Light Gradient Boosting Machine LGBM trained evaluated using kfold crossvalidation Performance assessed using precision recall F1score area receiver operating characteristic curve AUC bResultsb proposed metamodel demonstrated superior diagnostic performance achieving precision 99 recall 100 AUC 100 outperformed traditional diagnostic method standalone machine learning algorithms offering high accuracy generalizability bConclusionsb lightweight machine learning metamodel provides costeffective noninvasive rapid diagnostic alternative typhoid fever particularly suited resourcelimited settings reliance accessible clinical parameter ensures practical applicability scalability potentially improving patient outcome aiding disease control Future work focus broader validation integration clinical workflow enhance utility",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40075809/"
    },
    {
        "pmid": "40057834",
        "title": "Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh.",
        "abstract": "Bangladesh underwent four wave coronavirus disease 2019 COVID19 pandemic Analysing essential understanding change viral behaviour disease patterns severity response treatment Nevertheless data scarce low middleincome countries Therefore aimed compare clinical manifestations outcome therapy oxygen dexamethasone remdesivir well case fatality ancestral alphabeta delta omicrondriven waves conducted observational study five hospital Dhaka Bangladesh least one dedicated COVID19 unit treating patient followed national guideline November 2020 February 2022 collected data prospectively 1 July 2021 30 September 2021 delta retrospectively 1 November 2020 4 March 2021 ancestral 5 March 2021 30 May 2021 alphabeta 1 January 2022 28 February 2022 omicron period representing distinct wave COVID19 primary outcome 30day case fatality across waves used multivariable robust Poisson regression model robust variance estimate 30day case fatality risk ratio various waves Among 966 participants rate 30day case fatality comparable across different variants However proportion patient fever P  0001 cough P  0001 breathing difficulty P  0001 nausea P  0001 fatigue P  0001 headache P  0001 diarrhoea P  0001 loss smell P  0001 runny nose P  0001 chest pain P  0001 smaller omicron wave three waves adjusting potential confounders multivariable model showed likelihood case fatality significantly associated age adjusted risk ratio aRR  105 95 confidence interval CI  104107 hypoxaemia aRR  529 95 CI  158177 critical disease aRR  645 95 CI  1892199 modified early warning score ≥4 aRR  258 95 CI  171388 observed 85 aRR  015 95 CI  003072 reduction case fatality among patient oxygen Lmin compared without oxygen However individual requiring ≥15 Lmin oxygen showed significantly higher case fatality compared needing 15 Lmin oxygen aRR  563 95 CI  2681181 ancestral variant aRR  283 95 CI  125641 alphabeta variant aRR  273 95 CI  156477 delta variant aRR  284 95 CI  156516 omicron variant Remdesivir associated increased case fatality alphabeta aRR  696 95 CI  1543143 delta aRR  413 95 CI  1171458 omicron wave aRR  889 95 CI  2463213 compared ancestral wave Dexamethasone administered admission significant association death P  0239 entire cohort However dexamethasone reduced case fatality 78 among moderate severe COVID19 subgroup observed 37 reduction case fatality among vaccinated participant compared without vaccination aRR  063 95 CI  040099 study provides insight clinical patterns treatment impact case fatality across various SARSCoV2 variant resourcelimited settings finding underscored crucial role oxygen therapy vaccination reducing COVID19 case fatality also emphasise necessity continuous disease surveillance highlight importance close monitoring patient higher oxygen requirement ≥15 Lmin due association fatal outcomes well significance sustaining vaccination effort need clinical trial newer antiviral ongoing battle COVID19",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Bangladesh",
            "Male",
            "Female",
            "SARS-CoV-2",
            "Middle Aged",
            "Adult",
            "Treatment Outcome",
            "Adenosine Monophosphate",
            "Antiviral Agents",
            "COVID-19 Drug Treatment",
            "Aged",
            "Retrospective Studies",
            "Dexamethasone",
            "Young Adult",
            "Adolescent",
            "Alanine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40057834/"
    },
    {
        "pmid": "40032381",
        "title": "Effects of household concrete floors on maternal and child health: the CRADLE trial - a randomised controlled trial protocol.",
        "abstract": "Early life soiltransmitted helminth STH infection diarrhoea associated growth faltering anaemia impaired child development mortality Exposure faecally contaminated soil inside home may key contributor enteric infections large fraction rural home lowincome country soil floors objective study measure effect installing concrete floor home soil floor child STH infection maternal child health outcome rural Bangladesh Cementbased flooRs chiLd hEalth trial individually randomised trial Sirajganj Tangail districts Bangladesh Households pregnant woman soil floor wall made mud plan relocate 3 year eligible randomise 800 household intervention control 11 within geographical block 10 household account strong geographical clustering enteric infection Laboratory staff data analyst blinded participant unblinded instal concrete floor birth cohort utero measure outcome child age 3 6 12 18 24 months primary outcome prevalence STH infection iAscaris lumbricoidesi iNecator americanusi iTrichuris trichiurai detected quantitative PCR 6 12 18 24 month followup birth cohort Secondary outcome include household floor child hand contamination iEscherichia colii extendedspectrum betalactamase producing iE colii STH DNA child diarrhoea growth cognitive development maternal stress depression Study protocol approved institutional review board Stanford University International Centre Diarrheal Disease Research Bangladesh report finding ClinicalTrialsgov peerreviewed publication stakeholder workshop Bangladesh NCT05372068",
        "mesh_terms": [
            "Child, Preschool",
            "Female",
            "Humans",
            "Infant",
            "Pregnancy",
            "Bangladesh",
            "Child Health",
            "Construction Materials",
            "Diarrhea",
            "Family Characteristics",
            "Floors and Floorcoverings",
            "Helminthiasis",
            "Maternal Health",
            "Randomized Controlled Trials as Topic",
            "Rural Population",
            "Soil"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40032381/"
    },
    {
        "pmid": "40003395",
        "title": "Formative Research for Adapting the Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water Treatment and Hygiene Mobile Health Program for Scalable Delivery in Rural Bangladesh.",
        "abstract": "CholeraHospitalbasedInterventionfor7Days CHoBI7 mobile health mHealth program targeted water treatment hygiene WASH program household member diarrhea patients initiated healthcare facility single inperson visit reinforced weekly voice text message 3 months recent randomized controlled trial CHoBI7 mHealth program urban Dhaka Bangladesh found intervention significantly increased WASH behavior reduced diarrhea prevalence objective present study conduct formative research using implementation science framework adapt CHoBI7 mHealth program scalable implementation rural Bangladesh promote construction selfmade handwashing station CHoBI7 Scaleup program conducted 3month multiphase pilot 275 recipient 25 semistructured interviews 10 intervention planning workshops 2 focus group discussion intervention recipient program implementers High appropriateness acceptability adoption CHoBI7 Scaleup program observed recipient constructing selfmade handwashing station 90 chlorinating drinking water 63 50 participant observed handwashing soap final pilot phase recipient level facilitator included weekly voice text message video handwashing station construction served reminder promoted water treatment hand hygiene behaviors Barriers included perception selfmade iron filter commonly used household also removed microbial contamination water therefore chlorine treatment needed mobile message always shared among household members implementer level facilitator program implementation included followup phone call household member present healthcare facility time intervention delivery promotion multiple selfmade handwashing station designs Barriers included high patient volume healthcare facilities well high iron groundwater area reduced chlorination effectiveness finding provide valuable evidence adapting CHoBI7 mHealth program rural setting lowercost scalable design demonstrated important role formative research tailoring WASH program new contexts",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Cholera",
            "Water Purification",
            "Rural Population",
            "Hygiene",
            "Female",
            "Telemedicine",
            "Male",
            "Adult",
            "Hand Disinfection",
            "Middle Aged",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40003395/"
    },
    {
        "pmid": "40000088",
        "title": "Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.",
        "abstract": "Shigellosis second leading cause diarrhoeal death among child worldwide Oral azithromycin intravenous ceftriaxone recommended firstline secondline therapy shigellosis Bangladesh respectively growing antibiotic resistance require new antibiotic options Tebipenem pivoxil orally administered carbapenem antibiotic activity many strain antibioticresistant bacteria may viable option phase IIb randomised controlled trial planned determine efficacy safety oral tebipenem pivoxil compared intravenous ceftriaxone child iShigellai diarrhoea unresponsive firstline antibiotic therapy enrol 132 child trial 66 arm Children Bangladesh aged 2459 month suspected iShigellai diarrhoea clinical improvement within 48 hour starting firstline therapy randomised 3day course intravenous ceftriaxone 50 mgkg day 3day course oral tebipenem pivoxil 4 mgkg three time day child evaluated key clinical microbiological safety outcome subsequent 30day period Clinically failure day 3 defined presence fever axillary temperature ≥38°C diarrhoea three abnormally loose watery stool last 24 hours blood stool abdominal paintenderness day 3 followup death hospitalisation prior day 3 hypothesised child treated tebipenem pivoxil worse clinical microbiological failure rate compared ceftriaxone study protocol approved institutional review board International Centre Diarrhoeal Disease Research Bangladesh comprises research review committee ethic review committee addition use tebipenem pivoxil shigellosis approved Directorate General Drug Administration Bangladesh NCT05121974",
        "mesh_terms": [
            "Child, Preschool",
            "Female",
            "Humans",
            "Infant",
            "Male",
            "Administration, Oral",
            "Anti-Bacterial Agents",
            "Bangladesh",
            "Carbapenems",
            "Ceftriaxone",
            "Clinical Trials, Phase II as Topic",
            "Diarrhea",
            "Dysentery, Bacillary",
            "Equivalence Trials as Topic",
            "Randomized Controlled Trials as Topic",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40000088/"
    },
    {
        "pmid": "39983916",
        "title": "Role of hepcidin on benefits and risks of supplementation with iron syrup and multiple micronutrient powders in Bangladeshi children: a substudy to a randomized controlled trial.",
        "abstract": "Hepcidin determine individuals response iron supplementation limited evidence exists pediatric trials aimed examine influence hepcidin effect supplementation iron syrup multiple micronutrient powder MNPs hemoglobin ferritin concentration incidence diarrhea young children Participants included subsample 1281 8moold child enrolled 3arm doubleblind doubledummy individually randomized controlled trial examining efficacy 3 mo universal supplementation daily iron syrup 125 mg iron MNPs containing 125 mg iron placebo child living Bangladesh participant baseline immediately postintervention month 3 9 mo followup month 12 serum hepcidin concentration measured enzymelinked immunosorbent assay venous hemoglobin HemoCue 301 incidence diarrhea caregiver report used likelihoodbased longitudinal data analysis model examine effect modification baseline hepcidin effect iron syrup MNPs hemoglobin ferritin concentration logbinomial model incidence diarrhea month 3 12 Hepcidin modified effect MNPs iron syrup compared placebo hemoglobin ferritin concentration immediately postintervention treatment effect MNPs compared placebo change baseline month 3 larger among child low compared notlow baseline hepcidin hemoglobin mean difference 116 gL 72 159 compared 43 309 57 Pinteraction  0002 ferritin geometric mean ratio 24 16 36 compared 15 13 17 Pinteraction  0024 effect modification sustained month 12 Hepcidin modify effect either intervention incidence diarrhea Immediate effect MNPs child hemoglobin iron status larger among low compared notlow hepcidin indicating preintervention screening could help identify would benefit MNPs trial registered Australian New Zealand Clinical Trials Registry ACTRN12617000660381",
        "mesh_terms": [
            "Humans",
            "Hepcidins",
            "Bangladesh",
            "Dietary Supplements",
            "Male",
            "Micronutrients",
            "Female",
            "Infant",
            "Iron",
            "Powders",
            "Double-Blind Method",
            "Hemoglobins",
            "Ferritins",
            "Anemia, Iron-Deficiency",
            "Diarrhea"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39983916/"
    },
    {
        "pmid": "39963694",
        "title": "Shigellosis in an Urban Slum in Kenya: Risk Factors and Antimicrobial Resistance.",
        "abstract": "iShigellai spp among notable cause global diarrheal disease death accounting 132 death 2016 Antimicrobial resistance complicates shigellosis management Understanding local disease epidemiology crucial developing effective preventive strategies including vaccine use investigated antimicrobial resistance risk factor socioeconomic behavioral water sanitation hygiene WaSH clinical characteristic iShigellai diarrhea Mukuru informal settlement surrounding village Nairobi Kenya Patients presenting diarrhea fever treatment center stool rectal swab sample cultured bacteria identified biochemical serologic tests rate iShigellai isolation among 4689 individual presenting diarrhea 14 across ages similar isolation rate 15 among child 5 year age majority iShigellai spp 40 597 iShigella flexnerii majority iS flexnerii 34 40 85 resistant trimethoprimsulfamethoxazole however sensitive amoxicillinclavulanate ceftazidime ceftriaxone cefpodoxime rate multidrug resistance higher iShigella sonneii 13 481 iS flexnerii 3 75 iShigellai positivity associated bloody diarrhea severemoderate dehydration coated tongue high fever Consumption street food also associated iShigellai diarrhea Despite low prevalence shigellosis still pose significant burden diarrheal disease warranting future incidence studies Firstline antibiotic iShigellai remain effective intermediate resistance azithromycin ciprofloxacin concerning trend Improving household food preparation handling could potentially reduce iShigellai infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39963694/"
    },
    {
        "pmid": "39957977",
        "title": "Assessing Contributory Factors of Diarrhea Among Under-Five Children in Bangladesh From 2006 to 2019 and Recent Increases: A Cross-Sectional Study.",
        "abstract": "Onethird child death country caused diarrhea burden disease appears increasing recent year Bangladesh study aimed analyze prevalence diarrhea identify factor contributing diarrheal disease among child aged 05 year Bangladesh 2006 2019 understand recent increase serious health issue study using data Multiple Indicator Cluster Survey MICS total 31566 23402 24686 child five included from 2006 2012 2019 respectively Logistic regression applied analyze change factor influencing childhood diarrhea result revealed decline diarrhea prevalence MICS 2006 71 MICS 2012 39 However sharp increase 69 MICS 2019 Notably child aged 1223 month exhibited consistently 222 time adjusted odds ratio AOR  222 95 confidence interval CI 186265 524 time CI 2511095 336 time CI 267422 higher likelihood experiencing diarrhea compared older age group 4859 months MICS 2006 2012 2019 respectively mothers educational background also played role MICS 2006 2012 2019 child whose mother incomplete primary education 148 CI 118186 107 CI 076150 134 CI 106169 time higher chance diarrhea compared child mother secondary complete higher education Underweight status geographical division household wealth status unimproved shared toilet facility emerged contributing factor diarrhea among child aged 05 years finding underscore importance child nutrition basic hygiene practices special care rainy season mitigate underfive mortality rate associated diarrhea",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39957977/"
    },
    {
        "pmid": "39946552",
        "title": "Consequences of post-discharge hospitalisation on the growth of young Bangladeshi children hospitalised with diarrhoea: a secondary case-control analysis of Antibiotics for Children with Diarrhea (ABCD) trial.",
        "abstract": "Due scarcity published data growth among child severe diarrhoea requiring readmission postdischarge followup aimed investigate potential impact postdischarge readmission day90 followup growth diarrheal child aged 223 months performed secondary analysis using Bangladesh site data Antibiotic Children Diarrhea ABCD trial multicountry randomised doubleblind placebocontrolled study conducted July 2017 July 2019 Children aged 223 month severe diarrhoea defined acute diarrhoea somesevere dehydration severe stunting moderate wasting admitted facility analysis classified child rehospitalised within 90day postdischarge followup period case randomly selected control require rehospitalisation matching similar age sex 13 ratio gathered anthropometric data enrolment day 90 followup outcome variable change nutritional indicator heightforage ΔHAZ weightforage ΔWAZ weightforheight ΔWHZ midupper arm circumference ΔMUAC assessed growth change day 90 postdischarge followup using multivariate linear regression Among 1431 diarrhoeal child enrolled identified 145 case 435 controls term baseline admission characteristics case less likely immunised 81 vs 72 P  0031 vomit 11 vs 22 P  0001 dehydrating diarrhoea 26 vs 36 P  0026 controls adjusting potential covariates case significant reduction growth control 90 day postdischarge followup according anthropometric indices ΔHAZ β  011 95 confidence interval CI  021 001 P  0029 ΔWAZ β  024 95 CI  035 014 P  0001 ΔWHZ β  025 95 CI  039 012 P  0001 ΔMUAC for child 623 months β  017 95 CI  029 004 P  0011 Diarrhoeal child aged 223 month requiring readmission 90day postdischarge followup period significant deterioration ponderal linear growth compared require readmission finding underscore importance early identification child risk postdischarge readmission designing package postdischarge trials including social nutritional intervention may help reduce postdischarge readmission well subsequent growth faltering",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Infant",
            "Male",
            "Female",
            "Anti-Bacterial Agents",
            "Case-Control Studies",
            "Diarrhea",
            "Double-Blind Method",
            "Hospitalization",
            "Patient Readmission",
            "Patient Discharge",
            "Growth Disorders",
            "Body Height"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39946552/"
    },
    {
        "pmid": "39933176",
        "title": "Effect of Nitazoxanide and Probiotic Treatment on Bangladeshi Children with Cryptosporidiosis.",
        "abstract": "Cryptosporidium spp cause diarrhea morbidity mortality child 5 year age addition asymptomatic infection negative impact growth development low middleincome country greater number infant may malnourished result treating cryptosporidiosis Food Drug Administrationapproved drug nitazoxanide NTZ inconsistent Malnutrition risk factor cryptosporidiosis consequence infection parasite Treatment probiotic Lactobacillus reuteri DSM 17938 shown assist nutritional recovery restoration gut health pilot randomized clinical trial examined whether combined probiotic NTZ treatment could result reduction parasitemia infectionassociated growth stunting undernourished children Cryptosporidium spppositive Bangladeshi child weightforlength Z score 1 3 randomly assigned one three groups Group 1 n  26 received NTZ Lactobacillus group 2 n  28 received NTZ along placebo third control group n  10 received standard care difference duration infection improvement child anthropometric measurement treatment group compared control Therefore pilot study provide support treatment NTZ Lactobacillus two combination effective mean reducing duration Cryptosporidium spp infection improving growth growthstunted children",
        "mesh_terms": [
            "Humans",
            "Cryptosporidiosis",
            "Probiotics",
            "Bangladesh",
            "Thiazoles",
            "Male",
            "Child, Preschool",
            "Female",
            "Infant",
            "Nitro Compounds",
            "Pilot Projects",
            "Antiparasitic Agents",
            "Limosilactobacillus reuteri",
            "Growth Disorders"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39933176/"
    },
    {
        "pmid": "39928709",
        "title": "Sustainability of zinc coverage for acute childhood diarrhea in Bangladesh and other low- and middle-income countries: one decade following the SUZY project.",
        "abstract": "Oral zinc proven effective treatment diarrheal illness longterm monitoring key evaluating success effort scale zinc treatment examine zinc coverage diarrheal illness Bangladesh since conclusion Scaling Zinc Young Children SUZY project 2008 provide overview countries zinc scaleup program compare longterm effectiveness SUZY used data Bangladesh Demographic Health Surveys 20052022 examine proportion child five receiving zinc treatment diarrheal illness evaluate disparity zinc coverage urbanicity wealth quintile used qualitative framework synthesis compare SUZY project national largescale zinc scaleup program low middleincome country Ghana India Kenya Nepal Nigeria Uganda method synthesizing qualitative quantitative data used break component SUZY project national largescale zinc scaleup programs Bangladesh zinc coverage continued increase since conclusion SUZY project disparity coverage urban rural area across wealth quintiles resolved prevalence diarrheal illness decreased 10·8 2007 4·8 2022 country highest zinc coverage Bangladesh Kenya Uganda national rather regional scaleup campaigns finding demonstrate longterm success SUZY project provide insight best practice impactful zinc scaleup program including significant prelaunch implementation research addressing key knowledge gap partnering research organizations Longterm monitoring scaleup campaign important determine intervention become socially embedded selfsustaining improving health outcome long run",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39928709/"
    },
    {
        "pmid": "39925027",
        "title": "Assessment of Antidiarrheal Effect of Oleuropein Through µ-Oopioid Receptor Interaction Pathway: In Vivo and in Silico Studies.",
        "abstract": "Oleuropein OLP compound predominantly found olive leaves known numerous biological activities including antioxidant antiinflammatory antimicrobial properties Despite established therapeutic potential role treating diarrhea extensively explored study aimed evaluate antidiarrheal effect OLP vivo model investigate molecular interaction using silico docking studies pharmacokinetic predictions toxicity analysis vivo study castor oil used induce diarrhea 3dayold chicks antidiarrheal effect OLP tested dos 10 20 mgkg standard drug loperamide LOP 3 mgkg used comparison result showed OLP dos significantly p  005 reduced diarrheal secretion increased latency 20 mgkg dose demonstrating effective results combination OLP 20 mgkg LOP 3 mgkg enhanced antidiarrheal effect silico study molecular docking revealed OLP LOP exhibited strong binding affinity BAs key receptor μopioid receptor associated diarrhea OLP showed higher BA ‒89 kcalmol compared LOP ‒87 kcalmol Pharmacokinetic analysis OLP revealed favorable property toxicity study revealed acute toxicity LDsub50sub 2000 mgkg conclusion finding suggest OLP possesses significant antidiarrheal potential vivo receptor interaction positioning promising natural therapeutic agent managing diarrhea study warranted fully elucidate mechanism action clinical applicability",
        "mesh_terms": [
            "Antidiarrheals",
            "Animals",
            "Iridoid Glucosides",
            "Diarrhea",
            "Molecular Docking Simulation",
            "Receptors, Opioid, mu",
            "Iridoids",
            "Loperamide",
            "Chickens",
            "Male",
            "Castor Oil",
            "Computer Simulation",
            "Dose-Response Relationship, Drug"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39925027/"
    },
    {
        "pmid": "39922602",
        "title": "Maternal knowledge, attitude and practice regarding commercial oral rehydration salt solution: experience from a diarrhoeal disease hospital in Bangladesh.",
        "abstract": "Despite oral rehydration salt ORS solution lifesaving medication mother affected child often lack proper knowledge exhibit improper practice using ORS sachets aimed assess maternal knowledge attitude practice towards commercially available ORS use treating under5 child diarrhoea study conducted Dhaka Hospital Bangladesh included 350 mother under5 child suffering diarrhoea Data collected using pretested questionnaire modified Blooms cutoff used determine adequate knowledge ≥80 positive attitude ≥90 proper practice ≥75 Logistic regression model developed adjusting confounding variables Adjusted ORs AORs 95 CIs reported prevalence inadequate knowledge negative attitude improper practice 880 591 725 respectively Participants higher secondary level education significantly higher odds possessing adequate knowledge AOR 747 95 CI 276 2012 following proper practice AOR 304 95 CI 166 577 majority 974 reported aware process ORS preparation 29 correctly knew recommended steps Approximately half 511 knew purpose ORS use 246 believed antibiotic helpful ORS finding study emphasise need substantial improvement existing health education program focus parental education Emphasis given reading instruction sachet promoting access information via mass medium outlets",
        "mesh_terms": [
            "Humans",
            "Health Knowledge, Attitudes, Practice",
            "Bangladesh",
            "Female",
            "Diarrhea",
            "Fluid Therapy",
            "Mothers",
            "Adult",
            "Male",
            "Rehydration Solutions",
            "Infant",
            "Surveys and Questionnaires",
            "Child, Preschool",
            "Cross-Sectional Studies",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39922602/"
    },
    {
        "pmid": "39921733",
        "title": "Assessments of protodioscin's antinociceptive and antidiarrheal properties: in vivo and in silico investigations on macromolecule binding affinity and modulatory effects.",
        "abstract": "Protodioscin PRO furostanol saponin antioxidant antiinflammatory properties However proof nociception diarrhea study aim investigate antinociceptive antidiarrheal effect PRO comparing efficacy diclofenac sodium DFS loperamide LOP using vivo silico methods Antinociceptive activity evaluated using acetic acidinduced writhing formalininduced paw licking tests antidiarrheal effect assessed via castor oilinduced diarrhea mice Mice divided group receiving PRO 25 10 mgkg po DFS 25 mgkg po LOP 3 mgkg po combinations Molecular docking study conducted COX1 COX2 enzymes Muopioid receptor MOR toxicity prediction performed safety profiling vivo result demonstrated PRO significantly p  005 reduced pain diarrhea animals PRO 10 mgkg showed comparable efficacy DFS LOP 25 3 mgkg models Molecular docking revealed PRO stronger binding affinity COX1 ‒100 kcalmol COX2 ‒96 kcalmol enzymes MOR ‒77 kcalmol compared standard drugs Toxicity prediction indicate PRO relatively safe toxicity parameters PRO exhibit significant antinociceptive antidiarrheal activity comparable DFS LOP making promising natural alternative managing pain diarrhea Additional clinical trial pharmacokinetic assessment required evaluate longterm safety use",
        "mesh_terms": [
            "Animals",
            "Antidiarrheals",
            "Analgesics",
            "Molecular Docking Simulation",
            "Mice",
            "Diarrhea",
            "Male",
            "Cyclooxygenase 1",
            "Receptors, Opioid, mu",
            "Cyclooxygenase 2",
            "Saponins",
            "Loperamide",
            "Acetic Acid",
            "Pain",
            "Castor Oil",
            "Membrane Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39921733/"
    },
    {
        "pmid": "39911308",
        "title": "In silico design of an epitope-based vaccine ensemble for fasliolopsiasis.",
        "abstract": "Fasciolopsiasis foodborne intestinal disease common Asia Indian subcontinent Pigs reservoir host fasciolopsiasis widespread location pig reared aquatic plant widely consumed Human infection commonly documented China Bangladesh Southeast Asia part India predominates schoolage children significant worm burden uncommon causal organism iFasciolopsis buskii giant intestinal fluke infects human cause diarrhoea fever ascites intestinal blockage increasing prevalence medication resistance necessity effective vaccination make controlling disease challenging last decade achieved major advance understanding intestinal fluke biology indepth interrogation analysis evolving iF buskii omics datasets creation large omics datasets iF buskii group accelerated discovery key molecule involved intestinal fluke biology toxicity virulence targeted vaccine development Finding successful vaccination antigen combination huge number genesproteins available omics datasets key combating neglected tropical diseases present study developed iin silicoi workflow select antigen composing chimeric vaccine could significant technique developing fasciolopsiasis vaccine prevents parasite causing serious harm chimeric vaccine tested experimentally compared vaccine candidate determine potential influence human health Although result encouraging additional validation needed iin vivoi iin vitroi Considering extensive genetic data available intestinal fluke expanded technological advancements may need reassess method suggest sophisticated technique future identifying vaccine molecules",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39911308/"
    },
    {
        "pmid": "39900426",
        "title": "Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against <i>Vibrio cholerae</i> in Bangladesh: an interim analysis.",
        "abstract": "Millions EuvicholPlus dos deployed global oral cholera vaccine stockpile 20 choleraaffected countries However information EuvicholPluss effectiveness limited Using vaccine cholera epidemic Dhaka Bangladesh provided opportunity evaluate vaccine effectiveness VE using testnegative design twodose regimen EuvicholPlus administered individual aged 1 year population ca 900 000 two campaign round June August 2022 prospective registration person received least one dose conducted systematic surveillance two key facilities enrolling patient acute watery diarrhoea eligible vaccination campaigns start presented care 21 August 2022 20 August 2023 Faecal culturepositive cholera case matched four faecal culturenegative control age presentation date facility Vaccination status documented without knowledge culture results Conditional logistic regression model estimated vaccinationcholera association twodose regimen calculated 1OR × 100 analysis included 226 case 552 matched controls adjusted two dos EuvicholPlus vaccine medically attended cholera 66 995 CI 30 83 recipients Limited protection 12 95 CI 95 60 observed child aged 14 years whereas protection 79 95 CI 60 89 aged ≥5 years cholera moderate severe dehydration 69 95 CI 44 83 overall 6 95 CI 206 71 child aged 14 years EuvicholPlus provided significant protection medically attended cholera severity well cholera moderate severe dehydration However significant level protection observed aged ≥5 years",
        "mesh_terms": [
            "Humans",
            "Cholera Vaccines",
            "Bangladesh",
            "Cholera",
            "Child, Preschool",
            "Male",
            "Female",
            "Infant",
            "Child",
            "Adolescent",
            "Vibrio cholerae",
            "Adult",
            "Administration, Oral",
            "Vaccine Efficacy",
            "Young Adult",
            "Middle Aged",
            "Prospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39900426/"
    },
    {
        "pmid": "39883734",
        "title": "Concurrent transmission of Zika virus during the 2023 dengue outbreak in Dhaka, Bangladesh.",
        "abstract": "2023dengue outbreak Bangladesh diagnostic evaluation study conducted investigate concurrent Zika virus ZIKV dengue virus DENV transmission Dhaka 2023 study explored simultaneously detect presence ZIKV DENV andor CHIKV considering relevant clinical epidemiological risk factors using realtime multiplex RTPCR system Following this planned sequence selected sample identify genetic variation ZIKV infection within population study designed diagnostic evaluation participant meeting inclusion criterion prospectively recruited written informed consent total 399 febrile individual screened 185 meeting inclusion criterion fever onset within 25 days along one following clinical features eg headache myalgia arthralgia bone pain rash nausea vomiting diarrhea 152 undergoing realtime RTPCR testing Five ZIKVpositive case identified including one DENVZIKV coinfection Phylogenetic analysis revealed ZIKV strain part Asian lineage closely related Cambodian Chinese strain 2019 ZIKVpositive case male residing within onekilometer radius prior travel history suggesting communitylevel transmission study mark first identification ZIKV Dhaka city first report ZIKVDENV coinfection Bangladesh highlight diagnostic challenge posed symptomatic similarity ZIKV arbovirus underscore need enhanced surveillance public health intervention mitigate spread impact ZIKV dengueendemic regions",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Zika Virus Infection",
            "Dengue",
            "Zika Virus",
            "Male",
            "Disease Outbreaks",
            "Female",
            "Adult",
            "Dengue Virus",
            "Middle Aged",
            "Young Adult",
            "Adolescent",
            "Phylogeny",
            "Coinfection",
            "Prospective Studies",
            "Child"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39883734/"
    },
    {
        "pmid": "39883146",
        "title": "Alpelisib-Induced Hyperglycemia in <i>PIK3CA</i><sup>+</sup> Breast Cancer Patients.",
        "abstract": "Alpelisib phosphatidylinositol 3kinase inhibitor approved US Food Drug Administration treatment hormone receptorpositive metastatic breast cancer iPIK3CAi phosphatidylinositol45bisphosphate 3kinase catalytic subunit α mutation recent year number adverse effect observed associated therapy notable hyperglycemia literature search conducted include case studies case series systematic reviews metaanalyses within last 10 year evaluated patient iPIK3CAimutated hormone receptorpositive human epidermal growth factor receptor 2 negative metastatic breast cancer Hyperglycemia notable adverse effect found majority patient without preexisting diabetes mellitus Patients hyperglycemia highrisk group advanced age prediabetes mellitus history insulin resistance increased body mass index increased blood monocyte count increased hemoglobin A1c glycated hemoglobin Hyperglycemia manageable antihyperglycemic agent dose modificationdiscontinuation alpelisib severe progression notable adverse effect rash stomatitis diarrhea pneumonitis reduced appetite elevated liver enzymes nausea fatigue rare report diabetic ketoacidosis literature review aim highlight incidence risk factor alpelisibinduced hyperglycemia greater depth",
        "mesh_terms": [
            "Humans",
            "Breast Neoplasms",
            "Female",
            "Hyperglycemia",
            "Class I Phosphatidylinositol 3-Kinases",
            "Thiazolidines",
            "Phosphatidylinositol 3-Kinases",
            "Thiazoles"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39883146/"
    },
    {
        "pmid": "39874594",
        "title": "Influence of Enterocytozoon bieneusi Infection on Child Growth: A Secondary Analysis of the MAL-ED Birth Cohort Study.",
        "abstract": "Malnutrition early day life global public health concern affect childrens growth result variety factors including pathogenic infections Enterocytozoon bieneusi microsporidian parasite cause diarrhea malnutrition children study aimed assess impact E bieneusi child growth MALED study multicountry birth cohort research project investigated relationship enteric infection malnutrition participating child eight countries customized realtime polymerase chain reactionbased TaqMan array card used study identify enteropathogens stool samples E bieneusi one target pathogens impact E bieneusi infection growth measure assessed Mixedeffect linear model used investigate relationship E bieneusi growth outcomes including lengthforage LAZ weightforage WAZ weightforlength WLZ Z scores endpoint last month measurement infected group significantly lower score noninfected group outcomes adjusted differenceindifference DinD value 053 95 CI 067 038 LAZ 038 95 CI 052 023 WAZ 022 95 CI 038 006 WLZ Enterocytozoon bieneusi infection identified factor associated reduced linear growth weight gain weight gain relative linear growth children underscoring importance treating infection",
        "mesh_terms": [
            "Humans",
            "Enterocytozoon",
            "Microsporidiosis",
            "Male",
            "Infant",
            "Female",
            "Child, Preschool",
            "Feces",
            "Birth Cohort",
            "Diarrhea",
            "Child Development",
            "Cohort Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39874594/"
    },
    {
        "pmid": "39865113",
        "title": "Unveiling the biological activities of Heliotropium indicum L. plant extracts: anti-inflammatory activities, GC-MS analysis, and in-silico molecular docking.",
        "abstract": "Heliotropium indicum wellknown diverse medicinal properties traditionally utilized treat ailment diabetes obesity bacterial infections inflammation diarrhea study aim explore antiinflammatory effect extract using vitro method assess druglikeness potential using docking PASS ADME Fractionations crude methanol extract CME undertaken nhexane NHF chloroform CHF ethyl acetate EAF GCMS analysis conducted using Agilent technologies fraction evaluated radical scavenging antiinflammatory property vitro Molecular docking performed PyRx Biovia Discovery Studio followed druglikeness analysis using Swiss ADME ethyl acetate fraction EAF showed highest DPPH scavenging activity IC50 43 μgml followed chloroform CHF IC50 1295 μgml nhexane fraction NHF ICsub50sub 176 μgml Catechin ICsub50sub 35 μgml EAF CHF also exhibited highest hydroxyl radical scavenging activity 5169 μgml EAF demonstrated significant antiinflammatory activity inhibiting heatinduced hemolysis 7190 hypotonicityinduced hemolysis 6718 AAPHinduced hemolysis 7252 400 μgml Six major phytoconstituents EAF identified GCMS docked COX2 ADME druglikeness evaluation using Lipinskis rule five confirmed compound acceptable pharmacokinetic property fulfill pharmaceutical formulation requirement study depicts first novel report GCMS compound silico analysis EAF CHF exhibit significant antiinflammatory activity indicating potential source developing new therapeutic agent treating inflammation",
        "mesh_terms": [
            "Plant Extracts",
            "Gas Chromatography-Mass Spectrometry",
            "Anti-Inflammatory Agents",
            "Molecular Docking Simulation",
            "Heliotropium",
            "Animals",
            "Humans",
            "Cyclooxygenase 2",
            "Antioxidants"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39865113/"
    },
    {
        "pmid": "39856628",
        "title": "Unveiling the future: Wavelet- ARIMAX analysis of climate and diarrhea dynamics in Bangladesh's Urban centers.",
        "abstract": "Diarrheal infection continue major public health concern Bangladesh especially urban area population density environmental variable increase dissemination risks Identifying intricate connection weather variable diarrhea epidemic critical developing effective public health remedies deploy novel approach WaveletAutoregressive Integrated Moving Average Exogenous Variable WARIMAX traditional Autoregressive Integrated Moving Average Exogenous Variable ARIMAX technique forecast incidence diarrhea analyzing influence climate factors Higher temperature associated greater diarrheal occurrences demonstrating vulnerability diarrheal epidemic weather fluctuations WaveletARIMAX method us wavelet analysis within ARIMAX structure better forecasting performance model fit standard ARIMAX model Based climatic variables WaveletARIMAX accurately predict diarrheal occurrence indicated mean absolute error MAE root mean squared error RMSE root mean squared logarithmic error RMSLE outcome highlight necessity employing advanced timeseries modeling tool WaveletARIMAX better understand anticipate climatehealth interactions WaveletARIMAX us wavelet analysis identify timevarying pattern climatedisease interactions providing useful insight public health initiatives result research implication climateadaptive health planning emphasizing need focused action reduce impact climate change diarrheal illness burden town cities",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Diarrhea",
            "Wavelet Analysis",
            "Forecasting",
            "Climate",
            "Incidence",
            "Urban Population",
            "Climate Change",
            "Urban Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39856628/"
    },
    {
        "pmid": "39854517",
        "title": "First report of MDR virulent Pseudomonas aeruginosa in apparently healthy Japanese quail (Coturnix japonica) in Bangladesh.",
        "abstract": "Pseudomonas aeruginosa P aeruginosa major pathogen associated condition like septicaemia respiratory disorders diarrhoea poultry particularly Japanese quail Coturnix japonica infection cause huge economical loss due high transmissibility mortality zoonotic potential study aimed isolate identify detect virulence genes profile multidrug resistance MDR P aeruginosa Japanese quail Oral rectal swab collected 110 apparently healthy quail bird across various district Bangladesh Bacterial isolation identification performed using cultural morphological biochemical polymerase chain reaction PCR methods Antibiotic susceptibility assessed using disc diffusion method virulence gene detected PCR Multivariable logistic regression used identify risk factor P aeruginosa infection conventional PCR method revealed 25 2273 quail bird positive P aeruginosa result showed quail bird Narsingdi five time likely harbor Pseudomonas specie OR 502 95 CI 1341884 compared Mymensingh Sadar Additionally quail bird younger eight week nearly six time higher odds OR 593 95 CI 1961791 carrying Pseudomonas compared older birds Female quail bird almost four time higher odds OR 377 95 CI 1301093 harboring Pseudomonas specie males 25 P aeruginosa isolates exhibited multi drugresistance MDR patterns Virulence gene analysis revealed consistent presence exoA rhlR isolates exoS exoY rhlI rhlAB showed variable distribution high prevalence MDR virulent P aeruginosa apparently healthy quail bird particularly Mymensingh Dhaka divisions highlight urgent need comprehensive One Health approach proactively address mitigate potential risk organism pose quail human populations",
        "mesh_terms": [
            "Animals",
            "Pseudomonas aeruginosa",
            "Bangladesh",
            "Drug Resistance, Multiple, Bacterial",
            "Pseudomonas Infections",
            "Coturnix",
            "Male",
            "Female",
            "Virulence",
            "Anti-Bacterial Agents",
            "Virulence Factors",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39854517/"
    },
    {
        "pmid": "39831075",
        "title": "Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital-Based Cross-Sectional Study.",
        "abstract": "Dengue mosquitoborne viral disease frequently cause seasonal outbreak Bangladesh particularly monsoon month June September Recent outbreak shown significant shift clinical manifestations including change timeframe serotype mixing study focused clinical hematological profile patient 2022 outbreak notably severe quantitative crosssectional study Dhaka Medical College Hospital classified 67 denguepositive patient dengue fever DF dengue fever warning sign DFWS severe dengue SD Fishers exact test Pearsons chisquared test Wilcoxon ranksum test conducted statistical analysis using R software version 42 significance established ipi  005 Predominantly male patient 76 aged 2140 63 middleclass patient Dhaka 57 formed majority patient 45 lacked regular drainage system Laboratory test showed 63 NS1 antigen nonspecific antigen 1 positivity 16 tested positive NS1 IgM Immunoglobulin M Symptoms included headache 84 retroorbital pain 51 joint pain 75 myalgia 72 vomiting 75 abdominal pain 69 diarrhea 39 shock 48 Thrombocytopenia present 61 patients 79 showing elevated hematocrit HCT levels Pedal edema pleural effusion ascites observed DF DFWS cases SD case exhibited distinct HCT level variations Accurate clinical laboratory assessment vital treatment prediction dengue outcome Bangladesh given severe manifestation dengue shock syndrome DSS characterized headache muscle pain thrombocytopenia anemia leukopenia potential neurological complication mortality Severe case involve critical plasma leakage leading DSS fluid accumulation respiratory distress potential multiorgan involvement Enhancing physician awareness regarding dengue case detection management along routine dengue testing recommended early diagnosis improved patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39831075/"
    },
    {
        "pmid": "39818269",
        "title": "FilmArray® effectively detects all clades of F41 but encounters challenges with other adenovirus species.",
        "abstract": "BioFire FilmArray® Gastrointestinal GI Panel widely used diagnostic tool designed detect genetic material 22 common pathogen responsible gastroenteritis including viruses bacteria parasites detect human adenovirus HAdV specie F particularly serotypes F40 F41 major cause diarrhea mortality children However potential shortcoming detecting HAdV specie limit effectiveness broader HAdV detection clinical setting outbreak investigations aim study evaluate ability GI Panel detect three clade HAdVF41 HAdV specie viz A31 B3 C1 C2 C5 C26 D56 Japan Eighteen stool sample analyzed five contained HAdVF41 13 contained HAdV species confirmed via PCR sequencing Although GI Panel reliably detected clade HAdVF41 failed detect species highlighting limited diagnostic utility beyond F4041 serotypes Considering high falsenegative rate nonF4041 species integrating complementary diagnostic method PCR crucial comprehensive HAdV detection finding underscore limitation GI Panel detecting nonF4041 species HAdVC commonly associated pediatric gastroenteritis specie important immunocompromised patients Complementary diagnostic methods PCR immunochromatographic assays essential ensure accurate HAdV detection especially vulnerable populations",
        "mesh_terms": [
            "Humans",
            "Adenoviruses, Human",
            "Feces",
            "Adenovirus Infections, Human",
            "Gastroenteritis",
            "Japan",
            "Diarrhea",
            "Child",
            "Child, Preschool",
            "Serogroup",
            "DNA, Viral",
            "Molecular Diagnostic Techniques"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39818269/"
    },
    {
        "pmid": "39803243",
        "title": "Investigation on Anti-Diarrheal and Antipyretic Activities of <i>citrus maxima</i> Seeds in Swiss Albino Mice Model.",
        "abstract": "Rutaceae family iCitrus maximai biggest among fruits tradtionally used several purpose due diverse ethnomedicinal phytochemical pharmacological activities Different portion plant used sedative antiinflammatory medications well treat coughs fevers asthma diarrhea ulcers diabetes scientific potential methanolic seed extract contain bioactive compounds similar found part plant extract derived seed already demonstrated potential biological activity Moreover many vivo vitro research work plants seeds Therefore current research work undertaken analyze antidiarrheal antipyretic potential methanolic extract iCitrus maximai seed MCM evaluate MCMs effectiveness treating diarrhea castor oilinduced diarrhea model utilized evaluating method antipyretic effect mouse measured using brewers yeast induced pyrexia model MCM 200 400 mgkg dos markedly reduced hyperpyrexia induced yeast effect remained persistent 4th hour administration castor oil induced diarrhea model methanolic seed extract showed high level dose dependent inhibition diarrhea 4 h following castor oil administration investigation necessary elucidate clarify specific causative agent responsible dosedependent effect observed finding present study suggest MCM seed extract may represent promising alternative development innovative antidiarrheal antipyretic compounds",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39803243/"
    },
    {
        "pmid": "39787644",
        "title": "Impact of water, sanitation, and hygiene indicators on enteric viral pathogens among under-5 children in low resource settings.",
        "abstract": "Poor water sanitation hygiene WASH primary risk exposure enteric viral infection study aimed describe role WASH condition practice risk factor enteric viral infection child 5 Literature risk factor associated allcause diarrhea mask taxaspecific driver diarrhea specific pathogens limiting application relevant control strategies analyzed data child enrolled Global Enteric Multicenter Study GEMS across seven study site December 2007 March 2011 case moderatetosevere diarrhea MSD asymptomatic controls MSD defined new acute diarrhea least one following criterion MSD dehydration based study clinicians assessment dysentery hospitalization diarrhea dysentery Multiple logistic regression used examine role water quality sanitation access hygiene facility enteric viral pathogen adjusted potential covariates Among MSD symptomatic child cases longer water retrieval time ≥15 v 15 min associated increased Norovirus aOR 133 95  CI 108164 Astrovirus aOR 143 95  CI 101202 scooping drinking water retrieval method associated lower Rotavirus aOR 077 95  CI 062096 higher Adenovirus aOR 23 95  CI 132411 infection compared nonusers Among asymptomatic child controls consumption nontube well drinking water associated higher Norovirus infection aOR 138 95  CI 101189 Longer drinking water retrieval time ≥15 v 15 min increased Norovirus aOR 147 95  CI 121178 Rotavirus aOR 151 95  CI 120189 infections Pouring aOR 051 95  CI 032083 scooping drinking water cup aOR 052 95  CI 032 086 lower Astrovirus infection restricted water access aOR 157 95  CI 121202 higher Rotavirus infection Handwashing cooking associated lower Astrovirus aOR 064 95  CI 047088 infection asymptomatic children analysis find significant effect poor sanitation different enteric viral pathogen examined Norovirus Astrovirus detected commonly subSaharan Africa Rotavirus less prevalent South Asia Though found statistically significant associations observe overall pattern WASH enteric viral pathogens finding provide insight guide research targeted intervention enteric viral pathogens responsible major burden pediatric diarrhea globally",
        "mesh_terms": [
            "Humans",
            "Sanitation",
            "Child, Preschool",
            "Hygiene",
            "Diarrhea",
            "Infant",
            "Water Microbiology",
            "Female",
            "Risk Factors",
            "Water Supply",
            "Male",
            "Water Quality",
            "Virus Diseases",
            "Resource-Limited Settings"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39787644/"
    },
    {
        "pmid": "39752594",
        "title": "Phytometabolites, Pharmacological Effects, Ethnomedicinal Properties, and Bioeconomic Potential of Velvet Apple (Diospyros discolor Willd.): A Review.",
        "abstract": "Diospyros discolor Willd commonly known velvet apple Mabolo underutilized fruit Traditionally various part D discolor used medicine treating dysentery diarrhea respiratory issues Pharmacologically plant exhibited diverse effects including antiacetylcholinesterase antiasthmatic antiaging antimicrobial antioxidant cytotoxic thrombolytic activities finding substantiate traditional uses particularly potential antidiabetic antidiarrheal analgesic antiinflammatory vasorelaxant agent plant notable rich aromatic profile containing 39 volatile compound fruit peel ester αfarnesene predominant compounds Volatile ester methyl butyrate ethyl dominate aroma Nutritionally fruit contains dietary fiber malic acid vitamins essential fatty acids flavonoids triterpenes Additionally bioactive compounds including flavonoids triterpenes dimeric naphthoquinone eg diospyrin isolated plant essential oil derived flower enhances bioeconomic health benefits Moreover D discolor hold bioeconomic potential biosorbent source timber edible fruits material synthesizing silver nanoparticles review consolidates current knowledge traditional uses phytometabolites pharmacological properties bioeconomic potential D discolor potential toxicity plant component also reviewed",
        "mesh_terms": [
            "Humans",
            "Diospyros",
            "Fruit",
            "Medicine, Traditional",
            "Phytochemicals",
            "Plant Extracts",
            "Animals",
            "Anti-Infective Agents",
            "Antioxidants"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39752594/"
    },
    {
        "pmid": "39745446",
        "title": "Assembly and performance of a cholera RDT prototype that detects both <i>Vibrio cholerae</i> and associated bacteriophage as a proxy for pathogen detection.",
        "abstract": "Cholera rapid diagnostic test RDTs vulnerable virulent bacteriophage predation hypothesized enhanced cholera RDT detects common virulent bacteriophage ICP1 might serve proxy pathogen detection previously developed monoclonal antibody mAb ICP1 major capsid protein objective design assemble firstofitskind RDT detects bacterial pathogen iVibrio choleraei associated virulent bacteriophage ICP1 Candidate mAbs expanded increase design option evaluated immunological assay ELISA western blot subset mAbs selected gold conjugation printing RDT detection limit prototype RDTs determined diarrheal stool addition ICP1 Three mAb candidate developed evaluated capsid decoration protein ORF123 tail fiber protein ORF93 prior mAb major capsid protein ORF122 single mAb sandwich RDT prototype ORF122 able detect ICP1 RDTs mAbs ORF123 ORF93 failed detect ICP1 single dualsandwich configurations Biologically relevant concentration ICP1 detected boiling stool ICP1 analysis electron microscopy EM suggested increased epitope availability boiling study demonstrate proof concept functional RDT detect primary pathogen common virulent bacteriophage proxy pathogen detection optimization required scaled production implementationIMPORTANCEThis paper represents important step forward address vulnerability cholera RDTs effect phage predation target iVibrio choleraei assembly evaluation RDT detects primary pathogen phage proxy primary pathogen innovative solution optimized evaluated clinical studies tool may become critical cholera response tool kit well represent diagnostic proofofconcept infectious agents",
        "mesh_terms": [
            "Cholera",
            "Vibrio cholerae",
            "Humans",
            "Bacteriophages",
            "Antibodies, Monoclonal",
            "Feces",
            "Capsid Proteins",
            "Diagnostic Tests, Routine",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39745446/"
    },
    {
        "pmid": "39741573",
        "title": "Anthelmintic Potential of Discarded <i>Litchi chinensis</i> Seeds: a sustainable approach to agricultural by-product utilization.",
        "abstract": "iLitchi chinensisi Sonn belonging Sapindaceae family historically used treatment gastrointestinal ailments including ulcers gastritis diarrhea infectionsii Plants Sapindaceae family demonstrated potential anthelmintic effects efficacy iL chinensisi remains barely investigated iL chinensisi seed often discarded waste however utilizing seed promotes sustainable practice may provide natural alternative conventional anthelmintics study aim investigate qualitative phytochemical evaluate anthelmintic efficacy iL chinensisi seed ethanolic extract LCSE Fresh iL chinensisi fruit collected local market peeled fruit removed aril seed washed airdried extracted ethanol qualitative phytochemical screening assessment anthelmintic property LCSE conducted using standard procedures time required paralysis death adult earthworm iEisenia fetidai assessed analyzing test solution five distinct dosage 5 25 50 75 100 mgmL Albendazole served standard distilled water functioned control Statistical analysis performed using twoway ANOVA followed Tukeys multiple comparison test GraphPad Prism version 1012 Qualitative analysis revealed LCSE rich phytochemicals including alkaloids anthraquinones carbohydrates flavonoid glycosides protein amino acids phenols terpenoids tannins anthelmintic activity LCSE albendazole dosedependent time required paralysis mortality decreased proportion concentration increased LCSE exhibited strong anthelmintic efficacy concentration 100 mgmL paralysis 1267 ± 033 death 14 ± 058 significantly greater albendazole paralysis 15 ± 115 death 1767 ± 115 finding suggests LCSE hold potent anthelmintic properties making promising natural alternative conventional treatment like albendazole",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39741573/"
    },
    {
        "pmid": "39738375",
        "title": "Pharmacokinetics of tebipenem pivoxil used in children suffering from shigellosis: a pilot study in Bangladesh.",
        "abstract": "increasing antibiotic resistance gramnegative bacteria including causing Shigellosis evidence safety pharmacokinetics data new oral antibiotic crucial aimed investigate safety pharmacokinetic property oral carbapenem tebipenem pivoxil along ability produce desired result childhood shigellosis randomized pilot clinical trial conducted Dhaka Hospital icddrb 2022 May September Thirty suspected shigellosis case aged 2459 month randomized across two treatment group equally tebipenem pivoxil azithromycin Pharmacokinetics tebipenem assessed among fifteen child received tebipenem pivoxil using Noncompartmental analysis NCA Clinical absence fever abdominal paintenderness diarrhoea blood stool death Day3 microbiological absence Shigella Day7 culture success antibiotic intervention also evaluated Sociodemographic clinical characteristic comparable randomization arms Twelve children azithromycin arm tebipenem arm positive Shigella culture enrolment Csubmaxsub value 50533 25460 37592 ngmL observed plasma tebipenem Day0 1 2 respectively Clinical success observed among seven participant arm two azithromycin arm three tebipenem arm failed microbiologically tolerability efficaciousness tebipenem pivoxil appear comparable azithromycin treating childhood shigellosis Bangladesh recommend larger clinical trial determine noninferiority tebipenem regard current treatment guidelines",
        "mesh_terms": [
            "Humans",
            "Carbapenems",
            "Male",
            "Female",
            "Pilot Projects",
            "Bangladesh",
            "Child, Preschool",
            "Dysentery, Bacillary",
            "Anti-Bacterial Agents",
            "Azithromycin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39738375/"
    },
    {
        "pmid": "39726651",
        "title": "Age-dependent pathogenic profiles of enterotoxigenic <i>Escherichia coli</i> diarrhea in Bangladesh.",
        "abstract": "Age play significant role susceptibility enterotoxigenic iEscherichia colii ETEC infections yet distribution ETEC virulence factor across age group remains understudied study investigated differential pathogenic profile ETEC across various age groups emphasizing importance selecting potential ETEC antigen tailored infection pattern infant adult Bangladesh study utilized icddrbs 2 systematic hospital surveillance data diarrheal patient ini  14515 2017 2022 examine agespecific pathogenesis clinical manifestation ETEC infections total ETEC identified 1371 94 surveillance samples ETECassociated diarrhea higher child aged 02 year decreased significantly 317 year age group Among ETEC cases 56 adult ipi  00079 severe dehydration Distinct agespecific distribution ETEC toxin type colonization factor CFs observed heat labile toxin LTassociated ETEC infection decreased age ipi  00001 heat stable toxin STassociatedETEC prevalent across ages Adults exhibited significantly higher rate ETEC diarrhea strain secreting type toxins high prevalence antimicrobial resistance among ETEC strains particularly pediatric cases significant resistance observed commonly used antibiotic azithromycin line similar age specific toxin profiles common CFs CFAI CS3 CS5 CS6 CS21 CFAI positive ETEC infection common child ipi  0001 CS5 CS6 common adult ipi  00001 finding provide valuable insight ETEC epidemiology pathogenesis clinical manifestations observation imply agerelated difference hostpathogen interaction exist ETEC infection may influence development targeted vaccine therapeutic use specific populations",
        "mesh_terms": [
            "Humans",
            "Enterotoxigenic Escherichia coli",
            "Bangladesh",
            "Escherichia coli Infections",
            "Diarrhea",
            "Infant",
            "Child, Preschool",
            "Adolescent",
            "Adult",
            "Child",
            "Female",
            "Male",
            "Age Factors",
            "Infant, Newborn",
            "Young Adult",
            "Middle Aged",
            "Virulence Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39726651/"
    },
    {
        "pmid": "39723026",
        "title": "Isolation, Structure Elucidation, and Bioactivity Evaluation of Two Alkaloids From <i>Piper chaba</i> H. Stem: A Traditional Medicinal Spice and Its Chemico-Pharmacological Aspects.",
        "abstract": "Bangladesh endowed abundance excellent medicinal plant resources wellknown traditional medicinal plant iPiper chabai H Piperaceae family rich bioactive phytochemical antidiarrheal antimicrobial analgesic antioxidant anticancer cytotoxic effects plant locally known Chuijhal stem used spices current research program stem iP chabai plant selected chemical biological investigation antidiarrheal antimicrobial analgesic effect performed Moreover docking model accomplished exploiting PyRxVirtual Screening software implied isolated compound iP chabai exert different pharmacological activity inhibiting targeted receptors Phytochemical investigation revealed isolation Chingchengenamide A relatively rare alkaloid stem iP chabai Another alkaloid Chabamide piperine dimer also isolated structure confirmed comparing compounds spectral data sup1supH sup13supC NMR previously published spectral data Antidiarrheal activity show percent reduction diarrhea 4667 40 respectively Chabamide Chingchengenamide at 20 mgkg bw compared 80 reduction standard loperamide Similarly percent reduction writhing 5306 4286 respectively Chabamide Chingchengenamide similar dos compared 80 reduction diclofenac sodium considered standard alkaloid showed auspicious outcome test microorganism disk diffusion antimicrobial assay Molecular docking ADMET analysis alkaloid also validate potent pharmacological basis traditional utilization iP chabai treating diarrhea pain microbial infection result emphasize need investigate iP chabai potential source natural therapy common health issues laying foundation future research",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39723026/"
    },
    {
        "pmid": "39714997",
        "title": "GC-MS Analysis, Neuropharmacological, and Antidiarrheal Activities of the Acetone Extract of Najas gracillima Seaweed: In Vivo and In Silico Study.",
        "abstract": "Najas gracillima marine seaweed found North America Asia investigated neuropharmacological antidiarrheal properties Acetone extract N gracillima ANG analyzed using vivo silico methods Gas chromatographymass spectrometry GCMS analysis conducted identify bioactive compound present extract vivo assessments including elevated plus maze lightdark box hole board tests showed ANG dos 200 400 mgkg exhibited significant p  0001 anxiolytic effects dos also demonstrated antidepressant effect forced swimming tail suspension test significantly p  0001 reducing immobility time 200 mgkg dose showing pronounced effects Sedative activity confirmed open field hole cross tests dos exhibited significant p  0001 sedative effects ANG also demonstrated significant antidiarrheal effect 400 mgkg castor oilinduced diarrhea p  005 gastrointestinal motility test p  001 Molecular docking simulation revealed compound ANG strong binding affinity critical drug target involved anxiety depression sleep disorders diarrhea finding suggest N gracillima hold potential therapeutic use treating neuropharmacological disorder diarrhea warranting investigation",
        "mesh_terms": [
            "Animals",
            "Antidiarrheals",
            "Seaweed",
            "Molecular Docking Simulation",
            "Gas Chromatography-Mass Spectrometry",
            "Plant Extracts",
            "Diarrhea",
            "Male",
            "Acetone",
            "Mice",
            "Anti-Anxiety Agents",
            "Dose-Response Relationship, Drug",
            "Antidepressive Agents",
            "Rats",
            "Computer Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39714997/"
    },
    {
        "pmid": "39705040",
        "title": "Understanding the Effectiveness of Water, Sanitation, and Hygiene Interventions: A Counterfactual Simulation Approach to Generalizing the Outcomes of Intervention Trials.",
        "abstract": "water sanitation hygiene WASH intervention reduce diarrheal disease many largescale trial found expected health gain young child lowresource settings Evidencebased guidance needed improve intervention remove barrier diarrheal disease reduction aimed estimate sensitive WASH intervention effectiveness underlying contextual intervention factor WASH Benefits WASHB Bangladesh clusterrandomized controlled trial investigator measured diarrheal prevalence child enrolled WASHB trial three time point approximately 1 year apart math xmlnshttpwwww3org1998MathMathMLmrowminmimomomn17187mnmrowmath observations developed susceptibleinfectioussusceptible model transmission across multiple environmental pathway evaluated four intervention water W sanitation S hygiene H nutrition N applied individually combination compliance interventions impact individual enrolled study Leveraging set mechanistic parameter combination fit WASHB Bangladesh trial using hybrid Bayesian samplingimportance resampling maximumlikelihood estimation approach simulated trial outcome counterfactual scenario estimate change six WASH factor preexisting WASH conditions disease transmission potential intervention compliance intervenable fraction transmission intervention efficacy community coverage impacted intervention effectiveness Increasing community coverage greatest impact intervention effectiveness eg median increase effectiveness 340 455 percentage point WSH WSHN intervention arm increasing coverage 20 effect community coverage effectiveness depended much transmission along pathway modified interventions Intervention effectiveness reduced lower level preexisting WASH condition increased baseline disease burden Individual intervention complementary synergistic effect combined realize expected health gains future WASH intervention must address community coverage transmission along pathway traditionally covered WASH effectiveness individuallevel WASH improvement reduced community achieving coverage needed herd protection httpsdoiorg101289EHP15200",
        "mesh_terms": [
            "Sanitation",
            "Humans",
            "Bangladesh",
            "Hygiene",
            "Diarrhea",
            "Child, Preschool",
            "Infant",
            "Water Supply",
            "Bayes Theorem",
            "Female",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39705040/"
    },
    {
        "pmid": "39702517",
        "title": "A fatal case of Vibrio cholerae-associated diarrhea and bacteremia in a 30-year-old carrier of beta-thalassemia.",
        "abstract": "Bacterial infection leading bacteremia septicemic shock constitute emerging public health concern globally especially area sanitation poor safe drinking water scarce Enteric pathogen Vibrio cholerae responsible many death caused contaminated food water areas cholera prominent clinical threat posed V cholerae outcome like bacteremia turning sepsis associated morbidity mortality increasing globally recent times Here report alarming case fatal sepsis probable association V cholerae bacteremia Bangladesh September 2023 30yearold man precondition betathalassemia presented tertiary care hospital acute diarrhea abdominal pain nausea fever died within 36 h admission acute cholecystitis metabolic acidosis acute kidney injury pancytopenia refractory septic shock multiorgan dysfunction syndrome Blood culture detected V cholerae characterized hemolytic carrying hemolysin gene gene virulence factor typethree secretion system isolate confirmed V cholerae nonO1O139 NOVC differed genetic property contemporary NOVC isolates associated diarrheal case Bangladesh manage diarrhea septicemic condition patient treated empirically metronidazole meropenem However antibiotic susceptibility testing showed strain susceptible routinely prescribed drug V cholerae infections best knowledge investigation provides first molecular description fatal case V choleraeassociated bacteremia Bangladesh underscore need comprehensive investigation bacterial septicemia prevent future casualties",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39702517/"
    },
    {
        "pmid": "39698191",
        "title": "Clinical and Laboratory Features and Treatment Outcomes of Dengue Fever in Pediatric Cases.",
        "abstract": "Background Globally dengue fever DF leading cause arthropodborne viral illness considerably contributes atrocious death rate disease endemic part world including Bangladesh disorder exhibit wide range clinical laboratory feature children Judicial fluid resuscitation critical phase prompt referral appropriate health facility lifesaving Objectives research appraised clinical laboratory feature treatment outcome DF pediatric cases Methods prospective investigative work conducted Islami Bank Hospital Dhaka India July October 2023 study included 135 admitted pediatric case DF either dengue nonstructural protein 1 NS1 antidengue antibody IgM IgG positive Results Among selected cases boy predominant girls patient age group 5 10 year n46 34 belonging lowermiddleclass family n56 415 study participant raised body temperatures abdominal pain n82 607 vomiting n77 57 cough n43 319 headache n38 282 body ache n32 237 diarrhea n23 17 Dengue NS1 positive 911 n123 cases Raised hematocrit found 363 n49 cases leukopenia 47 n63 thrombocytopenia 696 n94 cases patient categorized DF 681 n92 followed dengue warning sign 163 n22 severe dengue present 156 n21 patients treated crystalloid crystalloid colloid solution Fortunately recovered death Conclusion DF may manifest varied clinical laboratory feature children Appropriate treatment critical phases depending clinical laboratory features crucial reducing dengueinduced misery fatal clinical outcome among pediatric population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39698191/"
    },
    {
        "pmid": "39697535",
        "title": "First-time report on compound isolation from two <i>Colocasia</i> species: vegetable-derived bioactive metabolites and their medicinal potential.",
        "abstract": "iColocasia affinisi Schott iColocasia giganteai Hookf two commonly found vegetable specie genus iColocasiai found mainly Asian region objective study isolate bioactive phytochemical iC affinisi iC giganteai elucidate structure employing NMR technique followed bioactivity evaluation Column chromatography utilized isolate phytochemicals followed NMR analysis characterization iin vivoi analgesic test performed acetic acidinduced writhing test antiinflammatory test performed formalininduced licking test antidiarrheal test performed castor oilinduced diarrhea model iin vitroi antimicrobial test executed disc diffusion method Computeraided simulation also implemented validate wet laboratory results Six compound iC affinisi iC giganteai isolated characterized dichloromethane DCMsoluble fraction methanolic extract two species Three compound iC giganteai proposed penduletin bC1b mixture αamyrin bC2ab βamyrin bC2bb monoglyceride stearic acid bC3b remaining three compound iC affinisi proposed penduletin bC4b which also isolated iC giganteai 783″3″dimethylpyrano4hydroxy flavonol bC5b lastly mixture 783″3″dimethylpyrano4hydroxy flavonol bC5b 478trihydroxy flavonol bC6b compound showed promising zone inhibition Grampositive Gramnegative bacteria fungi antidiarrheal test bC5b demonstrated highest reduction castor oilinduced diarrhea 4444 dose 20 mgkg compared loperamides 7778 reduction However analgesic assessment showed noteworthy inhibition acetic acidinduced writhing bC1C4b bC2b 5652 dose 20 mgkg compared 7609 diclofenac sodium comparison bC2b showed pronounced antiinflammatory action 6815 5206 reduction respectively early later phase compared ibuprofens outcome 7354 7468 Plausible target dihydrofolate reductase DHFR antimicrobial kappa opioid receptor KOR antidiarrheal cyclooxygenase 2 COX2 antiinflammatory analgesic activity showed noteworthy binding affinity isolated compounds ADMET study displayed phytochemicals druglikeness profiles best knowledge first report compound isolation plants demand extensive research absolute findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39697535/"
    },
    {
        "pmid": "39694230",
        "title": "Coinfection and clinical impact of enterotoxigenic Escherichia coli harboring diverse toxin variants and colonization factors: 2017-2022.",
        "abstract": "severity diarrhea disease exacerbated coinfections involve Enterotoxigenic Escherichia coli ETEC enteric pathogens complicate diagnosis treatment study explores prevalence clinical manifestations risk factor ETEC coinfections Dhaka Bangladesh study used data Diarrheal Disease Surveillance System Dhaka Hospital involving 16276 patient 2017 2022 identified 1404 ETECpositive patient 16276 data point investigate association ETEC infections coinfections clinical outcomes ETEC identified 1404 86 cases representing common infection among adult 566 ETEC coinfection occurred combined V cholerae 23 Aeromonas 146 rotavirus 118 Campylobacter 65 Shigella spp 17 respectively Adults likely develop coinfections ETEC V cholerae child five likely develop ETEC coinfections rotavirus Coinfections V cholerae rotavirus Salmonella spp increased likelihood fever ETEC coinfections V cholerae increased risk vomiting dehydration intravenous fluids ETEC coinfections exacerbate illness severity overburden healthcare systems Policymakers prioritize resilient healthcare strategy ETEC coinfections",
        "mesh_terms": [
            "Humans",
            "Enterotoxigenic Escherichia coli",
            "Bangladesh",
            "Escherichia coli Infections",
            "Coinfection",
            "Adult",
            "Female",
            "Male",
            "Child, Preschool",
            "Child",
            "Middle Aged",
            "Infant",
            "Diarrhea",
            "Risk Factors",
            "Adolescent",
            "Young Adult",
            "Prevalence",
            "Rotavirus Infections",
            "Vibrio cholerae",
            "Bacterial Toxins",
            "Cholera",
            "Shigella"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39694230/"
    },
    {
        "pmid": "39687605",
        "title": "Pain determinants and quality of life in Guillain-Barre syndrome: a prospective cohort study.",
        "abstract": "Pain serious manifestation acute chronic stage GuillainBarre syndrome GBS evaluated frequency characteristic associated factor pain impact quality life QoL among patient GBS enrolled 644 patient GBS prospective cohort study Bangladesh conducted 2010 2024 Data collected enrolment standard followup time point 26 weeks Pain intensity measured pain numeric rating scale Group difference tested using χ² Fishers exact test longitudinal change analysed repeatedmeasures analysis variance correlation analysed Spearmans rank test median age patient 31 years 70 men enrolment 71 patient reported pain persisted among 38 week 13 26 week 26 Pain significantly associated disease severity muscle weakness treatment intravenous immunoglobulin acute chronic stages Patients acute pain higher proportion axonal GBS p0000 without pain Chronic pain associated higher age p0006 male sex p0000 preceding diarrhoea p0033 dysautonomia p0000 Higher pain intensity reported among woman p0027 patient higher age p0029 severe form GBS p0038 compared counter groups Acute pain significantly associated selfcare p0023 usual activities p0049 anxietydepression p0048 domain QoL whereas chronic pain associated anxietydepression p0005 domain Pain presented serious symptom negatively affecting QoL GBS Systematic evaluation pain recommended ensure personalised treatment approach GBS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39687605/"
    },
    {
        "pmid": "40824448",
        "title": "A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity.",
        "abstract": "Inherited dihydropyrimidine dehydrogenase DPD deficiency risk factor severe 5fluorouracil toxicity report phenotyping approach thymine challenge test prospectively determine DPD activity association severe adverse events primary aim prospective study determine whether thymine challenge test could prospectively identify patient risk severe toxicity treatment 5fluorouracilcapecitabine combination chemotherapy schedule monotherapy focus prediction risk ≥ grade 3 gastrointestinal toxicity DPD activity determined thyminedihydrothymine THYDHT ratio measured urine sample thymine test dose 250 mg oral 166 patients 117 severe diarrhoeamucositis THYDHT ratio significantly different individual compared minimal toxicity However post hoc analysis found decreased DPD activity nongastrointestinal toxicity notably grade ≥ 2 HandFoot syndrome p  0001 data support primary hypothesis phenotyping approach would discriminate risk severelifethreatening gastrointestinal toxicity clinical factor influence gastrointestinal toxicity particularly patient receiving CAPOX require investigation ACTRN 12617001109392 registered 28072017",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824448/"
    },
    {
        "pmid": "40823568",
        "title": "Paroxysmal nocturnal hemoglobinuria masquerading as hemolytic uremic syndrome: a Case Report.",
        "abstract": "Paroxysmal nocturnal hemoglobinuria PNH rare acquired disorder intravascular hemolysis caused somatic mutation gene responsible glycosylphosphatidylinositol GPIanchored complement regulatory proteins mutation lead production abnormal blood cell clone lacking CD55 CD59 PNH result renal damage challenge early identification diagnosis lead misdiagnosis intravascular hemolytic conditions paper present case began fever diarrhea acute renal failure initially misdiagnosed atypical hemolytic uremic syndrome aHUS later confirmed PNH renal biopsy related diagnostic tests treatment patients renal function recovered anemia improved Intravascular hemolysis prominent feature common PNH HUS exhibit similar clinical manifestations pose challenge differential diagnosis Unlike previous reports patient case denied history hematologic disorders made diagnosis challenging",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823568/"
    },
    {
        "pmid": "40823499",
        "title": "Management of <i>Clostridioides difficile</i> infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10).",
        "abstract": "iClostridioides difficilei infection CDI pose significant challenge patient haematological malignancy HM undergoing cellular therapy haematopoietic cell transplantation HCT CAR Tcell therapy patient high rate colonization iClostridioides difficilei diarrhoea due noninfectious causes leading challenge establishing diagnosis optimal management CDI especially setting molecular detection toxin gene alone Current severity criterion limited usefulness since underlying haematological disease treatment impact white blood count inflammatory manifestation severe CDI Extensive exposure antibiotics profound microbiota damage bidirectional relationship gastrointestinal graftversushost disease transplant complicate clinical management Therefore 10th European Conference Infections Leukemia ECIL10 group comprehensively reviewed literature published 0101201015092024 epidemiology treatment prevention CDI formulated consensus recommendation management CDI specific population New definition proven probable possible CDI population developed proposed use clinical research standardise reporting",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823499/"
    },
    {
        "pmid": "40821900",
        "title": "Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study.",
        "abstract": "HH2853 novel dual EZH12 inhibitor exhibit superior antitumour activity compared tazemetostat across various preclinical models Here evaluated safety pharmacokinetic PK pharmacodynamic PD preliminary efficacy HH2853 patient refractory advanced solid tumour nonHodgkin lymphoma NHLs openlabel global multicentre phase study conducted 12 centre China USA enrolling patient aged ≥18 years relapsed refractory solid tumour NHLs dose escalation seven predefined dose level HH2853 50 100 200 400 600 800 1000 mg orally twice daily 28 days evaluated using standard Bayesian optimal interval accelerated titration design Two dose level selected dose extension Primary endpoint safety doselimiting toxicity DLT maximum tolerated dose MTD recommended phase II dose RP2D Secondary exploratory endpoint included PKPD profile preliminary efficacy study registered ClinicalTrialsgov NCT04390737 Sept 8 2020 Feb 28 2023 61 patient received HH2853 Jan 5 2024 median followup 157 month interquartile range IQR 138177 Two DLTs observed patient 800 mg dose level MTD reached dose level 400 mg 600 mg selected dose extension RP2D determined 400 mg twice daily Treatmentrelated adverse event TRAEs grade occurred 58 patient 951 common TRAEs diarrhoea n  31 508 blood bilirubin increased n  29 475 anaemia n  23 377 common TRAEs grade ≥3 included anaemia n  7 115 diarrhoea n  5 82 platelet count decreased n  4 66 treatmentrelated death reported Among 57 efficacyevaluable patients 17 279 achieved objective response four complete response 13 partial responses Ten 17 objective response 588 observed patient epithelioid sarcoma ES objective response rate patient ES 313 95 confidence interval CI 160500 median progressionfree survival 160 month 95 CI 52191 HH2853 showed manageable safety profile encouraging antitumour activity refractory solid tumour NHLs particularly promising antitumour activity ES trial needed phase II trial HH2853 patient ES underway Science Technology Economic Commission Shanghai Pudong New Area Municipality Shanghai Haihe Biopharma Co Ltd",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821900/"
    },
    {
        "pmid": "40821810",
        "title": "Complex probiotics can reduce diarrhea by boosting immunity and balancing gut microbiota in weaned piglets.",
        "abstract": "SOLVENS SLV zootechnical feed additive based viable spore iBacillus licheniformisi iBacillus subtilisi study aimed evaluate effect SLV intestinal health weaned piglets total 360 healthy 24dayold weaned Duroc × Landrace × Yorkshire piglet allocated three treatment group based body weight sex T1 Control CON T2 SLV 200 65×10sup8sup CFU per kg feed T3 SLV 400 13×10sup9sup CFU per kg feed treatment consisted 30 replicates four pig per replicate experiment lasted 42 days Piglets fed mash prestarter feed days 114 mash starter feed days 1542 Growth performance fecal microorganisms serum immunity intestinal barrier function assessed Experimental data analyzed using SPSS 270 oneway ANOVA multiple comparison made using DUNCAN method Compared control SLV 200 SLV 400 significantly reduced diarrhea rate iPi  005 SLV 200 increased fecal iLactobacillii decreased iEscherichia colii day 14 iPi  005 SLV 400 elevated iLactobacillii day 14 42 reduced iE colii day 14 iPi  005 SLV 200 increased fecal sIgA serum IgG day 42 iPi  005 whereas SLV 400 elevated serum IgG IgM day 14 iPi  005 serum IgA day 42 iPi  005 Additionally SLV 200 downregulated ileal iinterleukin1βi iIL1βi itumor necrosis factorαi iTNFαi gene expression iPi  005 SLV 400 reduced iTNFαi expression iPi  005 Dietary supplementation SLV improved intestinal health modulating gut microbiota enhancing immunity weaned piglets",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821810/"
    },
    {
        "pmid": "40821754",
        "title": "Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss in Patients with Obesity or Overweight: A Systematic Review.",
        "abstract": "Tirzepatide dual GLP1GIP agonist show promise weight loss safety compared GLP1 receptor agonist requires liraglutide semaglutide clarification clinical decisionmaking systematic review evaluates safety profile patient obesity overweight conducted PRISMAcompliant systematic review PROSPERO CRD42024576314 RCTs PubMed Embase Cochrane inception August 20 2024 Adults BMI ≥27 kgm² ≥25 kgm² Asians receiving GLP1GIP dual agonist tirzepatide 10 15 mg GLP1 receptor agonist semaglutide 24 mg liraglutide 30 mg included Network metaanalysis NMA conducted using odds ratio 95 CIs Primary outcome adverse event AEs serious AEs NMA performed using Stata 161 network metaanalysis included 19 randomized controlled trial 13529 participants Liraglutide 30 mg significantly increased incidence adverse event OR  153200 compared semaglutide tirzepatide tirzepatide showed higher severe hypoglycemia risk 54 mgdL Notably GLP1GIP dual agonist demonstrated superior safety profile neoplasm vs liraglutide  515 1282074 v semaglutide  355 1101154 respiratory infectionsnasopharyngitis suggesting enhanced antiinflammatory effects GLP1 agonist fewer diarrhea injectionsite reaction higher abdominal paindyspepsia rates Subgroup analysis revealed nonT2DM patient significantly higher incidence adverse event compared T2DM patient P  005 significant association observed race BMI treatment duration Sensitivity analysis confirmed robustness funnel plot indicated publication bias Liraglutide 30 mg associated higher overall adverse events tirzepatide 10 15 mg showed increased severe hypoglycemia injectionsite reaction risk superior antiinflammatory antineoplasm effect compared GLP1 monoagonists finding highlight therapyspecific safety pattern critical personalized treatment selection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821754/"
    },
    {
        "pmid": "40821428",
        "title": "Myalgia and Rigidity as Adverse Effects of Trametinib Therapy.",
        "abstract": "Mitogenactivated extracellular kinase inhibitors including trametinib selumetinib increasingly used treat pediatric lowgrade gliomas Trametinib administered orally minimal myelosuppression reported cause rash diarrhea fatigue Selumetinib associated skin irritation diarrhea musculoskeletal pain case report describes 8monthold male lowgrade glioma LGG progressed 6 month postchemotherapy started trametinib due liquid formulation minimal side effect profile However patient developed severe diarrhea abdominal pain neck pain rigidity decreased stamina symptom necessitated discontinuation trametinib symptom resolved within week case highlight first reported instance trametinibinduced myalgia rigidity pediatric patient receiving trametinib therapy LGG Clinicians consider rare significant adverse effect choosing antineoplastic therapy treatment progressive LGG",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821428/"
    },
    {
        "pmid": "40821331",
        "title": "Invasive Gastric Candidiasis With Concurrent Clostridioides difficile Colitis: A Case Report and Review of the Literature.",
        "abstract": "Invasive gastric candidiasis rare fungal infection stomach often arising setting immunosuppression critical illness mucosal barrier disruption gut microbial alterations antibiotic use Though iCandida sppi normal flora within gastrointestinal tract compromised host defense contribute overgrowth invasion fungal specie deeper tissues report case 89yearold man presenting concurrent upper gastrointestinal bleeding diffuse gastric ulcer secondary invasive gastric candidiasis diarrhea resulting iClostridioides difficilei colitis pathophysiology diagnosis management invasive candidiasis well interaction gastrointestinal candidiasis iClostridioides difficilei infection discussed Overall case highlight interplay antibiotic use gut barrier translocation interaction microorganisms worsening infectious disease elderly patient Similarly stress importance maintaining high index suspicion fungal infection patient large atypical appearing gastric ulcers even absence overt immunosuppression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821331/"
    },
    {
        "pmid": "40821330",
        "title": "Synchronous Intestinal Tuberculosis and Ulcerative Colitis: A Diagnostic Challenge.",
        "abstract": "Intestinal tuberculosis ITB rare manifestation extrapulmonary tuberculosis often mimic inflammatory bowel diseases particularly ulcerative colitis UC complicating diagnostic process report case 54yearold woman poorly controlled type 2 diabetes presented fivemonth history abdominal pain diarrhea bloating fatigue lowgrade fever Initial imaging suggested feature consistent inflammatory bowel disease IBD colonoscopy revealed mucosal ulcerations Histopathological examination confirmed diagnosis ITB patient started standard antituberculous therapy However clinical improvement remained limited followup colonoscopy six month later demonstrated persistent inflammatory changes raising suspicion coexisting UC Initiation mesalamine therapy resulted significant symptom resolution case underscore diagnostic challenge posed overlapping gastrointestinal pathology ITB UC Timely recognition coexisting condition critical guiding appropriate treatment optimizing patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821330/"
    },
    {
        "pmid": "40821309",
        "title": "Recurrent Cholinergic Crisis Caused by Therapeutic-Dose Rivastigmine Patch in an Elderly Patient With Alzheimer's Disease: A Case Report.",
        "abstract": "Cholinesterase inhibitor ChEIs widely used treatment dementia conditions may rarely cause cholinergic crisis potentially lifethreatening complication report elderly female patient Alzheimers disease experienced three episode cholinergic crisis 32 month receiving therapeutic dose transdermal rivastigmine 18 mgday episode involved vomiting diarrhea diaphoresis neurological symptoms marked reduction serum cholinesterase level 5363 UL presentation first two episodes alternative diagnosis acute gastroenteritis possible pesticide exposure initially suspected cholinergic crisis secondary rivastigmine recognized third episode rivastigmine permanently discontinued resulting complete resolution acute chronic mild gastrointestinal autonomic symptoms case highlight diagnostic challenge cholinergic crisis elderly patient receiving ChEIs underscore importance considering condition unexplained gastrointestinal autonomic symptom occur even standard therapeutic dosing",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821309/"
    },
    {
        "pmid": "40820642",
        "title": "Unveiling Gastrointestinal Involvement in Hypopituitarism: Clinical Features and Treatment Approaches.",
        "abstract": "Hypopituitarism characterized deficiency one pituitary hormones lead diverse gastrointestinal GI manifestation often underrecognized particularly elderly patients symptoms ranging nausea constipation severe complication like malabsorption hepatic dysfunction significantly impact patient outcome addressed promptly review aim elucidate GI implication hypopituitarism focusing clinical features underlying mechanism therapeutic approaches emphasis hormone replacement therapy HRT potential benefit risks comprehensive literature review conducted explore relationship pituitary hormone deficiency GI function study synthesizes finding deficiency growth hormone GH adrenocorticotropic hormone ACTH thyroidstimulating hormone TSH gonadotropins prolactin arginine vasopressin affect gut motility nutrient absorption overall GI health Relevant study identified database searches clinical evidence evaluated highlight diagnostic therapeutic strategies GI manifestation hypopituitarism include nausea vomiting constipation malabsorption intestinal pseudoobstruction hepatic dysfunction driven specific hormonal deficiencies GH deficiency impairs gut motility mucosal integrity ACTH deficiency lead nausea nutrient malabsorption TSH deficiency cause slowed GI transit arginine vasopressin deficiency contributes dehydrationrelated constipation HRT including hydrocortisone levothyroxine GH alleviate symptoms overtreatment may result adverse effect gastric ulcers diarrhoea hyperglycaemia Multidisciplinary management including nutritional support symptomatic treatment crucial optimizing outcomes Hypopituitarism significantly impact GI function necessitating increased clinical awareness timely diagnosis management Tailored HRT combined vigilant monitoring overtreatment lifestyle interventions effectively address GI symptom improve quality life research needed clarify mechanism linking hormonal deficiency GI dysfunction refine therapeutic strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820642/"
    },
    {
        "pmid": "40819946",
        "title": "[Advantages and limitations of transcutaneous electrical acupoint stimulation in the treatment of patients with severe gastrointestinal function injury in intensive care unit: a prospective randomized controlled trial].",
        "abstract": "evaluate advantage limitation transcutaneous electrical acupoint stimulation TEAS treatment patient severe gastrointestinal function injury intensive care unit ICU analyzing dynamic change intestinal fatty acid binding protein IFABP Dlactic acid citrulline prospective singlecenter randomized controlled trial conducted Patients severe gastrointestinal function injury admitted ICU February 2021 January 2024 enrolled age  18 year old acute gastrointestinal injury AGI grade 2 3 stable hemodynamics Patients different AGI grade randomly assigned 11 ratio TEAS group control group using simple randomization group received conventional treatment enteral nutrition EN addition TEAS group underwent TEAS Neiguan Zusanli point 30 minute per session twice daily 7 days Baseline data including age gender underlying diseases primary diagnoses recorded Three intestinal biomarkers IFABP Dlactic acid citrulline measured 7 day treatment EN tolerance indicator 28 day survival status documented difference various indicator compared two groups subgroup analysis conducted based AGI grading interaction AGI grade TEAS analyzed 28day KaplanMeier survival curve generated groups Finally 133 patient included 68 TEAS group 65 control group Baseline characteristic comparable two groups comparison dynamic change intestinal biomarkers revealed IFABP level group decreased treatment compared pretreatment pronounced reduction TEAS group least square mean difference LS Mean difference corrected IFABP level two group observation period 023 μgL 95 confidence interval 95CI 045 001 statistically significant P  0041 Additionally significant interaction AGI observed P  0004 Posttreatment Dlactic acid level decreased group compared pretreatment significant reduction TEAS group LS Mean difference corrected Dlactic acid level 008 mmolL 95CI 011 005 statistically significant P  0001 interaction AGI also significant P  0005 significant change citrulline level two group treatment LS Mean difference corrected citrulline level 017 μmolL 95CI 187 153 statistically significant P  0845 significant interaction AGI observed P  0913 Comparison EN tolerance parameter two group revealed TEAS group longer total EN time hours 72±31 vs 60±28 higher total EN calorie kJ 11 46923±7 23734 vs 6 63876±5 09837 well higher 70 target caloric attainment rate 529 vs 323 compared control group all P  005 incidence abdominal distension EN lower TEAS group control group 235 vs 431 P  005 incidence diarrhea EN higher TEAS group 221 vs 77 P  005 significantly difference AGI grade reduction rate postEN vomitinggastric retention rate incidence feeding interruption 28day survival rate two groups Furthermore significantly interaction observation measure AGI KaplanMeier survival analysis showed significantly difference 28day cumulative survival rate TEAS group control group LogRank test P  0501 hazard ratio HR  081 95CI 043151 significantly interaction AGI P  0702 advantage TEAS treatment ICU patient severe gastrointestinal function injury lie ability reverse intestinal cell necrosis promote reconstruction intestinal barrier function Additionally gastrointestinal tolerance significantly improved duration total calorie EN increased However limitation TEAS therapy promote recovery intestinal cell absorption synthesis function target patients Moreover may lead nutrient solution overload due improved gastrointestinal tolerance Furthermore TEAS appear improve 28day cumulative survival rate target patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819946/"
    },
    {
        "pmid": "40818563",
        "title": "Genetically Tractable Rodent Models for Cryptosporidium hominis and C. parvum Infections: Identifying Differences in Infection Sites Between Host Species.",
        "abstract": "Cryptosporidiosis cause severe diarrhea child livestock However absence suitable rodent model led lack effective drug vaccines study genetically tractable rat mouse model developed two main cause human cryptosporidiosis Cryptosporidium hominis C parvum Neonatal mouse rat successfully infected two nonhuman primateadapted C hominis isolates one C parvum IId isolate resulting high oocyst shedding Using isolates tagged fluorescent protein luciferases enabled easy detection quantification oocyst shedding Cryptosporidium specie primarily infected ileum cecum colon neonatal mice contrast parasite primarily colonized duodenum jejunum neonatal rats specie responded treatment lysyltRNA synthetase inhibitor rat model Developing tractable animal model different infection site allow comparative study biology immunity major humanpathogenic Cryptosporidium species well evaluation potential drug vaccines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818563/"
    },
    {
        "pmid": "40816579",
        "title": "Safety and efficacy of Artemisia argyi extract RW0117 for functional dyspepsia: A randomized, double-blind, placebo-controlled clinical study.",
        "abstract": "Artemisia argyi A argyi herbaceous perennial plant long employed traditional medicine management gastrointestinal condition abdominal pain gastric ulcer diarrhea gastritis evaluate efficacy safety RW0117 ethanol extract A argyi alleviating symptom functional dyspepsia FD randomized doubleblind placebocontrolled clinical trial participant randomly assigned receive either one tablet RW0117 680 mgday containing 240 mg ethanol extract A argyi one placebo tablet 12 weeks primary outcome change baseline gastrointestinal symptomrating scale GSRS Secondary outcome included change baseline total GSRS score gastrointestinal symptom GIS Nepean Dyspepsia IndexKorean version NDIK score Functional Dyspepsiarelated Quality Life FDQoL adverse events study showed five individual symptom upper abdominal GSRS two symptom lower abdominal GSRS well total GSRS scores improved significantly RW0117 group compared placebo group Furthermore patient receiving RW0117 showed significant improvement GIS NDIK FDQoL score end treatment compared placebo group conclusion treatment RW0117 safe showed significant potential reducing FD symptoms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816579/"
    },
    {
        "pmid": "40816116",
        "title": "Promoting sow-piglet information transfer and playful foraging by changes in pen design and feeding strategy to ease weaning: effects on pig performance and behaviour.",
        "abstract": "Strategies inspired natural behaviour pigs including learning sow playful foraging may alleviate behavioural problem weanling piglet enhance performance investigated effect family feeding system Fs dietary treatment providing family feeds Ff 2 × 2 design performance behaviour day 35 postweaning Sows n  104 piglet either kept Fs conventional system Cs fed either Ff Cf Fs sow could obtain feed throughout day provided plate accessible piglets Piglets sow could also jointly drink explore enrichment materials piglet feeder identical systems Fs contained enrichment material stimulate playful foraging Piglets weaned 27 day age Ff piglet feed offered postnatal day 2 day 9 postweaning contained artificial flavour several ingredient Ff sows diet allowing flavour transfer varying pellet size length increase texture diversity Fs piglet were apart piglet feed provided sow feed first 45 postweaning days Sow piglet performance body damage number eater postweaning behaviour diarrhoea determined Less Fs Cs sow shoulder lesions Fs proportion eaters preweaning piglet growth weaning weight higher day 9 postweaning Fs piglets feed intake higher growth lower possibly due higher incidence diarrhoea period BW day 35 postweaning unaffected system Ear tail damage body lesion score decreased Fs compared Cs piglet pre postweaning along ear tail biting behaviour postweaning Ff affect preweaning performance increased postweaning diarrhoea day 9 proportion piglet damaged ear day 9 tail biting frequency effect postweaning growth postweaning intake sows feed Fs piglet use ingredient sows diet Ff piglet diet might partly explain high incidence diarrhoea piglets thereby absence positive effect Fs Ff postweaning gain conclusion strategy based natural behaviour pig seem promising enhance piglet welfare around weaning adjustment postweaning nutritional need required",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816116/"
    },
    {
        "pmid": "40815944",
        "title": "Qu-yu-jie-du decoction maintenance therapy improves postoperative survival in metastatic colorectal cancer: a single-center randomized trial with 36-month follow-up.",
        "abstract": "Quyujiedu QYJD decoction established traditional Chinese medicine TCM formulation ten years empirical evidence support benefit colorectal cancer patients yet RCT validation postoperative maintenance therapy lacking Despite achieving evidence disease NED status curativeintent resection metastatic colorectal cancer mCRC 60  patient relapse within five years guidelinerecommended maintenance therapy determine whether QYJD decoction improves diseasefree survival DFS modulates inflammationlactate metabolism postoperative mCRCNED patients singlecenter randomized trial 140 stage IV mCRC patient achieving postresection NED status randomized ratio 11 either QYJD group 200 mLday 2 years control group routine followup Two patient per group withdrew consent prior intervention resulting intentiontotreat ITT population 136 patient 68 per group final analysis received standard adjuvant chemotherapy primary outcome DFS secondary outcome OS 123year survival rates adverse events inflammationlactate metabolism markers Compared control group QYJD decoction significantly improved DFS throughout observation period HR  0515 p  0004 1year DFS rate 912  6268 QYJD group versus 735  5068 control group p  001 2year DFS rate 569  4068 QYJD group versus 351  2568 control group p  0002 3year DFS rate 474  3268 QYJD group versus 324  2268 control group p  003 Significant difference observed across time point 1year 2year 3year DFS Regarding overall survival OS 2year OS rate 954  6568 QYJD group versus 851  5868 control group p  001 3year OS rate 687  4768 QYJD group versus 577  3968 control group HR  0407 p  0019 QYJD also significantly reduced inflammatory marker lactate dehydrogenase LDH p  005 common adverse event grade 1 hematologic toxicity anorexia diarrhea nausea generally mild manageable QYJD decoction significantly improves DFS show OS benefit postoperative mCRCNED patients also reduces systemic inflammationLDH term safety cause mild adverse events Chinese Clinical Trial Registry ChiCTR2100053521 registered November 24 2021",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815944/"
    },
    {
        "pmid": "40815117",
        "title": "Safety and Efficacy of Givinostat for patients with Muscular dystrophy: A Systematic review.",
        "abstract": "Muscular dystrophyMD refers group genetic disorder leading progressive weakness degeneration skeletal muscle Among them Duchenne muscular dystrophyDMD Becker muscular dystrophyBMD common types Histone deacetylaseHDAC inhibitorsie Givinostat recently approved therapy DMD systematic review aim evaluate Givinostat MD patient regarding safety efficacy systematic review performed according PRISMA guideline searching Medline Embase Cochrane Library Web Science RCT comparing Givinostat v placebo therapy included primary outcome motor function alteration histopathologic muscle change secondary outcome adverse reactions total 188 record identified screening two clinical trial met inclusion criteria DMD patients Givinostat significantly slowed disease progression improving four stairclimb time p0037 reducing muscle fat infiltration BMD patients fibrosis progression significantly different p08282 MRI showed reduced muscle fat replacement Common adverse event included diarrhea thrombocytopenia hypertriglyceridemia leading dose reductions though new safety signal treatmentrelated death observed Givinostat seems effective slowing disease progression DMD little benefit BMD safety profile requires rigorous monitoring Efficacy difference might explained pathophysiology disease progression rate Larger longer followup trial warranted confirm longer term benefit optimize dosing strategies Givinostat offer potential diseasemodifying therapy DMD requires investigation establish role BMD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815117/"
    },
    {
        "pmid": "40814560",
        "title": "Efficacy and safety of EGFR-TKI for EGFR-mutated NSCLC: systematic review and network meta-analysis.",
        "abstract": "Afatinib Dacomitinib Osimertinib Aumolertinib Furmonertinib Gefitinib Erlotinib Icotinib shown work safe people epidermal growth factor receptor EGFRpositive nonsmall cell lung cancer NSCLC recent years difference efficacy safety lack comparative trial cause clinical confusion treatment selection study analyzes efficacy safety via network metaanalysis inform clinical decisions searched PubMed Embase Cochrane Library Web Science pertinent studies objective response rate ORR median progressionfree survival mPFS time treatment failure TTF median overall survival mOS adverse event AEs extracted efficacy analysis Afatinib greatest ORR SUCRA959 outperforming Gefitinib SUCRA227 Icotinib SUCRA307 Furmonertinib longest mPFS SUCRA926 outperforming Gefitinib SUCRA101 Afatinib SUCRA118 Dacomitinib best TTF SUCRA841 followed Afatinib Icotinib longer TTF Gefitinib SUCRA70 safety evaluations Aumolertinib performed best overall grade 15 AEs SUCRA300 highgrade ≥3 AEs safety SUCRA95 Afatinib worst overall safety rating SUCRA683 Osimertinib worst highgrade ≥3 AEs profile Afatinib Osimertinib showed significantly greater grade ≥3 AEs compared Furmonertinib Icotinib Gefitinib Aumolertinib reduced frequency rash diarrhea AfatinibDacomitinib increased risk vomiting network metaanalysis reveals firstline treatment thirdgeneration EGFRTKI Furmonertinib exceptional advantage mPFS safety suited patient longterm disease control needs Although secondgeneration Afatinib highest objective remission rate also increase possibility grade ≥3 AEs Clinically personalized program devised based patients mutation type tolerance factors headtohead trial required future validate finding optimize treatment techniques",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814560/"
    },
    {
        "pmid": "40813488",
        "title": "Fecal gut microbiome alterations and its association with lactose intolerance in children with rotavirus infection-related diarrhea.",
        "abstract": "Rotavirus RV major cause childhood diarrhea damage intestinal epithelium may induce lactose intolerance patients Increasing study emphasized importance dysregulated gut microbiome community diseases study fecal sample rotavirusinfected child n  48 healthy control n  29 analyzed based 16S rRNA gene sequencing clinical data rotavirusinfected group stratified lactose tolerance status investigate distinctive feature gut microbial communities study verified shift gut microbiome constitution abundance feces healthy donor rotavirus infection children Notably Agathobacter Streptococcus Veillonella Roseburia significantly increased rotavirus infection patients relative abundance Ruminococcus gnavus group decreased Analyses alpha diversity unveiled significant difference abundance gut microbiota rotavirus infection patient without lactose intolerance particular abundance Parasutterella Lachnospiraceae NK4A136 group Morganella Veillonellaceae unclassified decreased significantly rotavirus infection patient lactose intolerance Further PLR inflammatory hematological ratio significantly elevated rotavirus infection patient lactose intolerance Overall study indicated characteristic change diversity taxonomy function gut microbiota rotavirus infection healthy control children revealing existence dysbiosis rotavirus infection Further analysis identified compositional uniqueness gut microbiota rotavirus infection patient without lactose intolerance highlighting diversity taxonomy gut microbiome association inflammatory state • Rotavirus causing diarrhea child worldwide causing damage intestinal epithelium lactose intolerancerelated diarrhea children • Results demonstrated characteristic change gut microbiome rotavirusinfected child investigated different gut microbiome composition rotavirus infectionrelated lactose intolerance lactose tolerance patients • Further relationship gut microbiome inflammatory hematological ratio explored",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813488/"
    },
    {
        "pmid": "40813226",
        "title": "New Onset Systemic Lupus Erythematous After Kidney Transplant: Case Report.",
        "abstract": "diagnosis new onset autoimmune disease kidney transplant patient challenging new onset SLE kidney transplant rare condition case reported describe case kidney transplant patient who 9 year presented intermittent fever diarrhea inflammatory migratory polyarthralgia myalgias cramp erythematous rash cleavage area Immunological testing revealed positive antinuclear antibody ANA 1640 antidoublestranded DNA antibody 532 IUmL elevated beta2 microglobulin 10559 UmL leading diagnosis de novo SLE according EULARACR 2019 criteria Notably patient exhibited evidence renal involvement onset stable kidney function normal urinary sediment throughout followup Ten month undergoing treatment corticosteroid belimumab partial clinical serological improvement case highlight rare presentation posttransplant SLE without renal involvement reinforcing need high index suspicion transplant recipient presenting nonspecific inflammatory symptoms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813226/"
    },
    {
        "pmid": "40813099",
        "title": "From poverty to health: intraurban inequalities in child health indicators in low-income and middle-income countries during the SDG era.",
        "abstract": "Urban area generally associated better health outcomes However many lowincome middleincome country LMICs rapid urbanisation led significant health disparities inequalities especially affecting urban poor often overlooked study focused solely ruralurban differences study aimed assess overall countryspecific intraurban inequality under5 neonatal mortality rates immunisation coverage careseeking acute respiratory infection ARIs coverage diarrhoea treatment stunting wasting overweight child 5 Demographic Health Survey datasets collected since 2015 48 LMICs analysed constructed urban poor cluster using United Nations Human Settlements Programme definition slum categorised urban poor urban nonpoor clusters Wagstaff normalised concentration index WCI concentration curve used assess urban povertyrelated inequality child health indicators LMICs 137 95 CI 136 139 urban child lived poor clusters 65 urban cluster classified poor Chad Ethiopia Afghanistan child health indicators except neonatal mortality exhibited significant inequality urban poor nonpoor Despite inconsistency across countries prourban poor inequality under5 mortality WCI0069 stunting WCI0121 wasting WCI0088 Full vaccination coverage WCI0078 overweight WCI0087 careseeking child acute respiratory infection WCI0131 receiving oral rehydration salt zinc diarrhoea WCI0127 showed prourban nonpoor inequality LMICs Substantial intraurban inequality observed child health indicators Under5 mortality stunting wasting concentrated among urban poor children health service utilisation overweight concentrated among urban nonpoor children Improving access clean water sanitation quality healthcare education underserved urban areas along combating urban poverty promoting healthy lifestyles essential achieving better health outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813099/"
    },
    {
        "pmid": "40811904",
        "title": "Roridin E and satratoxin H, macrocyclic trichothecene mycotoxins, induce endoplasmic reticulum stress-dependent apoptosis through ribosome interaction in B16 mouse melanoma cells.",
        "abstract": "Podostroma cornudamae commonly known red deers horn mushroom highly toxic specie responsible severe poisoning characterized vomiting diarrhea dehydration impaired consciousness potentially death mushroom notorious content macrocyclic trichothecene mycotoxins ongoing research aimed discovering bioactive natural compounds isolated thirteen macrocyclic trichothecene mycotoxin P1P13 methanol extract plate culture P cornudamae chemical structure mycotoxin elucidated analysis nuclear magnetic resonance NMR spectroscopy highresolution electrospray ionization mass spectrometry HRESIMS macrocyclic trichothecene mycotoxin previously reported exhibit antifungal antiviral anticancer activities antimelanoma effect documented date study examined cytotoxicity isolated mycotoxin P1P13 mouse melanoma B16F10 cell explored underlying molecular mechanisms Among isolated compounds P1 roridin E P5 satratoxin H exhibited substantial cytotoxicity demonstrated dosedependent inhibition cell proliferation increased expression level cleaved caspase3 Bax elevated intracellular reactive oxygen specie ROS Importantly cytotoxic effect elicited roridin E satratoxin H significantly attenuated following scavenging ROS glutathione GSH Additionally molecular docking analysis indicated high binding affinity roridin E satratoxin H toward ribosomal targets Treatment two mycotoxin led increased expression critical endoplasmic reticulum ER stress biomarkers activation unfolded protein response UPR signaling pathway involving activating transcription factor 6 ATF6 protein kinase RNAlike endoplasmic reticulum kinase PERK inositolrequiring enzyme 1 IRE1 Collectively finding suggest roridin E satratoxin H induce ER stressmediated caspasedependent apoptosis melanoma cells result highlight potential macrocyclic trichothecene mycotoxin promising therapeutic candidate melanoma treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811904/"
    },
    {
        "pmid": "40810941",
        "title": "Prevalence and Treatment of Diarrhea Among Children in India, 2016-2021.",
        "abstract": "World Health Organization recommends use oral rehydration solution ORS treatment child diarrhea India adherence guideline remains far less complete elucidate geographic variation ORS treatment child diarrhea within Indias 720 districts repeated crosssectional study used data 2 round Indias National Family Health Survey 2016 2021 Complete diarrhea data available 246 695 child 2016 223 785 child 2021 720 district waves Data ORS treatment available 22 413 child 2016 15 302 child 2021 child lived 716 Indias 720 district 2016 718 district 2021 data analyzed October 2024 primary outcome districtlevel percentage child received ORS treatment diarrhea past 2 weeks prevalence diarrhea also estimated value estimated outcome 2016 2021 change time could estimated SD communitylevel prevalence child received ORS treatment district measure withindistrict inequality also estimated 2016 2021 study included 246 695 child younger 5 year mean SD age 20 14 years 128 098 boy 118 597 girls diarrhea prevalence 22 413 child younger 5 year mean SD age 15 13 years 12 050 boy 10 363 girls ORS treatment 2016 study also included 223 785 child younger 5 year mean SD age 20 14 years 115 632 boy 108 153 girls diarrhea prevalence 15 302 child younger 5 year mean SD age 16 14 years 8160 boy 7142 girls ORS treatment 2021 92 95 CI 9193 child diarrhea 2 week prior survey 2016 506 95 CI 500513 treated ORS 2021 73 95 CI 7274 child diarrhea 607 95 CI 599615 treated ORS considerable betweendistrict variation prevalence ORS treatment child diarrhea as 2021 state Union Territory lowest districtlevel prevalence ORS treatment Haryana 490 state Union Territory highest districtlevel prevalence ORS treatment Jammu Kashmir 834 prevalence ORS treatment decreased 249 percentage point 185 district 2016 2021 even though nationally prevalence ORS treatment increased period median 575 IQR 472665 median 624 IQR 569725 Finally many district high prevalence child diarrhea low prevalence ORS treatment 71 districts prevalence child diarrhea increased prevalence ORS treatment decreased 2016 2021 crosssectional study prevalence child diarrhea treatment ORS India found prevalence ORS treatment child diarrhea increased national level 2016 2021 increase even within Indias 720 districts finding suggest effort aimed promoting ORS treatment child diarrhea India must address placebased factor might associated underuse treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810941/"
    },
    {
        "pmid": "40810318",
        "title": "Is budesonide on demand an option for microscopic colitis treatment? A qualitative study on patient's perspective.",
        "abstract": "Budesonide standard treatment microscopic colitis MC effectively alleviating diarrhoea However diarrhoea recurrence upon discontinuation raise idea feasibility ondemand treatment selfmanagement emphasized care chronic diseases less known patients perspective initiating budesonide ondemand qualitative study conducted using semistructured interview 15 patient diagnosed MC previous experience budesonide treatment Data analysed using qualitative content analysis explore patients perception ondemand treatment Three main category emerged 1 bSelfmanagement confidence handling flaresb Patients expressed strong desire selfmanagement valuing ability initiate treatment independently flares However hesitant due uncertainty proper dosing treatment duration 2 bPerceptions budesonide attitude towards medicationb budesonide perceived highly effective concern longterm use side effects potential loss efficacy influenced adherence adjusted dos based diarrhoea others preferred guidance physician initiating treatment 3 bThe role healthcare treatment decisionsb Patients emphasized importance accessible healthcare clear treatment guidelines structured followup Many felt healthcare provider focused primarily prescribing medication rather providing holistic approach model integrating personcentred care professional guidance seen ideal optimizing treatment outcomes Ondemand budesonide treatment could provide patient greater flexibility requires individualized support structured approach balance selfmanagement followup personcentred guidance may enhance adherence improve quality life patient MC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810318/"
    },
    {
        "pmid": "40810084",
        "title": "Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis.",
        "abstract": "Immune checkpoint inhibitor ICIs cause severe gastrointestinal immunerelated adverse event irAEs often leading treatment interruption increased morbidity Immunemediated colitis IMC range mild diarrhea lifethreatening colitis sometimes requiring urgent intervention corticosteroid firstline treatment selective immunosuppressive therapy SIT either infliximab vedolizumab used steroidrefractory dependent cases However standardized practice lacking treatment decision largely left provider discretion study compare infliximab vedolizumab IMC focusing remission rates recurrence SIT dosing systemic steroid exposure duration identified six retrospective cohort study compared infliximab vedolizumab treatment IMC systematic search PubMed EMBASE Cochrane Library Scopus CINAHL Google Scholar Web Science English inception October 2024 identified literature extracted pertinent data remission recurrence IMC Pooled analysis heterogeneity analysis performed using R Studio version 441 risk bias assessed using NewcastleOttawa Scale total six study 645 patient included ICIassociated colitis vedolizumab associated lower recurrence rate odds ratio OR 029 95 confidence interval CI 015  054 shorter systemic steroid exposure mean difference MD 1688 days 95 CI 2047 1330 compared infliximab vedolizumab showed improved remission statistically significant difference remission rate vedolizumab infliximab monotherapy OR 316 95 CI 029  3401 Remission achieved fewer dos infliximab vedolizumab MD 116 95 CI 009  222 mean number vedolizumab dos 257 raw mean score MRAW 257 95 CI 143  271 mean number infliximab dos 136 MRAW 136 95 CI 069  202 Among patient ICIinduced colitis vedolizumab demonstrated superiority infliximab associated lower rate colitis recurrence decreased systemic steroid exposure although required higher number dos compared infliximab",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810084/"
    },
    {
        "pmid": "40809648",
        "title": "Adult Measles Outbreak in New Jersey: The Dangers of Declining Vaccination Rates.",
        "abstract": "case highlight rare presentation measles unvaccinated adult male New Jersey emphasizing risk posed declining vaccination rates outbreak linked case illustrates public health danger vaccine hesitancy insufficient immunization coverage 32yearold male presented five day worsening fever nausea vomiting diarrhea spreading maculopapular rash Physical examination revealed petechial lesion soft palate lacypatterned rash tachycardia Laboratory finding included thrombocytopenia electrolyte imbalances hyperglycemia elevated liver enzymes Serologic testing confirmed diagnosis measles patient received supportive care delay isolation protocol resulted secondary transmission four unvaccinated contacts including three child one adult Public health authority alerted outbreak containment measure implemented case underscore critical role vaccination preventing measles outbreak need proactive public health strategy address vaccine hesitancy serf reminder consequence declining vaccination rate importance maintaining herd immunity protect vulnerable populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809648/"
    },
    {
        "pmid": "40809193",
        "title": "The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia.",
        "abstract": "antiapoptotic protein myeloid cell leukemia 1 Mcl1 promotes cell survival acute myeloid leukemia AML overexpression associated resistance venetoclax Voruciclib oral cyclindependent kinase 9 inhibitor indirectly decrease Mcl1 protein expression synergistic activity venetoclax AML preclinical models hypothesized voruciclib combination venetoclax would induce response patient AML disease progression venetoclax therapy doseescalation study evaluated voruciclib administered day 1 14 28day cycle venetoclax daily study enrolled 41 adult patient AML failure previous standard therapies Patients median 2 range 17 previous line therapy 19 patient 46 ≥3 previous line therapy 39 95 previous venetoclax doselimiting toxicity reported 7 dose level evaluated common adverse event nausea 34 febrile neutropenia 32 diarrhea 22 dyspnea 22 hypokalemia 22 thrombocytopenia 22 Antileukemic activity observed 10 24 patients including 3 complete marrow remission 7 stable disease lasting ≥3 months observed rebound circulating blast 14 day singleagent venetoclax dosing 40 evaluable patients Mcl1 protein expression RNA polymerase II Ser2 phosphorylation decreased voruciclib Overall combination voruciclib venetoclax tolerable patient relapsedrefractory AML antileukemic activity showed ontarget effect heavily pretreated patient disease progression venetoclax trial registered wwwClinicalTrialsgov NCT03547115",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809193/"
    },
    {
        "pmid": "40807514",
        "title": "Impact of Chitooligosaccharide Conjugated Epigallocatechin Gallate and Non-Thermal High-Voltage Atmospheric Cold Plasma on <i>Vibrio parahaemolyticus</i>: An In Vitro Study and the Use in Blood Clam Meat.",
        "abstract": "iVibrio parahaemolyticusi leading cause bacterial diarrhea human shellfish consumption Thailand blood clam popular shellfish homemade cooking often result insufficient heating Therefore consumer may suffer food poisoning due iVibrioi infection study aimed determine effect chitooligosaccharide conjugated epigallocatechin gallate COSEGCG different concentration 200 400 ppm combined highvoltage atmospheric cold plasma HVACP inhibiting iV parahaemolyticusi vitro challenged blood clam meat Firstly HVACP condition optimized gas composition treatment time 20 60 s 70 Ar 30 Osub2sub gas mixture resulted highest ozone formation treatment time 60 used study COSEGCG conjugate 400 ppm HVACP ACPCE400 completely killed iV parahaemolyticusi incubation 37 °C 6 h Furthermore antibacterial ability ACPCE400 treatment bacterial cell advocated due increased cell membrane damage permeability leakage protein nucleic acids Scanning electron microscopy SEM showed cell elongation pore formation confocal microscopy revealed disrupted biofilm formation Additionally shelf life challenged blood clam meat treated ACPCE400 extended nine days SEM analysis revealed damaged bacterial cell meat surface ACPCE400 treatment indicating antibacterial activity combined treatment Thus HVACP combined COSEGCG conjugate especially highest concentration 400 ppm effectively inhibited microbial growth extended shelf life contaminated blood clam meat",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807514/"
    },
    {
        "pmid": "40807050",
        "title": "Constipation in Ulcerative Colitis: An Underestimated Problem.",
        "abstract": "Ulcerative colitis chronic intestinal disorder belongs category inflammatory bowel diseases usually characterized presence bloody diarrhea abdominal pain due accelerated transit intestinal sensibilization following inflammation colonic mucosa However literature report ulcerative colitis may sometimes feature fecal stasis constipation apparent paradox may partially explained motor abnormality large bowel following inflammation damage enteric innervation onset parietal fibrosis time Moreover anorectal abnormality pelvic floor dyssynergia may explain symptom constipation reported subset patients Since abnormality may responsible diagnostic delay non partial response therapy important recognize early possible avoid incorrect clinical therapeutic approach patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807050/"
    },
    {
        "pmid": "40805239",
        "title": "Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study.",
        "abstract": "study aimed assess realworld toxicity efficacy data patient early advanced breast cancer BC received treatment abemaciclib prospectiveretrospective multiinstitutional collection clinicopathological toxicity outcome data patient early metastatic hormone receptor HRpositive human epidermal growth factor receptor 2 HER2negative BC received treatment abemaciclib combination endocrine therapy department oncology Greece Treatment combination abemaciclib endocrine therapy accepted primary end point toxicity rate patient study June2021 May2024 245 woman received abemaciclibendocrine combination therapy median age 57 years these 169 69 received abemaciclib adjuvant therapy earlystage disease 76 31 treated advanced BC time data cutoff 133 847 patient remained 2year treatment period common adverse event AE diarrhea 51 primarily Grade ≤ 2 Dose modification due AEs required 192 cases treatment discontinuation occurred 51 difference dose modificationdiscontinuation rate older patient 65 years remaining patients earlystage BC patients 2year DFS OS rate 908 100 respectively patient advanced cancer 70 308 1year PFS OS rate 78 963 respectively study confirms safety effectiveness abemaciclib alignment registrational trial offering valuable insight toxicity management clinical outcome routine practice without identifying new safety concerns ClinicalTrialsgov NCT04985058",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805239/"
    },
    {
        "pmid": "40805202",
        "title": "Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer.",
        "abstract": "bBackgroundObjectivesb Treatment borderline resectable BRPC locally advanced LAPC pancreatic cancer involves neoadjuvant chemotherapy followed complex surgery posing significant risk toxicity complications change quality life QoL study aim investigate impact neoadjuvant chemotherapy followed resection overall survival OS QoL bMethodsb Consecutive patient BRPC LAPC included populationbased study NORPACT2 January 2018 December 2020 reviewed bResultsb total 54 patient BRPC n  43 LAPC n  11 underwent neoadjuvant chemotherapy followed pancreatectomy majority 667 received mFOLFIRINOX Fortysix 852 patient underwent pancreatoduodenectomy Vascular resection performed 32 593 patients Fourteen 259 patient experienced major complications majority resected specimen demonstrated T2 63 N 796 R1 852 status Median OS 31 CI 247373 months multivariate analysis CAP 3 ipi  0035 predicted worse survival Forty 741 patient experienced recurrence Global QoL ipi  0031 social role functioning ipi  0024 ipi  0031 improved three month surgery Pain ipi  0042 dyspnea ipi  0004 appetite loss ipi  0028 diarrhea ipi  0007 improved postresection bConclusionsb Patients BRPC LAPC undergoing neoadjuvant chemotherapy resection survival comparable primary resectable pancreatic cancer Postoperative morbidity acceptable QoL recovered postsurgery CAP grade independent negative prognostic factor",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805202/"
    },
    {
        "pmid": "40805136",
        "title": "Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15).",
        "abstract": "Studies suggested synergism lenalidomide LEN ibrutinib IBR multiple myeloma MM downregulate IRF4 key target master transcriptional factor regulating myeloma cell survival 3  3 phase trial conducted determine maximum tolerated dose MTD IBR combination LEN  dexamethasone DEX patient relapsedrefractory RR MM least one prior line therapy Three dose level DLs planned cycle length 28 days IBR administered orally daily dos 560 mg DL12 840 mg DL3 LEN administered orally day 121 dos 15 mg DL1 25 mg DL23 DEX administered orally day 1 8 15 22 dose 40 mg age  75 year dose 20 mg ≥75 year DL13 Patients glomerular filtration rate GFR 60 ≥30 mLmin treated accordance manufacturers instruction LEN 10 mg Doselimiting toxicity DLTs included following grade 4 neutropenia lasting 5 days thrombocytopenia febrile neutropenia nausea vomiting diarrhea grade 3 thrombocytopenia bleeding platelet transfusion grade 34 hyperglycemia thromboticembolic event nonhematologic toxicities overall response rate ORR defined percentage patient partial response PR good partial response VGPR complete response CR according IMWG criterion two consecutive evaluation least 4 week apart clinical benefit rate CBR defined percentage patient stable disease SD better outcome two consecutive evaluation week apart Fourteen patient DL1 six patients DL2 three patients DL3 five patients registered study March 2019 May 2023 prior closure due limited accrual Thirteen patient included summary toxicity response one patient DL3 halted participation prior start treatment Two patient DL3 excluded determination MTD one discontinued cycle 1 treatment due COVID19 infection another mistakenly taken 280 mgday IBR instead assigned 840 mgday dose cycle 1 one patient developed DLT DL1 grade 3 nonviral hepatitis median number cycle administered 4 range 156 Severe toxicity reported included grade 4 lymphocytopenia 1 grade 4 thrombocytopenia 1 grade 5 sepsis setting PD 1 Disease response included VGPR DL1 CR DL3 Thus ORR 154 90 CI 28410 One patient DL1 maintained SD 46 year discontinuing treatment undergo alternative therapy Another five patient maintained SD ≥ 2 consecutive cycles Thus CBR 615 90 CI 355834 combination LEN IBR RR MM proved feasible manageable toxicity majority discontinuation due disease progression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805136/"
    },
    {
        "pmid": "40804690",
        "title": "Efficacy of Credelio Quattro<sup>™</sup> (lotilaner, moxidectin, pyrantel, praziquantel) and Credelio<sup>™</sup> (lotilaner) against longhorned tick, Haemaphysalis longicornis,-induced infestations on dogs.",
        "abstract": "Haemaphysalis longicornis longhorned tick invasive tick specie identified increasing number region across USA tick specie competent vector various pathogen dogs humans species heavy infestation documented lead exsanguination Therefore determination ectoparasiticides providing adequate treatment control H longicornis imperative help reduce vectorborne disease transmission protect infestation dogs Three laboratory study conducted evaluate efficacy Credelio Quattro Credelio treatment control H longicornis total 30 dog per study randomized receive either placebo Credelio Quattro Credelio Day 0 according complete block design basis pretreatment live attached H longicornis counts infested Day 7 assess efficacy preexisting infestations enrolled dog infested 50 unfed adult H longicornis Day 2 1 prior treatment Residual efficacy posttreatment evaluated subsequent infestation Days 5 12 19 30 tick collected evaluated live dead free attached 48 h treatment infestation Adequacy infestation achieved least two study every infestation time point evaluated Credelio Quattro Credelio provided 100 efficacy H longicornis Day 2 Day 32 live tick observed dogs statistically significant number dead tick recovered treated group compared control assessment days Posttreatment treatmentrelated diarrhea reported six dog receiving Credelio Quattro one dog receiving Credelio Day 0 dog recovering Day 1 laboratory study described confirm safety effectiveness single dose Credelio Quattro Credelio minimum effective dosage 20 mgkg lotilaner 002 mgkg moxidectin 5 mgkg praziquantel 5 mgkg pyrantel 20 mgkg lotilaner respectively treatment control H longicornis infestation dog one month",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804690/"
    },
    {
        "pmid": "40804463",
        "title": "Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.",
        "abstract": "Overweight obesity major global health issues increasing disease risk straining healthcare systems Glucagonlike peptide1 receptor agonist GLP1 RAs effective weight loss cause gastrointestinal side effects affecting adherence Research often focus diabetics leaving gap understanding effect nondiabetic individual overweight obesity systematic review doseresponse network metaanalysis address gap analyzing gastrointestinal adverse event GLP1 RAs nondiabetic subject overweight obesity evaluated available evidence searching PubMed EMBASE databases according specific inclusion exclusion eligibility criterion evaluate gastrointestinal adverse event associated GLP1 RAs nondiabetic individual overweight obesity Quality assessment included study conducted using Cochrane Collaborations tool Thirtynine article included review showing total number 33354 individuals Nausea vomiting diarrhea constipation common gastrointestinal adverse effects evaluated GLP1 RAs led significant increase nausea risk orforglipron showing highest risk followed exenatide tirzepatide semaglutide liraglutide Additionally liraglutide orforglipron semaglutide tirzepatide associated increased vomiting risk cagrilinitide exenatide showed significant increase Exenatide cagrilinitide orforglipron associated diarrhea risk Finally semaglutide liraglutide associated increased constipation risk cagrilinitide exenatide showed significant increase GLP1 RAs showed several adverse gastrointestinal effect nondiabetic patient overweight obesity Understanding different risk profile GLP1 RAs help clinician make informed treatment decision balancing therapeutic benefit potential side effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804463/"
    },
    {
        "pmid": "40803807",
        "title": "Perceptions and interventions concerning coccidiosis in Dutch sheep farms.",
        "abstract": "Coccidiosis sheep protozoan disease young lamb yet fully understood control still largely relies use coccidiostats despite development resistance hypothesized Netherlands proper diagnosis always made treatment initiated possibly leading overuse coccidiostats aim study investigate perception intervention Dutch sheep farmer veterinarian regarding coccidiosis special attention treatment use anticoccidial drugs online survey completed 114 sheep farmer 57 veterinary practitioners surveyed sheep farmer appeared genuinely interested coccidiosis threequarters considering important problem flock Seventy per cent sheep farmer 84  veterinarian reported diarrhoea important symptom coccidiosis Almost threequarters sheep farmer conducted faecal examination two preceding years 87  per cent performed treatments half used coccidiostats annually wide variety treatment approaches Standard treatment lamb without clinical indication 4 week age treatment adult sheep reported 26  13  13  responding farmers respectively latter two considered incorrect treatments contrast veterinarian estimated that average coccidiostats prescribed 30  sheep farm practice treatment primarily based clinical sign faecal examination results Potential obstacle correct diagnosis included practical difficulty collecting faecal samples additional costs Remarkably questionable treatment common including treatment without history coccidiosis treatment lamb younger one month age treatment adult sheep Although correct dosage coccidiostats crucial 43  veterinarian advised dosing based heaviest animals case weight visually estimated farmer veterinarian Unfortunately treatment frequently applied without proper diagnosis applied dosage often correct may lead unnecessary incorrect use coccidiostats resulting increased risk resistance development Since veterinarian regarded important advisors play key role solution supporting veterinarians preventive measure prudent use coccidiostats promoted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803807/"
    },
    {
        "pmid": "40802670",
        "title": "Pediatric Graves' disease: insights into clinical characteristics and treatment outcomes.",
        "abstract": "identify early manifestation Graves disease young patient treatment outcomes hospitalbased review case record 47 child aged 1 month 18 years Graves disease 2011 2022 Data summarized statistically analyzed study included 47 patient Graves disease 31 66 girls average age initial diagnosis 1279 ± 375 years Common presenting complaint included heat intolerance 766 excessive sweating 745 palpitation 681 tremor 489 weight loss 383 increased appetite 34 diarrhea 319 constipation 43 mean thyrotropin receptor antibody titer 1693 ± 1347 IUL Remission achieved two 43 patient treated antithyroid drugs Graves disease common cause juvenile hyperthyroidism treating physician aware sign symptom avoid treatment delays",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802670/"
    },
    {
        "pmid": "40802252",
        "title": "Management of diarrhea in solid organ transplantation.",
        "abstract": "Diarrhea common complaint solid organ transplant recipients review infectious noninfectious cause diarrhea management Diagnostics diarrhea commonly incorporated multiplex gastrointestinal panel provide rapid testing identification pathogens rate Clostridium difficile transplant population increased fidaxomicin recommended therapy choice first episode recurrence available Oral vancomycin remains alternative Norovirus important rule case chronic diarrhea Nitazoxanide shown mixed result used norovirus therapy SARSCoV2 despite respiratory virus infect gut epithelium present diarrhea Noninfectious cause especially mycophenolaterelated well inflammatory bowel disease differential especially infectious cause identified detailed history diagnostics including molecular testing endoscopy targeted therapy infectious cause mainstay management diarrhea transplant recipient",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802252/"
    },
    {
        "pmid": "40801049",
        "title": "Fufang Taizishen Granules Attenuate Chemotherapy-Induced Intestinal Mucositis by Modulating Gut Microbiota and Amino Acid Metabolism.",
        "abstract": "Chemotherapyinduced intestinal mucositis severe adverse effect affecting cancer patients currently effective strategy prevention Fufang Taizishen granule FFTZS traditional Chinese medicine TCM known antiinflammatory antifatigue immunostimulatory properties shown therapeutic potential However effect FFTZS chemotherapyinduced intestinal mucositis underlying mechanism remain unclear mouse model intestinal mucositis induced using 5FU irinotecan assess protective effect FFTZS study found FFTZS enhanced food intake reduced diarrhea index improved histopathological damage colonic tissues FFTZS also reduced inflammatory cell infiltration inhibited apoptosis Moreover FFTZS treatment increased expression Claudin1 ZO1 proteins Microbial analysis revealed enrichment beneficial bacteria reduction opportunistic pathogens whereas metabolomic analysis showed FFTZS corrected amino acid metabolic disturbance induced chemotherapy finding suggest FFTZS mitigates chemotherapyinduced intestinal mucositis preserving mucosal integrity modulating gut microbiota restoring metabolic homeostasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801049/"
    },
    {
        "pmid": "40799553",
        "title": "Identification of natural products and synthetic analogs which inhibit microsporidia spores and prevent infection.",
        "abstract": "Microsporidiosis disease caused microsporidia affect many animals symptom ranging diarrhea death especially immunocompromised individuals Current treatments albendazole fumagillin limited efficacy address problem utilized iCaenorhabditis elegansi infected natural microsporidian iNematocida parisiii evaluate 4080 structurally diverse compound Boston University Center Molecular Discovery BUCMD chemical library screen identified 34 compound effectively inhibited iN parisiii infection restored reproductive capacity iC elegansi  17 compound validated prevented iN parisiii infection iC elegansi  10 capable suppressing microsporidia invasion inactivating mature spores Additionally five identified compound also effective iPancytospora epiphagai  specie related human ii infecting microsporidia Together work identifies characterizes compound inhibit microsporidia infection Microsporidia large group microbial parasite infect many animals including humans Many agriculturally important animal honey bees shrimp crabs fish infected microsporidia infection often result smaller animals fewer offspring death two drug commonly used treat microsporidia infections due specie resistant host toxicity need identify microsporidia inhibitors study screened 4000 small molecule using model round worm infected microsporidia identified several dozen inhibitor characterized compound prevented infection determining stage parasite act upon Together work identified characterized compound could used starting point design better microsporidia inhibitors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799553/"
    },
    {
        "pmid": "40797386",
        "title": "Safety evaluation of tucatinib: Adverse event signal mining and analysis based on the FAERS database.",
        "abstract": "purpose study evaluate adverse event AEs associated tucatinib mining data US Food Drug Administration Adverse Event Reporting System FAERS explore potential drugrelated AEs thereby guiding safe clinical use extracted AE report involving tucatinib FAERS database spanning 1st quarter 2020 4th quarter 2024 report categorized based preferred term system organ classes risk signal subsequently grouped analysis Among 12225 AEs listing tucatinib primary suspected drug total 103 preferred term AEs identified across 22 different system organ classes reports proportion female higher male 9702 v 126 highest number AEs reported 45 59 year 1529 median interquartile range time AE onset 3000 day 80010400 AEs occurred mainly within 1st month n  152 2616 60 day drug administration n  106 1824 Among numerous positive risk signals diarrhea nausea vomiting stomatitis rash palmarplantar erythrodysesthesia syndrome hepatotoxicity anemia peripheral neuropathy exhibited high signal strength largely aligned current prescribing information addition AEs explicitly mentioned package insert also observed included platelet count abnormal ejection fraction decreased aortic valve incompetence dehydration hypokalemia various nail skinrelated problem eg fingerprint loss ingrowing nail onychalgia onychomadesis skin discolorationhypertrophyhyperpigmentationexfoliation pigmentation disorder blister etc well nervous system disorder eg memory impairment brain edema central nervous system lesion hyperesthesia taste disorder emotional disorder paronychia also risk various AEs treatment tucatinib clinical application essential monitor closely dermatologicnail conditions gastrointestinal issues cardiovascular abnormalities neuropsychiatric manifestations adverse event occur disease progression observed timely intervention necessary prevent severe organ damage disease deterioration",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797386/"
    },
    {
        "pmid": "40797385",
        "title": "Investigation of lung transplant recipients' medical treatment compliance and gastrointestinal symptoms in the long term: A cross-sectional study.",
        "abstract": "study aim examine lung transplant recipients adherence drug regimen gastrointestinal disorder suffered sample descriptive crosssectional research comprised 58 lung transplant recipient discharged hospital data collection process used sociodemographic healthrelated characteristic information form immunosuppressant therapy adherence scale Morisky medication adherence scale gastrointestinal symptom rating scale data analysis utilized descriptive statistical methods Mann Whitney U Spearman correlation mean age lung transplant recipient 4437 ± 918 years participant lung transplant recipients 534 female 655 struggling comorbidities 517 underwent lung transplantation 5 year ago 172 oxygendependent 517 coughs 31 dyspnea 293 hypertension lung transplant recipient using corticosteroid 914 using tacrolimus found statistically significant connection use mycophenolate mofetil constipation use tacrolimus diarrhea use amlodipine gastroesophageal reflux lung transplant recipients Lung transplant recipients adherence immunosuppressant medication average medication used associated gastrointestinal symptoms finding study highlight lung transplant recipients inhome care treatment need continue",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797385/"
    },
    {
        "pmid": "40797223",
        "title": "PEDV infection downregulates goblet cell differentiation through activating the Notch pathway.",
        "abstract": "Porcine epidemic diarrhoea virus PEDV widespread porcine coronavirus worldwide causing high mortality high incidence rate among piglets molecular mechanism PEDV regulates epithelial cell function differentiation well disruption intestinal mucosal barrier yet fully understood study reveals PEDV infection reduces number goblet cell impairs intestinal barrier integrity newborn piglets Regarding pathway involved differentiation intestinal stem cell ISCs PEDV infection concurrently activates Notch MAPK pathway suppressing Wntβcatenin pathway intestine piglets Furthermore vitro experiment using intestinal monolayer organoid model showed PEDV infection hinders goblet cell differentiation activating Notch signalling pathway Additionally PEDVencoded ORF3 protein crucial activating Notch pathway inhibits goblet cell differentiation PEDVinfected intestinal monolayer organoids study offer new insight mechanism underlying intestinal mucosal barrier dysfunction induced PEDV infection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797223/"
    },
    {
        "pmid": "40792279",
        "title": "Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database.",
        "abstract": "Pacritinib selective Janus kinase JAK inhibitor approved treatment myelofibrosis adult severe thrombocytopenia However safety profile realworld population remains unclear aim study provided comprehensive profile pacritinibs safety evaluating adverse event AEs using realworld pharmacovigilance database Data FDA Adverse Event Reporting System FAERS database spanning first quarter 2022 second quarter 2024 served basis analysis identify potential AE risk signals several disproportionality analysis method applied including reporting odds ratio proportional reporting ratio multiitem gamma Poisson shrinker Bayesian confidence propagation neural network total 4304335 AE report collected FAERS 1940 report identifying pacritinib primary suspect drug Significant disproportionality observed following system organ classes gastrointestinal disorders investigations surgical medical procedures Common preferred term identified including diarrhea fatigue death nausea platelet count decreased hemoglobin decreased Notably 26 offlabel AEs also identified study would provide valuable insight postmarketing safety surveillance assessment pacritinib guide clinical practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792279/"
    },
    {
        "pmid": "40792054",
        "title": "Yeast peptides alleviate diarrhea in neonatal lambs by enhancing the colonic barrier function and modulating colonic microbiota.",
        "abstract": "underdeveloped intestinal tissue immature microbiota neonatal lamb predispose frequent diarrhea even death expanding breeding losses Yeast peptide enzymatic product yeast strains recognized antimicrobial peptide due demonstrated antimicrobial properties study aimed investigate impact yeast peptide supplementation incidence diarrhea neonatal lambs well underlying regulatory mechanism involved Thirtytwo onedayold lamb randomly allocated four treatments CON YP500 YP1000 YP2000 receiving 0 mgd 500 mgd 1000 mgd 2000 mgd yeast peptides respectively dietary supplementation yeast peptide elicited significant reduction fecal score incidence diarrhea ipi  005 administration yeast peptide neonatal lamb markedly elevated level antiinflammatory factor IL4 IL10 concurrently suppressing level proinflammatory factor IL1β IL6 colonic mucosa ipi  005 Furthermore yeast peptide enhanced intestinal antioxidant capacity ultimately strengthened colonic barrier function ipi  005 Supplementation yeast peptide altered colonic microbiota lambs characterized marked increase iRoseburiai decrease iStaphylococcusi iEscherichiaShigellai abundances Correlation analysis revealed observed attenuation inflammatory response enhancement barrier function associated enrichment iRoseburiai suppression iStaphylococcusi iEscherichiaShigellai conclusion yeast peptide demonstrate potential ameliorating diarrhea lamb modulation microbial community enhancement barrier function colon lambs recommended dosage yeast peptide 2000 mgd",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792054/"
    },
    {
        "pmid": "40792001",
        "title": "Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Observational Cohort Study in Poland.",
        "abstract": "compare efficacy safety semaglutide liraglutide one year obese Polish patient type 2 diabetes prospective observational cohort study conducted Poland 2024 460 patient aged 1880 enrolled 333 received semaglutide Group 1 133 received liraglutide Group 2 12 months HbA1c level significantly decreased groups Group 1 609 ± 114 542 ± 082 mean decrease 067 ± 037 ipi00001 Group 2 578 ± 075 517 ± 054 mean decrease 061 ± 028 ipi0001 BMI decreased 536 ± 345 kgm² Group 1 441 ± 463 kgm² Group 2 ipi00001 greater reduction Group 1 ipi0017 Gastrointestinal adverse effect common including nausea vomiting constipation gastritis diarrhea higher incidence Group 1 HbA1c reduction correlated baseline HbA1c age gender BMI reduction correlated baseline HbA1c BMI Semaglutide effective liraglutide reducing HbA1c BMI Gastrointestinal symptom frequent side effect groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792001/"
    },
    {
        "pmid": "40789179",
        "title": "Irritable Bowel Syndrome.",
        "abstract": "Irritable bowel syndrome IBS common gastrointestinal disorder prevalence 4 10 chronic condition characterized abdominal pain conjunction altered bowel habits abdominal distention bloating IBS present 3 different defecation patterns IBS constipation IBS diarrhea mixed IBS Recent advance IBS include positive diagnosis based symptombased criterion treatment plan based IBS subtype bothersome symptoms addition diet lifestyle modifications article discusses role new pharmacologic nonpharmacologic treatment option management IBS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789179/"
    },
    {
        "pmid": "40788441",
        "title": "Assessing participants' experiences with the COVID-19 symptom diary in a clinical trial.",
        "abstract": "phase 23 study twicedaily nirmatrelvir 300 mg coadministered ritonavir 100 mg versus placebo 5 day NCT05011513 participant reported presence severity COVID19 symptom using COVID19 symptom diary accordance FDA guidance Here aimed evaluate content validity COVID19 symptom diary global impression item qualitative interview recommended FDA Study participant kept daily electronic diary record presence severity 14 COVID19 symptom stuffy runny nose sore throat shortness breath cough low energy tiredness muscle body aches headache chillsshivering feeling hot feverish nausea frequency vomiting frequency diarrhea sense smell sense taste also answered question regarding 3 global impression item return health return usual activities overall symptom severity subset clinical trial participant interviewed study completion assess content validity diary Overall 25 participant interviewed across 10 clinical sites 14 symptom included diary reported ≥ 1 participant low energytiredness reported frequently 880 Twelve participant 480 reported ≥ 1 symptom captured diary dizziness common 120 Rates symptom lower ≤ 120 14 prespecified symptom included diary 160880 Based participant feedback 14 diary item clear generally easy answer using response scales interpreted intended 3 global item received similar feedback although participant noted challenge interpreting items describing question vague confusing response limited onethird reported difficulty calculating overall symptom experience multiple symptoms Participants reported electronic application diary global item easy use enabled item easily completed Exit interview result support content validity COVID19 symptom diary global impression items 14 symptom included diary reflecting commonly experienced COVID19 symptoms NCT05011513 httpsclassicclinicaltrialsgovct2showNCT05011513 ",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "COVID-19",
            "COVID-19 Drug Treatment",
            "Diaries as Topic",
            "Ritonavir",
            "SARS-CoV-2",
            "Severity of Illness Index",
            "Lactams",
            "Leucine",
            "Nitriles",
            "Proline"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788441/"
    },
    {
        "pmid": "40788293",
        "title": "Disease and treatment awareness, prescription patterns, and self-medication practices in patients of functional bowel disorders: A cross-sectional survey.",
        "abstract": "Functional bowel disorder FBD chronic recurrent debilitating disorder affecting mid lower gastrointestinal tract identifiable underlying pathology dearth Indian study focusing treatment awareness prescription evaluation FBD Due chronic course patient tend selfmedicate study planned evaluate disease drug treatment awareness selfmedication practices prescription pattern FBD patients crosssectional singlecenter questionnairebased study carried FBD patient getting clearance Institutional Ethics Committee patient administered two questionnaires ie diseasedrug awareness selfmedication questionnaire Prescriptions analyzed based World Health Organization prescribing indicators total 118 FBD patient enrolled common disorder functional constipation 94118 797 Number male 77118 65 greater female 41118 34 disease awareness 98118 83 patient opined FBD occurs frequently agreed medication treat FBD treatment awareness 106118 90 patient aware importance drug compliance 10118 9 knew adverse effects prescription patterns total 311 medication prescribed total 173 medication primary drug FBD Laxatives common class 98138 689 prescribed polyethylene glycol 77138 557 common drug prescribed functional constipation total 28118 237 patients selfmedicated prior visiting current OPD FBD patient aware dosing schedule consulted treating doctor awareness regarding drug name adverse effect poor among patients Laxativepolyethylene glycol common drug prescribed less 14 th patient resorted selfmedication commonly herbal remedies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788293/"
    },
    {
        "pmid": "40787502",
        "title": "Efficacy of botulinum toxin in the treatment of chronic anal fissure: a comprehensive systematic review.",
        "abstract": "Acute anal fissure maintains debilitating state produce enduring wound damage anal mucosa internal anal sphincter demonstrates increased muscle tone study aim conduct comprehensive systematic review evaluate efficacy botulinum toxin BT treatment chronic anal fissure synthesizing current evidence clinical trial observational study guide evidencebased practice review systematic research investigates performance security along extended outcome linked BT therapy treating chronic anal fissure analyzing 23 clinical studies healing response BT injection reach 6085 without producing headache side effect commonly experienced topical glyceryl trinitrate GTN medications Lateral internal sphincterotomy LIS produce excellent longterm healing result 9095 cases although lead fecal incontinence risk 515 rate Expanding BT treatment usually necessitates additional injection surgical intervention high rate recurrence 13 year 3040 Combining Botox treatment GTN administration achieves healing rate 70 80 study provide inconsistent research data optimal dosage range BT treatment 2030 units Botox performs equally well Dysport achieving results BT provides patient want surgery benefit safe minimally invasive procedure time LIS offer definitive solution patient cannot respond treatments Research must establish standardized dose instruction improving injection method developing extended strategy stop relapses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787502/"
    },
    {
        "pmid": "40787254",
        "title": "Effect of Sodium Butyrate and Sishen Pill Combination on Diarrhea with Kidney-Yang Deficiency Syndrome Was Associated with Intestinal Mucosal Microbiota and Immune Barrier.",
        "abstract": "investigate therapeutic mechanism sodium butyrate combined SSP treating diarrhea kidneyyang deficiency syndrome providing experimental evidence modern application classical Chinese medicine formulas mouse model diarrhea kidneyyang deficiency syndrome established via adenine combined iFolium sennaei gavage successful model establishment drug intervention group administered gavage 100 SSP decoction 300 mgmL sodium butyrate 100 mgkg sodium butyrate  50 SSP decoction respectively General physical condition organ index assessed Serum tumor necrosis factorα TNFα interleukin6 IL6 levels well colonic immunoglobulin sIgA mucin 2 MUC2 levels determined via ELISA Kidney intestinal histology evaluated via hematoxylin‒eosin HE staining characteristic small intestinal mucosal microbiota different intervention analysed via 16S rRNA sequencing Compared natural recovery combination 100 mgkg sodium butyrate  50 SSP significantly restored colonic sIgA level ipi 005 MUC2 levels indicating improvement intestinal mucosal barrier function Histological analysis revealed combination 100 mgkg sodium butyrate  50 SSP improved renal inflammation restored intestinal villus length crypt depth combination therapy controlled relative abundance iCorynebacteriumi restoring iDwaynesavagellai iMegasphaeraAi Correlation analysis indicated iMammaliicoccusi iCorynebacteriumi significantly negatively correlated sIgA MUC2 level relative abundance inhibited combination therapy Sodium butyrate enhanced therapeutic efficacy SSP combination therapy effectively repaired damaged kidney intestine alleviated diarrhea kidneyYang deficiency syndrome modulating relative abundance intestinal microbiota enhancing intestinal immunity well mucosal barrier function interaction intestinal microbiota intestinal mucosal protective factor may key mechanism combined treatment diarrhea kidneyyang deficiency syndrome",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787254/"
    },
    {
        "pmid": "40786849",
        "title": "Infection of <i>Enterocytozoon bieneusi</i> in a Patient with Long-Term Immunosuppression after Liver Transplantation: A Case Report and Literature Review.",
        "abstract": "iEnterocytozoon bieneusii iEbi cause opportunistic infection immunocompromised patients especially HIVAIDS recipients currently still case report iEbi infection solid organ transplant recipients iEbi cannot diagnosed routine examination culture often overlooked possible cause chronic diarrhea transplant recipients known established guideline iEbi effective available treatment option limited article reported case persistent chronic diarrhea renal failure due iEbi infection liver transplantation definitively diagnosed using metagenomic nextgeneration sequencing mNGS Short course albendazole applied patient resulting rapid resolution clinical symptom recovery renal function case demonstrates advantage mNGS diagnosis rare pathogenic bacterial infections together previous case reports suggests albendazole may serve effective therapy treatment iEbi patient article review relevant literature provides updated comprehensive reference selection iEbi treatment drugs note overview showed may individualized difference efficacy albendazole need study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786849/"
    },
    {
        "pmid": "40786213",
        "title": "Short febrile illness with rashes and diarrhea after clozapine therapy: A case report.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786213/"
    },
    {
        "pmid": "40785902",
        "title": "Donafenib <i>vs.</i> lenvatinib combined with transarterial chemoembolization as initial therapy for unresectable hepatocellular carcinoma: a retrospective real-world study.",
        "abstract": "combination tyrosine kinase inhibitor TKIs transarterial chemoembolization TACE hold promise unresectable hepatocellular carcinoma HCC study aimed directly compare efficacy safety donafenib DonaTACE ivsi lenvatinib LENTACE firstline therapies retrospective study 93 unresectable HCC patient 49 DonaTACE 44 LENTACE 93 hepatitis B virusinfected treated October 2020 May 2023 analyzed Patients received TACE conventional drugeluting beads combined Dona 200 mg twice daily LEN 812 mgday Outcomes included overall survival OS progressionfree survival PFS objective response rate ORR disease control rate DCR adverse event AEs Survival analysis employed KaplanMeier logrank tests Median OS mOS 1400 month DonaTACE ivsi 1900 month LENTACE hazard ratio HR 125 95 confidence interval CI 078199 P0330 Median PFS 737 ivsi 577 month HR 0785 95 CI 046133 P0354 significant differences ORR 5510 ivsi 6136 P0541 DCR 7551 ivsi 8182 P0460 comparable DonaTACE showed significantly lower overall AE rate any grade 8571 ivsi 10000 P0013 grade ≥3 2245 ivsi 4545 P0027 including reduced hypertension 204 ivsi 3636 P0001 diarrhea 612 ivsi 2500 P0011 vomiting 000 ivsi 4091 P0001 DonaTACE LENTACE demonstrated comparable efficacy unresectable HCC DonaTACE exhibited superior safety profile suggesting potential preferable option patient higher comorbidity risks prospective study warranted validate findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785902/"
    },
    {
        "pmid": "40785798",
        "title": "Management of gastrointestinal adverse effects in immune-based combination therapy for advanced renal carcinoma: when the oncologist meets the gastroenterologist.",
        "abstract": "advent combination immunotherapy revolutionized treatment metastatic renal cell carcinoma mRCC leveraging immune checkpoint inhibitor tyrosine kinase inhibitor improve survival outcomes However advancement come significant challenge management adverse effects impair patients quality life lead therapy discontinuation review explores prevalence mechanisms management gastrointestinal GI toxicity associated immunotherapy combination mRCC gastroenterologists perspective Diarrhea colitis nausea vomiting frequently reported adverse events often necessitating multidisciplinary approach timely diagnosis intervention mitigate risk ensure therapeutic continuity highlight management strategies ranging symptomatic treatment dietary modification advanced therapy severe cases even discussing emerging approach refractory cases integrating oncological gastroenterological expertise clinician optimize outcome patient minimizing GIrelated complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785798/"
    },
    {
        "pmid": "40785621",
        "title": "Efficacy and Safety of Afatinib Plus Bevacizumab as First-Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II Trial.",
        "abstract": "Studies indicated afatinib combined angiogenesis inhibitor may achieve promising efficacy nonsmall cell lung cancer NSCLC patient epidermal growth factor receptor EGFR mutations multicenter Phase II trial explore efficacy safety afatinib plus bevacizumab firstline setting EGFRmutant NSCLC patients primary end point progressionfree survival PFS secondary end point included objective response rate ORR disease control rate DCR safety July 11 2020 November 11 2021 54 treatmentnaïve NSCLC patient enrolled afatinib plus bevacizumab combination cohort Meanwhile 81 NSCLC patient EGFR mutation treated firstline afatinib monotherapy retrospectively collected median followup time 266 months significant difference PFS observed afatinib plus bevacizumab combination cohort afatinib monotherapy cohort 145 vs 122 months HR 087 p  015 confirmed propensity score matching PSM analysis Patients pleural metastasis HR 056 95 CI 032098 p  005 uncommon EGFR mutation HR 061 95 CI 025147 p  005 experienced longer PFS combination cohort ORR combination cohort favorable afatinib monotherapy cohort 778 vs 420 p  005 Diarrhea common treatmentrelated adverse event TRAEs 111 654 patient grade ≥ 3 TRAEs treated afatinib plus bevacizumab Afatinib combined bevacizumab well tolerated moderate efficacy among patient NSCLC might prospective strategy patient uncommon EGFR mutation pleural metastasis wwwchictrorgcn",
        "mesh_terms": [
            "Humans",
            "Bevacizumab",
            "Male",
            "Afatinib",
            "Carcinoma, Non-Small-Cell Lung",
            "Female",
            "Lung Neoplasms",
            "Middle Aged",
            "Aged",
            "Mutation",
            "ErbB Receptors",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Adult",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785621/"
    },
    {
        "pmid": "40785148",
        "title": "Colonic Stricture Formation in a Dog Treated for Acute Hemorrhagic Diarrhea Syndrome With a Rectal Foley Catheter.",
        "abstract": "describe complication subsequent surgical management colonic stricture associated use rectal Foley catheter treatment dog acute hemorrhagic diarrhea syndrome 5yearold intact female Poodle mix initially presented 1224h history bloody diarrhea lethargy diagnosis severe acute hemorrhagic diarrhea syndrome made dog hospitalized supportive care including placement 18French rectal Foley catheter reduce patient fecal contamination Fourquadrant antibiotic therapy started sign sepsis identified rectal Foley catheter remained place 72 h removal patient made full recovery discharged 5 day initial presentation Four week later patient returned 10day history obstipation hyporexia intermittent vomiting colonoscopy performed identified complete colonic stricture consistent previous site rectal Foley catheter retention balloon stricture could dilated rectal balloon catheter subsequently dog underwent colonic resection anastomosis Within hour postoperatively dog passed feces discharged following day 12month followup patient clinically well recurrence obstipation tenesmus Risks associated rectal Foley catheter use dog previously reported therefore treating clinician carefully consider potential complication placement authors knowledge first paper veterinary medicine document complication associated use rectal Foley catheter dog",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785148/"
    },
    {
        "pmid": "40784986",
        "title": "Afatinib amplifies cAMP-induced fluid secretion in a mouse mini-gut model via TMEM16A-mediated fluid secretion and secretory cell differentiation.",
        "abstract": "Afatinib effective treatment metastatic nonsmall cell lung cancer despite occurrence common gastrointestinal toxicity especially diarrheas lead dose adjustment treatment cessation severe cases Underlying mechanism afatinibinduced diarrhea prolonged treatment remain elusive study aimed investigate mechanism involved afatinibinduced fluid secretion threedimensional 3D mouse minigut model prolonged treatment 24 h swelling assay qRTPCR immunoblotting experiment performed result showed afatinib amplified cAMPinduced fluid secretion 2 fold mechanism requiring TMEM16A Ksubvsub7 channel via EPACcalciumdependent pathways Additionally afatinib treatment increased Ksubvsub71 NKCC1 expression Interestingly afatinib induced secretory cell differentiation upregulation Paneth cell markers Treatment PI3K inhibitor mimicked effect afatinib increasing expression membrane transporter secretory lineage cell marker additive effect observed combination afatinib suggesting observed effect afatinib via PI3K inhibition Collectively result indicate prolonged afatinib treatment enhances cAMPinduced fluid secretion mechanism involving EPACTMEM16AKsubvsub71mediated fluid secretion secretory cell differentiation 3D mouse minigut models EPACTMEM16AKsubvsub71mediated fluid secretion represents promising therapeutic target treating afatinibinduced diarrheas",
        "mesh_terms": [
            "Animals",
            "Anoctamin-1",
            "Mice",
            "Cell Differentiation",
            "Afatinib",
            "Cyclic AMP",
            "Guanine Nucleotide Exchange Factors",
            "Diarrhea"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784986/"
    },
    {
        "pmid": "40784972",
        "title": "Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome.",
        "abstract": "safety efficacy microbiotabased product patient irritable bowel syndrome IBS recurrent Clostridioides difficile infection rCDI studied Fecal microbiota livejslm RBL REBYOTAsup®sup FDAapproved singledose microbiotabased product prevent rCDI adult following standardofcare SOC antibiotic treatment exploratory subgroup analysis PUNCH CD3OLS phase 3 openlabel prospective study conducted United States US Canada evaluate safety efficacy RBL participant documented rCDI concurrent IBS Participants aged ≥ 18 year diagnosis rCDI completed SOC antibiotic treatment enrolled study primary endpoint PUNCH CD3OLS number participant RBL administrationrelated treatmentemergent adverse event TEAEs Secondary endpoint included treatment success 8 week sustained clinical response 6 months subgroup analysis ongoing IBS confirmed based medical record documentation time RBL administration Among 697 RBL recipients 90 comorbid IBS RBL administration 52 participant IBS 578 278 participant without IBS 458 experienced TEAEs 8 weeks TEAEs mild 222 IBS 201 without IBS moderate 267 IBS 188 without IBS Serious TEAEs reported 1 participant IBS pneumonia reported unrelated RBL 26 participant without IBS most related preexisting condition 31 Among participants 689 IBS 756 without IBS absence CDI diarrhea 8 week RBL administration participant treatment success 823 IBS 922 without IBS sustained clinical response 6 months RBL safe efficacious option prevent CDI recurrence patient concurrent IBS ClinicalTrialsgov identifier NCT03931941",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784972/"
    },
    {
        "pmid": "40784408",
        "title": "Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia.",
        "abstract": "determine incidence side effect associated betalactam antibiotic commonly used pneumonia treatment risk factor side effect Patients communityacquired healthcareassociated pneumonia prospectively enrolled June 2002 December 2012 Patients administered betalactam antibiotic treatment pneumonia side effect observed antibiotic treatment recorded Multivariate analysis performed identify independent risk factor side effect total 1162 patient enrolled study antibiotic used treatment ampicillinsulbactam 362 piperacillintazobactam 111 cefotiam 89 ceftriaxone 140 cefepime 130 imipenemcilastatin 110 meropenem 97 others 123 cases Diarrhea elevated liver enzyme levels skin rash observed 174 150  52 45  28 24  patients respectively multivariate analysis female sex p  005 use either piperacillintazobactam p  005 cefepime p  005 imipenemcilastatin p  005 significantly associated diarrhea Use cefotiam p  005 meropenem p  005 significantly associated elevated liver enzyme levels significant risk factor found skin rashes Broadspectrum antibiotic tended cause diarrhea frequently use cefotiam meropenem associated increased liver enzyme levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784408/"
    },
    {
        "pmid": "40782291",
        "title": "Safety of Risdiplam in Japanese Patients with Spinal Muscular Atrophy: A 12‑Month Interim Analysis of a Postmarketing Surveillance Study.",
        "abstract": "Risdiplam oral splicing modifier survival motor neuron2 gene SMN2 approved treating spinal muscular atrophy SMA safety efficacy demonstrated global trials limited realworld data safety Japanese patient SMA allcase postmarketing surveillance PMS study aimed assess safety usage pattern risdiplam Japan 12month interim analysis part ongoing PMS study includes Japanese patient SMA received risdiplam full observation period PMS 24 month initiation risdiplam treatment Safety data including adverse drug reaction ADRs collected case report form CRFs submitted participating healthcare facilities ADRs coded using MedDRAJ classification study included 538 patient SMA 259 institution Japan August 2021 August 2022 median age minimummaximum enrolment 225 083 years 515 patient male SMA type II 472 III 279 common phenotypes median treatment duration 3660 days 861 patient continued risdiplam treatment ADRs reported 112 patient 208 serious ADRs reported eight patient 15 common ADRs classified MedDRA System Organ Class gastrointestinal disorder 86 160 patient diarrhoea 43 80 faeces soft 23 43 stomatitis 10 19 patients Exploratory analysis suggested advanced age comorbidities concomitant medication use might associated increased incidence gastrointestinal ADRs 12month interim analysis PMS data indicated risdiplam well tolerated among Japanese patient SMA consistent previous clinical trial findings comprehensive evaluation safety efficacy risdiplam provided final 24month analysis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782291/"
    },
    {
        "pmid": "40782264",
        "title": "Severe immune-related adverse event colitis successfully treated with single-dose infliximab in an older adult with hepatocellular carcinoma receiving STRIDE therapy.",
        "abstract": "Severe immunerelated adverse event irAEs steroidrefractory patient remain clinical challenge among older patient hepatocellular carcinoma HCC treated immune checkpoint inhibitors Although infliximab recommended steroidrefractory irAE colitis safety outcome older patient liver disease remain unclear Here report case highlight safety effectiveness singledose infliximab steroidrefractory irAE colitis older patient HCC 84yearold man alcoholrelated HCC received STRIDE therapy durvalumab plus tremelimumab day 35 developed severe headache followed watery bloody diarrhea day 40 Based clinical course endoscopic findings patient diagnosed grade 4 irAE colitis condition refractory prednisolone 60 mgday single dose infliximab 400 mg administered day 5 steroid therapy Rapid clinical improvement remission observed lenvatinib resumed day 220 without irAE recurrence Singledose infliximab may safe effective option severe irAE colitis older patient HCC allowing continuation cancer therapy case may serve practical reference clinician managing severe irAEs highrisk populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782264/"
    },
    {
        "pmid": "40782189",
        "title": "Canine Microencapsulated Probiotic Formulations Modulate Immunity and Improve Acute Diarrhea in Dogs.",
        "abstract": "Hostderived probiotic strain offer effective alternative antibiotic improving animal gastrointestinal health study two probiotic strainsLactiplantibacillus plantarum TUCO16 Lacticaseibacillus rhamnosus TUCO17isolated initially canine colostrum milk scaled formulated oligosaccharide freezedried preparations formulation evaluated vitro using canine human cell model assess cytotoxicity adhesion capacity immunerelated gene expression reactive oxygen specie ROS production paracellular permeability strain demonstrated high adhesion 92 p  0001 cytotoxic effects induced significant p  00001 expression pro antiinflammatory cytokines also stimulated expression mucin tight junction protein epithelial cell increase 414fold 21fold p  00001 respectively addition formulation enhanced ROS production macrophage p  00001 maintained reduced epithelial permeability p  00001 vivo trial dog acute diarrhea confirmed safety formulations showed improvement stool consistency end treatment without affecting frequency contrasting effect metronidazole Overall result support using hostspecific probiotic immunomodulatory agent enhance intestinal barrier integrity offer safe antibioticfree alternative managing acute diarrhea dogs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782189/"
    },
    {
        "pmid": "40781941",
        "title": "Comparison of depressive symptoms between patients with myeloproliferative neoplasms without the Philadelphia chromosome treated with interferon alpha and patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.",
        "abstract": "aim study compare occurrence depressive symptom group patient MPN essential thrombocythemia polycythemia vera primary myelofibrosis treated interferonalpha patient chronic myelogenous leukaemia CML treated tyrosine kinase inhibitor check whether individual side effect may contribute occurrence depressive symptoms study involved 175 adult patient MPN CML treated IFNα TKI minimum 3 months study used David Goldberg Questionnaire GHQ28 FourDimensional Questionnaire 4DSQ survey Approximately 40 patient MPN almost 20 patient CML obtained moderately strongly elevated score depression scale analysis revealed statistically significant difference woman men Bone joint pain β0196 p0013 nausea indigestion β0191 p0007 fatigue β0136 p0053 cramp muscle ache β0159 p0038 diarrhoea β0138 p0050 side effect affected possibility developing depressive symptom groups common predictor depressive symptom number side effects type illness age older person was greater severity depressive symptoms significant difference prevalence depression patient CML MPN Specific side effect interferonalpha TKI treatment influence occurrence depressive symptoms association interferon treatment development depression confirmed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781941/"
    },
    {
        "pmid": "40781661",
        "title": "Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database.",
        "abstract": "study sought comprehensively evaluate safety profile tremelimumab durvalumab patient hepatocellular carcinoma HCC examining adverse drug reaction ADR documented Food Drug Administrations Adverse Event Reporting System FAERS database Data FAERS database spanning first quarter 2004 first quarter 2025 extracted filtered standardized Reporting Odds Ratio ROR Bayesian Confidence Propagation Neural Network BCPNN method utilized analyze signal strength identify potential ADRs total 574 case 1021 ADR report identified Gastrointestinal disorder 1565 n  188 hepatobiliary disorder 1216 n  146 general disorder administration site condition 1174 n  141 emerged frequently reported category system organ class SOC Death diarrhea malignant neoplasm progression identified three common preferred term PT based reporting frequency Immunemediated ADRs elevated ROR BCPNN value prevalent across multiple systems particularly within gastrointestinal 52822 903 hepatic 86382 970 cardiac 36524 849 endocrine 32126 831 dermatological 74471 951 domains study underscored intricate safety profile tremelimumab durvalumab HCC patients characterized predominantly immunemediated toxicity significant gastrointestinal hepatobiliary risks Utilization drug necessitated meticulous patient selection multidisciplinary management approach optimize patient outcome mitigate ADRs",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Hepatocellular",
            "Liver Neoplasms",
            "Adverse Drug Reaction Reporting Systems",
            "United States Food and Drug Administration",
            "Antibodies, Monoclonal, Humanized",
            "United States",
            "Antibodies, Monoclonal",
            "Male",
            "Female",
            "Middle Aged",
            "Databases, Factual",
            "Aged",
            "Adult",
            "Aged, 80 and over",
            "Antineoplastic Agents, Immunological",
            "Drug-Related Side Effects and Adverse Reactions",
            "Bayes Theorem"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781661/"
    },
    {
        "pmid": "40780642",
        "title": "High lignan- and flavonoid-based polyherbal mixtures improve performance in Holstein calves via modulating diarrhea frequency, rumen volatile fatty acid levels, and serum health parameters.",
        "abstract": "study aimed determine effect polyherbal mixture PM containing 423 lignans 212 flavonoid performance ruminal fermentation serum biomarkers preweaning Holstein calves Sixtyfour neonatal calf 406 ± 43 kg BW 48 female 16 males allocated randomized complete block design stratified birth weight birth date sex Starter feed provided ad libitum 4 weaning Treatments included control no PM supplementation milk milk combined PM supplement 10 20 40 gd result revealed feed efficiency body length heart girth significantly differ among treatments However BW DMI ADG wither height shank circumference increased linearly increasing PM supplementation diarrhea frequency decreased linearly 4 15 Ruminal ammonianitrogen molar proportion individual VFA significantly affected PM supplementation ruminal pH total VFA showed linear decrease increase increasing PM respectively Similarly serum glucose BUN total protein albumin globulin aspartate aminotransferase alanine aminotransferase IL6 IgM significantly affected PM supplementation triglyceride concentration showed quadratic cubic decrease increasing PM IGF1 concentration total antioxidant capacity IL10 concentration increased linearly tumor necrosis factorα concentration increased quadratically increasing PM supplementation conclusion PM addition improved growth performance preweaning Holstein calf reduced diarrhea frequency PM supplementation 40 gd exerting significant effect",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780642/"
    },
    {
        "pmid": "40778736",
        "title": "Effects of manual acupuncture on fatty acid metabolism in a rat model of diarrhea-predominant irritable bowel syndrome: a multi-tissue metabolomic and plasma lipidomic investigation.",
        "abstract": "Diarrheapredominant irritable bowel syndrome IBSD subtype IBS Many patient dissatisfied efficacy drug treatment seek complementary alternative medical therapies especially acupuncture treatment study evaluated effect manual acupuncture MA IBSD using rat model investigated underlying mechanism action analyzing change untargeted metabolomics plasmalivercolon targeted plasma lipidomics Thirty male SpragueDawley rat divided Control IBSD group n  10 each IBSDMA group received acetic acid enema combined restraint stress Control group received saline enemas group received daily ST36 2 week modeling Pain stool quality measured abdominal withdrawal reflex AWR Bristol stool form scale BSFS Plasmalivercolon sample collected ultrahigh performance liquid chromatography UHPLCQOrbitrap mass spectromy MS untargeted metabolomics Plasma also subjected UHPLCMSMS targeted lipidomics treatment improved BSFS AWR score IBSD model rats suggesting reduced intestinal hypersensitivity Metabolomic result showed impacted 18 metabolite plasma liver colon mainly involved arachidonic acid metabolism biosynthesis unsaturated fatty acids amino sugar nucleotide sugar metabolism Targeted lipidomic result showed restored low level four mediumchain one longchain fatty acid normal level IBSD suggesting acupuncture treatment IBSD involves fatty acid metabolic pathways reduced marker intestinal hypersensitivity impacted number metabolic pathway rat model IBSD",
        "mesh_terms": [
            "Animals",
            "Irritable Bowel Syndrome",
            "Rats, Sprague-Dawley",
            "Male",
            "Rats",
            "Fatty Acids",
            "Diarrhea",
            "Disease Models, Animal",
            "Lipidomics",
            "Acupuncture Therapy",
            "Metabolomics",
            "Humans",
            "Liver",
            "Colon"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778736/"
    },
    {
        "pmid": "40778205",
        "title": "Potential relationship between gut microbiota and animal diarrhea: a systematic review.",
        "abstract": "Diarrhea pose significant challenge growth livestock industry decreasing productivity increasing mortality rate animals Several factor bacteria viruses parasites stress identified potential contributor diarrhea gut microbiota complex microecosystem consisting trillion microorganism bacteria fungi viruses play key role host metabolism immunity nutrient absorption gut microbial homeostasis essential intestine perform physiological function maintain host health Conversely gut microbial dysbiosis lead development various diseases Recent research highlighted gut microbial dysbiosis driving factor animal diarrhea Consequently maintaining gut microbial homeostasis become key focus prevention treatment diarrhea review examines composition metabolite function gut microbiota well cause diarrhea alteration gut microbiota diarrhea Furthermore review provides insight future research field especially alleviating animal diarrhea gut microbial perspective",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778205/"
    },
    {
        "pmid": "40778139",
        "title": "Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.",
        "abstract": "Cancers respond immunotherapy typically harbor nonT cellinflamed tumor microenvironment TME characterized absence type III interferon IFN signaling CD8supsup cell infiltration previously reported iIDH1i somatic mutation enriched nonT cellinflamed tumor across tumor types Consistent this mutant IDH1 mIDH1 demonstrated drive immune exclusion metabolic reprogramming TME IDH inhibition enhanced antitumor immunity preclinical models Based pancancer observations conducted Phase II study assessing preliminary activity ivosidenib IDH1 inhibitor combination nivolumab antiPD1 antibody patient mIDH1 advanced solid tumor NCT04056910 Patients advanced refractory solid tumor harboring iIDH1i mutation prior exposure IDH1 inhibitor enrolled Participants administered ivosidenib 500 mg mouth daily nivolumab 480 mg intravenously every 4 weeks Given heterogeneity tumor types including RECIST response uncommon ie sarcoma composite primary endpoint utilized including either sixmonth progression free survival PFS6 overall response rate ORR Translational analysis included pharmacodynamic proteomic spatial transcriptomic investigations 15 patient enrolled median age 54 years female 533 ECOG 1 60 glioma 467 R132H 40 One patient partial response ORR 67 without progression 6 month PFS6 whereas two patient achieved PFS6 alone total 3 15 patient met primary endpoint 315 20 median PFS 194 months common treatment adverse event leukopenia 67 rash 67 diarrhea 33 nausea 27 QTC prolongation 27 Pharmacodynamic study demonstrated combining ivosidenib nivolumab significantly decreased plasma R2HG concentration correlated clinical benefit Serum proteomic spatial omic analysis suggested immunemodulatory effect mIDH1 inhibition plus antiPD1 treatment refractory mIDH1 solid tumors combination ivosidenib nivolumab safe however demonstrated similar antitumor activity predominantly disease stabilization compared previously described ivosidenib monotherapy Translational investigation suggests evaluation IDH1 inhibition combination partner immunecheckpoint inhibition may justified",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778139/"
    },
    {
        "pmid": "40777955",
        "title": "Factors associated with acute kidney injury and outcomes in patients with malaria in a district hospital in Rwanda.",
        "abstract": "Acute kidney injury AKI remains one complication severe malaria Evidence associated factor outcome patient complicated malaria AKI limited Rwanda assess factor associated acute kidney injury outcome patient malaria district hospital Rwanda retrospective study design applied census sampling strategy used select 122 file patient admitted severe malaria patient 20162017 developed clinical audit form used collect data patients files descriptive inferential statistic used analyze data Among confirmed severe malaria files 44 participant 50 year 525 males majority 915 communitybased health insurance 163 acute kidney injury significant associated clinical factor dehydration p01 highgrade fever p002 profuse sweating p034 vomiting p043 diarrhea p025 20 patient developed AKI 55 completely recovered 15 died 30 case transferred highest facility hemodialysis existence AKI among severe malaria patient evident recovering others dying need educating healthcare professionals mostly district hospital diagnosis management AKI result complicated malaria",
        "mesh_terms": [
            "Humans",
            "Acute Kidney Injury",
            "Male",
            "Female",
            "Rwanda",
            "Retrospective Studies",
            "Malaria",
            "Middle Aged",
            "Hospitals, District",
            "Adult",
            "Risk Factors",
            "Young Adult",
            "Adolescent",
            "Aged",
            "Dehydration",
            "Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777955/"
    },
    {
        "pmid": "40777715",
        "title": "Clinical and Histological Co-occurrence of Tropical Sprue and Helicobacter pylori Infection in Northeastern India: An Observational Study.",
        "abstract": "Tropical sprue TS infection caused iHelicobacter pylorii frequent cause morbidity tropics disease entities apart common regional distribution probably also share hosts sometimes exhibit symptom overlap likely modify others course data supporting association scant may testify association causing human suffering enrolled 67 patient dyspepsia also associated history suggestive malabsorption any two following chronic diarrhea greater four week andor unintentional significant weight loss 5 body weight three month andor nutritional deficiency iron B12 folate various proportions presented gastroenterology referral OPD tertiary care hospital northeastern region India period two half years patient incorporated informed consent fulfilling inclusion exclusion criteria initially underwent battery blood stool test exclude prevalent cause malabsorption followed upper gastrointestinal endoscopy additional rapid urease testing RUT wherever indicated mandatory biopsy taken stomach corpus antrum second part duodenum significant 53 67 patient found iH pylorii infection as diagnosed endoscopic findings RUT histopathological examination gastric biopsies concurrent feature TS duodenal biopsies Literature supporting close association TS iH pylorii scarce presentation TS dyspepsia peculiar unusual study offer new insight symptom overlap coexistence iH pylorii infection TS patient presenting iH pylorii infection feature malabsorption clinically prudent evaluate underlying TS ensure inclusive effective treatment approach",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777715/"
    },
    {
        "pmid": "40777656",
        "title": "Machine learning algorithms to predict feeding practices during diarrheal disease and its determinants among under-five children in East Africa.",
        "abstract": "Diarrhea leading cause childhood malnutrition Although replacement continued feeding increasing appropriate fluid home diarrhea episode cornerstone treatment packages food fluid restriction common diarrheal illness Africa fill methodological current evidence gaps study aimed build model predict determinant increase feeding practice child East Africa diarrheal outbreaks used recent demographic health survey DHS statistic 12 East African nation collected 2012 2023 analysis included total weighted sample 20059 child aged 5 years Python software utilized data processing machine learning model building employed four ML algorithms Random Forest RF Decision Tree DT XGB Extreme Gradient Boosting Logistic Regression LR work evaluated predictive models performance using performance assessment criterion accuracy precision recall AUC curve study 20059 child aged 5 year used final analysis Among proposed machine learning models random forest performed best overall proposed classifier accuracy 9786 precision 98 recall 77 Fmeasure 86 AUC curve 97 significant determinant increasing feeding practice richest household faculty delivery use modern contraception method number child 35 womens employment status maternal age 2534 medium exposure healthseeking decision made mother associated positively whereas using contraception home delivery total number child large sex household male associated negatively feeding practice diarrhea East Africa Machine learning ML algorithm provided valuable insight complex factor influencing feeding practice diarrheal disease underfive child East Africa diarrhea 11 100 child received acceptable child feeding practices onethird patient received less usual nothing Reducing diarrhearelated child mortality improving diarrhea management practice recommended particularly focusing identified aspects",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "Child, Preschool",
            "Female",
            "Diarrhea",
            "Male",
            "Africa, Eastern",
            "Infant",
            "Algorithms",
            "Feeding Behavior"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777656/"
    },
    {
        "pmid": "40774377",
        "title": "Iconographic validation of the Bristol scale in patient with neurological diseases.",
        "abstract": "Bristol Stool Scale published Heaton et al 1988 population patient suffering irritable bowel syndrome selfassessment tool estimate stool appearance therefore transit timeIt widely used scale recommended 2016 ROME IV criterion diagnose chronic constipationAlthough initially validated large population patient gastrointestinal disorders specific evaluation population suffering neurological disease never validated Subjects asked orally categorize nine color photo stool various consistencies viewed computer screen according Bristol scale provided paper color authorization obtained Rome Foundation use scale study Then asked comprehension scale acceptability completeness difficulty position single categoryThe primary endpoint agreement subjects response intraclass agreement coefficient ICC scoring sample stool photograph Bristol scaleSecondary end point comprehension acceptability appropriateness collected qualitative interview subjects calculated intraclass correlation index 092 stool photograph extremity scale Bristol 1 7 subject response sameThe scale considered difficult understood well accepted population Bristol scale used subject neurological diseases well understood accepted population helpful management rehabilitation medical treatment constipation andor fecal incontinence observed population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774377/"
    },
    {
        "pmid": "40773042",
        "title": "Safety Assessment and Efficacy of Probiotic Bacillus clausii PBC429™ (MTCC 25459) for Management of Diarrhea.",
        "abstract": "study evaluated vivo safety rat efficacy probiotic strain Bacillus clausii shouchella clausi PBC429™ mouse treatment diarrhea acute toxicity study single oral dose 2000 mgkg 500 × 10sup9sup CFUg administered rats followed subacute toxicity study 28 day repeated oral administration Bacillus clausii PBC429™ dose 250 500 1000 mgkgday present study two dos Bacillus clausii PBC429™ tested mouse castor oilinduced diarrhea result study indicate toxic effect Bacillus clausii PBC429™ observed dose administered 28 days significant change body weight clinical signs hematological examinations clinical biochemistry gross pathology histopathology observed control test groups Based results NOAEL found 2000 mgkg 1000 mgkg 5 × 10sup11sup CFU respectively Bacillus clausii PBC429™ reduced frequency defecation onset diarrhea total fecal weight percentage defecation Thus result study suggest Bacillus clausii safe human consumption effective antidiarrheal agent",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773042/"
    },
    {
        "pmid": "40772207",
        "title": "Comparative Efficacy and Toxicity of Modified FOLFIRINOX and Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Retrospective Analysis.",
        "abstract": "Background Pancreatic ductal adenocarcinoma PDAC remains highly lethal malignancy limited effective systemic therapies Modified FOLFIRINOX mFOLFIRINOX gemcitabine plus nabpaclitaxel GN commonly used firstline regimens purpose study evaluate realworld efficacy response rates progressionfree survival PFS overall survival OS toxicity grade 34 hematologic nonhematologic toxicities firstline mFOLFIRINOX gemcitabine plus nabpaclitaxel patient advanced pancreatic ductal adenocarcinoma Methods conducted retrospective analysis 64 patient advanced PDAC treated May 2023 May 2025 Thirty patient received GN 34 received mFOLFIRINOX Efficacy outcome included overall response rate ORR clinical benefit rate CBR PFS OS Toxicities graded using Common Terminology Criteria Adverse Events CTCAE v40 Statistical analysis included KaplanMeier survival estimate Cox regression modeling Results median age 59 year range 3275 predominance male patient 682 Eastern Cooperative Oncology Group Performance Status ECOG PS 01 891 Patients receiving mFOLFIRINOX younger likely tumor pancreatic head whereas elevated CA199 level common GN group ORR 57 GN arm 529 mFOLFIRINOX P0179 CBR comparable 77 vs 765 P0985 median progressionfree survival patient receiving GN 697 month 85 month FOLFIRINOX HR 114 95 CI 058  222 P0713 mFOLFIRINOX median overall survival benefit HR 1352 95 CI 063  290 P0428 reach statistical significance Oneyear OS higher mFOLFIRINOX 916 vs 824 15year OS 763 vs 550 Paradoxically oneyear PFS favored GN 325 vs 203 Grade 34 hematologic toxicity frequent mFOLFIRINOX eg neutropenia 20 vs 88 anemia 20 vs 59 GN associated grade 34 vomiting 382 vs 10 P0009 diarrhea 265 vs 33 P0011 neuropathy 294 vs 67 P002 Dose modification treatment delay similar though delay frequent mFOLFIRINOX arm Conclusions mFOLFIRINOX GN demonstrated comparable efficacy realworld treatment advanced PDAC mFOLFIRINOX offered better longterm OS carried higher risk hematologic toxicity GN associated greater gastrointestinal neurological adverse effects Treatment selection guided patientspecific factor comorbidities tolerance toxicity Sequential treatment planning including access secondline therapy significantly impact survival integral care strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772207/"
    },
    {
        "pmid": "40772201",
        "title": "Adult Hemolytic Uremic Syndrome as a Diagnostic Challenge.",
        "abstract": "Hemolytic uremic syndrome HUS rare serious condition adults typically characterized triad microangiopathic hemolytic anemia MAHA thrombocytopenia acute kidney injury AKI commonly associated pediatric population Shiga toxinproducing iEscherichia colii STEC adultonset case remain underrecognized especially resourcelimited setting like India report case 35yearold male patient presented lowgrade fever bloody diarrhea jaundice dark browncolored urine Laboratory evaluation revealed MAHA hemoglobin 98 gdL schistocytes 2 elevated lactate dehydrogenase thrombocytopenia platelet count 45400mm³ acute kidney injury AKI serum creatinine 045 mgdL initially transient rise Notably direct bilirubin disproportionately elevated 65 mgdL raising suspicion hepatic involvement Blood culture grew iEscherichia colii iE colii though stool culture negative Peripheral smear elevated reticulocyte count absence disseminated intravascular coagulation DIC supported diagnosis typical HUS ADAMTS13 levels complement assays stool Shiga toxin testing unavailable patient also severe vitamin B12 deficiency raising consideration pseudothrombotic microangiopathy pseudoTMA concurrently treated later developed noncardiogenic pulmonary edema managed corticosteroid supportive therapy discharged hematinics followup two month revealed hemoglobin improvement 102 gdL full renal recovery case highlight diagnostic therapeutic challenge adult HUS especially overlapping feature pseudoTMA potential infectious triggers absence definitive diagnostic modality like ADAMTS13 testing necessitated reliance clinical scoring peripheral smear exclusion mimickers elevated direct bilirubin rare pulmonary involvement broadened clinical complexity Early recognition supportive care led favorable outcomes Yet inability completely exclude atypical cause iStreptococcus pneumoniaeiassociated HUS SpHUS B12 deficiency imposes clinical challenge Adult HUS remains diagnostic challenge due rarity atypical presentations limited access confirmatory testing many settings case emphasizes need systematic evaluation awareness differential diagnosis like pseudoTMA SpHUS timely supportive management also contributes growing literature adult HUS India underscoring importance clinical vigilance atypical hemolytic syndromes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772201/"
    },
    {
        "pmid": "40771267",
        "title": "Secondary Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: A Case Report.",
        "abstract": "Hemophagocytic lymphohistiocytosis fatal hyperinflammatory disorder CD8 cytotoxic Tcells natural killer cells macrophage destroy hematopoietic cell vital organs Viral infections EpsteinBarr virus known cause secondary hemophagocytic lymphohistiocytosis adult patients However despite rarity dengue virus identified potentially cause hemophagocytic syndrome associated significant mortality morbidity Herein present case report 52yearold male patient presented fevers worsening nonbloody copious diarrhea excessive fatigue nausea vomiting known sickle cell trait diagnosis hemophagocytic lymphohistiocytosis confirmed liver biopsy accompanied elevated ferritin level 33539 ngmL IL2R level 59442 pgmL thrombocytopenia 49 kμL anemia hemoglobin mean corpuscular volume 73 gdL 773 fL elevated bilirubin total bilirubin 32 mgdL addition elevated IgG IgM antibody determined reinfection dengue virus administration dexamethasone etoposide additional supportive medication initiated Despite efforts patients neurological status declined patient died case dengueinduced hemophagocytic lymphohistiocytosis worrisome challenging diagnostic condition primarily due similarity symptom hemophagocytic lymphohistiocytosis dengue hemorrhagic fever Treatment delay may inevitable consequence Differentiating dengue hemorrhagic fever dengueinduced hemophagocytic lymphohistiocytosis requires evaluating clinical laboratory biopsy findings role sickle cell trait unknown presentation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771267/"
    },
    {
        "pmid": "40771189",
        "title": "Cerebrotendinous Xanthomatosis Disease Prevalence in Patients with Autism Spectrum Disorder: A Prospective Observational Study.",
        "abstract": "Cerebrotendinous xanthomatosis CTX autosomal recessive congenital metabolic disorder characterized impairment enzymatic activity sterol 27hydroxylase CTX rare neurodegenerative disease sterol metabolism affect multiple systems including nervous system demonstrated many congenital metabolic disease like CTX associated autism spectrum disorder ASD aim study identify prevalence CTX disease patient ASD clinical condition patient evaluated using Mignarri Scoring Index sociodemographic form Gilliam Autism Rating Scale2 applied participants total 101 child adolescent ASD analyzed genes Following genetic analyses 4 patient mutation iCYP27A1i gene two homozygous variants two different heterozygous mutation identified common symptom diarrhea Overall 673 patient 3 4 case iCYP27A1i gene mutation gone psychiatric evaluation family history psychiatric disorder present 198 case 75 case mutations Moreover mutant case comorbid oppositional defiant disorder total 812 patient mutant patient diagnosed behavioral disorder Psychiatric manifestation ranging personality change behavioral disorder might accompany CTX Better understanding knowledge CTX disease distinguishing specific psychiatric systemic symptom might help prevent missed diagnoses progressive neurological deterioration permanent disability early initiation chenodeoxycholic acid treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771189/"
    },
    {
        "pmid": "40770648",
        "title": "Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial.",
        "abstract": "PI3KAKT pathway frequently altered advanced triplenegative breast cancer aTNBC representing promising target Ipatasertib panAKT inhibitor shown activity taxanebased chemotherapy acceptable safety study evaluated safety efficacy ipatasertib nontaxane chemotherapy aTNBC PATHFINDER trial multicenter openlabel noncomparative phase IIa study safety runin phase Eligible patient TNBC pretreated advanced setting one two chemotherapy regimens including taxane prior exposure PI3KmTORAKT inhibitors Patients received 21day cycle ipatasertib combined capecitabine arm A eribulin arm B carboplatin plus gemcitabine arm C safety runin phase determined feasibility phase IIa doses primary endpoint incidence treatmentemergent adverse event TEAEs Key secondary endpoint included progressionfree survival PFS overall survival OS objective response rate ORR analysis exploratory without formal hypothesis testing total 54 patient assigned arm N  22 B N  25 C N  7 Arm C discontinued due toxicity safety runin phase data cutoff November 2023 overall median followup 121 range 02356 months Common TEAEs arm diarrhea 591 00 G ≥ 3 fatigue 364 00 G ≥ 3 nausea 364 00 G ≥ 3 arm B neutropenia 520 320 G ≥ 3 diarrhea 520 40 G3 stomatitis 440 80 G3 arm C thrombocytopenia 857 857G ≥ 3 anemia 857 571 G ≥ 3 neutropenia 714 714 G ≥ 3 treatmentrelated death occurred Median PFS 27 95CI 1541 38 95CI 1596 months median OS 155 95CI 118193 115 95CI 88251 months ORR 91 360 arm B respectively significant difference efficacy observed PIK3CA mutational status Ipatasertib combined capecitabine eribulin showed acceptable safety tolerable carboplatin plus gemcitabine addition ipatasertib capecitabine eribulin show potential efficacy signal patient population compared historical monotherapy data treatments Identifying biomarkers predict response AKT inhibitor TNBC crucial www gov  NCT04464174 Registered 09 July 2020",
        "mesh_terms": [
            "Humans",
            "Female",
            "Triple Negative Breast Neoplasms",
            "Middle Aged",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Adult",
            "Aged",
            "Capecitabine",
            "Carboplatin",
            "Pyrimidines",
            "Furans",
            "Ketones",
            "Gemcitabine",
            "Deoxycytidine",
            "Progression-Free Survival",
            "Polyether Polyketides",
            "Piperazines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770648/"
    },
    {
        "pmid": "40769686",
        "title": "Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial.",
        "abstract": "introduction daratumumablenalidomidedexamethasone firstline treatment patient newly diagnosed transplantineligible multiple myeloma lenalidomidedexamethasone standard care aimed explore whether addition secondgeneration proteasome inhibitor carfilzomib lenalidomidedexamethasone improved rate measurable residual disease MRD negativity progressionfree survival EMN20 randomised openlabel multicentre phase 3 trial comparing weekly carfilzomiblenalidomidedexamethasone versus lenalidomidedexamethasone patient newly diagnosed transplantineligible multiple myeloma conducted 27 centre Italy Key inclusion criterion included fit intermediatefit status according International Myeloma Working Group IMWG frailty score measurable disease according IMWG criteria Eastern Cooperative Oncology Group performance status lower 3 Patients randomly assigned carfilzomiblenalidomidedexamethasone group received 28day carfilzomiblenalidomidedexamethasone cycle carfilzomib 20 mgmsup2sup intravenously day 1 cycle 1 followed 56 mgmsup2sup intravenously day 8 15 cycle 1 56 mgmsup2sup intravenously day 1 8 15 cycle 212 56 mgmsup2sup intravenously day 1 15 cycle 13 5 year randomisation lenalidomide 25 mg orally day 121 disease progression intolerance dexamethasone 40 mg orally day 1 8 15 22 disease progression intolerance Patients assigned lenalidomidedexamethasone group received 28day cycle lenalidomidedexamethasone same dosing schedule used carfilzomiblenalidomidedexamethasone group Primary endpoint MRD negativity nextgeneration sequencing sensitivity 10sup5sup 2 year treatment progressionfree survival assessed intentiontotreat ITT population all patient eligible receive treatment randomly assigned one treatment groups Nov 23 2021 enrolling 30 planned patient 101340 trial prematurely stopped due introduction daratumumablenalidomidedexamethasone firstline treatment Italy caused lenalidomidedexamethasone control group longer considered standard treatment trial registered ClinicalTrialsgov NCT04096066 study recruitment complete Nov 14 2019 Nov 23 2021 82 101 enrolled patient assessed eligibility randomised receive carfilzomiblenalidomidedexamethasone n42 lenalidomidedexamethasone n40 ITT population 35 43 82 patient female 47 57 male data cutoff March 29 2024 median followup 35·2 month IQR 30·338·7 2year MRD negativity rate 25 60 95 CI 4374 42 patient carfilzomiblenalidomidedexamethasone versus 0 0 09 40 patient lenalidomidedexamethasone p0·0001 Median progressionfree survival reached not reachednot reached carfilzomiblenalidomidedexamethasone versus 20·9 month 15·7not reached lenalidomidedexamethasone hazard ratio 0·24 95 CI 0·110·56 p0·00084 One patient excluded safety analysis died starting treatment frequent grade 3 worse adverse event neutropenia nine 22 41 patients thrombocytopenia four 10 diarrhoea four 10 cardiac event three 7 infection three 7 arterial hypertension two 5 carfilzomiblenalidomidedexamethasone neutropenia six 15 40 skin rash four 10 lenalidomidedexamethasone common serious adverse event SARSCoV2related pneumonia carfilzomiblenalidomidedexamethasone group two 5 41 patients lenalidomidedexamethasone group three 7 40 patients Treatmentemergent adverse event leading death observed two patient carfilzomiblenalidomidedexamethasone two SARSCoV2 infections four patient lenalidomidedexamethasone group one acute myocardial infraction one heart failure one septic shock one SARSCoV2 infection limitation smaller sample size planned due trials early interruption results knowledge showed firsttime high rate MRD negativity weekly carfilzomib added lenalidomidedexamethasone patient transplantationineligible newly diagnosed multiple myeloma carfilzomiblenalidomidedexamethasone group higher MRD negativity rate associated progressionfree survival advantage lenalidomidedexamethasone Toxicities predictable generally manageable Amgen Bristol Myers Squibb",
        "mesh_terms": [
            "Humans",
            "Multiple Myeloma",
            "Lenalidomide",
            "Dexamethasone",
            "Male",
            "Female",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Aged",
            "Middle Aged",
            "Oligopeptides",
            "Transplantation, Autologous"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769686/"
    },
    {
        "pmid": "40769540",
        "title": "[Research progress in active substances and their mechanisms of action against porcine epidemic diarrhea virus].",
        "abstract": "Porcine epidemic diarrhea virus PEDV intestinal coronavirus cause porcine epidemic diarrhea leading diarrhea vomiting weight loss even death piglets Due diversity PEDV strains traditional vaccine difficult sustainably effectively prevent control PEDV article review strategy mechanism active substance regulating intracellular signaling pathways viral proteins microbial metabolite enhance host immune function PEDV emphasizes prevention PEDV resistance potential harm PEDV breaking interspecies barrier human society aiming provide reliable theoretical support development new antiviral drug vaccines",
        "mesh_terms": [
            "Porcine epidemic diarrhea virus",
            "Animals",
            "Swine",
            "Swine Diseases",
            "Antiviral Agents",
            "Coronavirus Infections",
            "Viral Vaccines",
            "Humans",
            "Signal Transduction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769540/"
    },
    {
        "pmid": "40769220",
        "title": "Chrysin inhibits PEDV replication by antagonizing apoptosis via the ROS/JNK/p53 axis.",
        "abstract": "Porcine epidemic diarrhea virus PEDV remains significant threat global swine industry immunization strategy limited viral genome variation lack effective therapeutic drugs flavonoid compound chrysin shown potential antiPEDV activity specific antiviral mechanism remain unclear study validated inhibitory effect chrysin PEDV using IFA qPCR Additionally Transcriptome sequencing conducted PEDVinfected Vero cell without chrysin treatment reveal antiviral mechanism result showed 5813 DEGs 12 hpi 3374 DEGs 24 hpi enrichment pathway related transcription translation metabolism innate immunity apoptosis Notably KEGG analysis indicated Chrysin regulate PEDVinduced apoptosis modulating TNF MAPK p53 signaling pathways might antagonize PEDV infection Subsequent result confirmed chrysin significantly downregulate reactive ROS level cell apoptosis rate induced PEDV infection P005 inhibit activation JNK p53 pathways including phosphorylation ASK1 JNK p53 Chrysin also significantly reduced cleaved caspase 389 level BaxBcl2 ratios thereby affecting PEDV N protein expression P  005 Moreover similar inhibitory effect PEDV also achieved JNK inhibitor SP600125 p53 inhibitor PFTα finding revealed chrysin antagonize PEDVinduced apoptosis ROSJNKp53 signaling axis thereby inhibiting viral replication study provides scientific basis developing chrysin novel antiPEDV drug offer insight screening research antiviral drug targets",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769220/"
    },
    {
        "pmid": "40769093",
        "title": "Enhancing pediatric practice: A comprehensive review on malabsorption in pediatrics for diagnostic and management approach.",
        "abstract": "Malabsorption child present significant diagnostic therapeutic challenge due diverse etiology broad spectrum symptoms review aim support pediatric clinician providing structured guide recognizing diagnosing managing malabsorption syndrome children promoting early intervention prevent longterm complications Malabsorption defined inefficient absorption nutrients manifest symptom diarrhea failure thrive systemic nutritional deficiencies etiology categorized intestinal pancreatic hepatobiliary extraintestinal causes necessitating multidisciplinary approach tailored patients age clinical presentation Diagnostic strategy emphasize stool analysis serological testing imaging identify condition Celiac disease Crohns disease exocrine pancreatic insufficiency review explores gastrointestinal systems complexity detailing critical phase digestionluminal mucosal transportand process specific neonate infants Common issue like lactose intolerance small intestinal bacterial overgrowth SIBO bile acid malabsorption addressed alongside rare genetic metabolic disorder require targeted diagnostic approaches Management focus dietary modifications enzyme replacement therapy conditionspecific intervention ensure optimal growth development Special attention given unique challenge neonatal infant cases developmental immaturity congenital disorder often complicate evaluation treatment synthesizing current evidence clinical guidelines review provides pediatrician practical framework addressing multifaceted challenge malabsorption emphasizes importance early recognition multidisciplinary care improve patient outcome quality life",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769093/"
    },
    {
        "pmid": "40768480",
        "title": "Economics of vaccination against diarrhoea and respiratory diseases in French cow calves' systems: A modelling approach.",
        "abstract": "assess economic benefit vaccination diarrhoea respiratory disease cowcalf systems stochastic mechanistic mathematical programming bioeconomic model developed beef Charolais breed farm model reproduced herd dynamic weekly basis 10year period including animal growth reproduction disease risk control treatments vaccination Three baseline risk level diarrhoea respiratory disease considered simulate low average high infection risk farm result demonstrated models ability reproduce average farm dynamics diarrhoea prevalence ranging 8 33 respiratory disease 13 79 average prevalence decreased 24 50 respectively due vaccination also reduced 2day 1month mortality rate 23 1517 respectively net value vaccination positive except case low infection risk diarrhoea respiratory diseases return investment ROI vaccination 0405 €1 invested yield €0405 baseline scenario middle infection risks negative low infection risks reached 1 €1 invested yield €1 high infection risks result also showed farmer may earn €5875 additional revenue per extra hour labour dedicated vaccination mediumrisk scenario Despite limited availability data cowcalf systems study demonstrated economic benefit vaccination combination scenario risks profitability vaccination challenged low disease risk considered cases vaccination may serve insurance financial loss case health status deterioration",
        "mesh_terms": [
            "Cattle",
            "Animals",
            "Vaccination",
            "Diarrhea",
            "Cattle Diseases",
            "Models, Economic",
            "France",
            "Respiratory Tract Diseases",
            "Cost-Benefit Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768480/"
    },
    {
        "pmid": "40768129",
        "title": "Computational exploration and molecular dynamics simulations for investigating the potential inhibitory mechanism of amantadine on the ion channel activity of bovine viral diarrhea virus p7.",
        "abstract": "Bovine viral diarrhea virus BVDV p7 function viroporin ion balance membrane permeabilization Blocking function viroporin promising strategy treatment viral infection Previous study demonstrated antiviral drug amantadine inhibits BVDV replication inhibiting BVDV p7 activity However mechanism amantadine act BVDV p7 remains unclear study AlphaFold2 molecular docking molecular dynamic MD simulation employed investigate binding site amantadine BVDV p7 Structural analysis AlphaFold2 MD simulation showed BVDV p7 may undergo antiparallel oligomerization forming stable hexamer generates pore channel Notably residue E21 Y25 L28 R34 within channel likely involved ion transport Subsequently interaction amantadine BVDV p7 hexamer investigated docking study MD simulation analysis indicating residue Y25 L28 van der Waals forces alkyl PiAlkyl interaction amantadine Importantly hydrogen bonding observed NHsub3subsupsup group amantadine residue Y25 integrating finding potential hexameric assembly BVDV p7 proposed potential ion channel model E21 Y25 R34 hypothesized selectively recruit dehydrate ions residue L28 act hydrophobic restrictor limiting free movement water binding amantadine residue Y25 L28 likely disrupts ion transport finding provide possible structural insight BVDV p7 ion channel offer mechanistic explanation inhibitory amantadine BVDV p7mediated ion channel conductance though experimental validation remains necessary",
        "mesh_terms": [
            "Amantadine",
            "Molecular Dynamics Simulation",
            "Antiviral Agents",
            "Molecular Docking Simulation",
            "Binding Sites",
            "Animals",
            "Ion Channels",
            "Viral Proteins",
            "Diarrhea Viruses, Bovine Viral",
            "Cattle",
            "Hydrogen Bonding",
            "Protein Binding"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768129/"
    },
    {
        "pmid": "40767981",
        "title": "Bifidobacteria in antibiotic-associated dysbiosis: restoring balance in the gut microbiome.",
        "abstract": "Antibioticassociated dysbiosis disrupts guts microbial balance leading reduced diversity overgrowth antibioticresistant strains compromised gut homeostasis result inflammation increased intestinal permeability impaired immunity heightened susceptibility infections context probiotic highlighted promising remedy alleviating antibioticinduced gut microbiome aberration subsequent decrease detrimental effects Bifidobacteria prominent bacterial group promising probiotic attributes shown effectiveness restoring gut microbiome strong adherence colons mucosal lining enhancing immune response increased antiinflammatory cytokines also play crucial role key producer acetic acid support butyric acidproducing bacteria essential colonocyte health dysbiosis synergistic use bifidobacteria probiotic specie prebiotic substrate enhanced survival colonization capacity overall impact gut microbial restoration Advanced metagenomic analysis begun reveal strainspecific functions paving way personalized probiotic therapy tailored individuals unique microbiome profile Despite encouraging progress critical research gap persist particularly regarding strainspecific efficacy formulation stability longterm outcomes underlying mechanisms systemic interactions distinct specific role bifidobacteria Addressing gap targeted clinical investigation essential fully harness therapeutic potential develop optimized strategy restoring microbial balance gut microbiome",
        "mesh_terms": [
            "Dysbiosis",
            "Humans",
            "Probiotics",
            "Gastrointestinal Microbiome",
            "Bifidobacterium",
            "Anti-Bacterial Agents",
            "Animals",
            "Prebiotics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767981/"
    },
    {
        "pmid": "40767957",
        "title": "[Rapid weight loss through GLP-1 receptor agonists as lifestyle phenomenon and implications for plastic esthetic medicine].",
        "abstract": "Glucagonlike peptide‑1 receptor agonist GLP‑1 RA semaglutide tirzepatide originally developed treatment type 2 diabetes shown significant weight loss effects led increasing offlabel use esthetic weight reduction associated facial changes particularly volume loss skin laxity increased wrinkle formation gaining attention plastic esthetic medicine study review current literature GLP‑1 RAs esthetic effect potential therapeutic approaches selective literature review GLP‑1 RAs conducted focusing mechanism action clinical effects offlabel use esthetic consequence treatment options use GLP‑1 RAs promotes weight loss regulating appetite delaying gastric emptying Frequent side effect include gastrointestinal symptoms nausea vomiting diarrhea obstipation possible association thyroid tumor remains unclear increasing offlabel use led supply shortage regions Esthetic changes termed Ozempic face include volume loss skin laxity pronounced wrinkles Treatment option discussed literature include noninvasive highintensity focused ultrasound HIFU radiofrequency minimally invasive fillers biostimulators surgical procedure facelifting fat grafting rising offlabel use GLP‑1 RAs present new challenge esthetic medicine Rapid fat loss result pronounced facial changes driving demand corrective interventions however systematic study effectiveness safety treatment lacking research needed develop evidencebased strategy standardized guideline esthetic management affected patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767957/"
    },
    {
        "pmid": "40767554",
        "title": "PgtE protease enables virulent <i>Salmonella</i> to evade C3-mediated serum and neutrophil killing.",
        "abstract": "Nontyphoidal iSalmonellai serovars iSalmonella entericai serovar Typhimurium STm leading cause inflammatory diarrhea otherwise healthy individuals Among children elderly immunocompromised individuals STm spread systemic site cause potentially lethal bacteremia Phagocytic cell immune complement system pivotal preventing dissemination STm PgtE STm outer membrane protease previously described cleave dozen mammalian protein substrate iin vitroi including complement protein C3 However activity mostly observed mutant avirulent strain truncated Oantigen render bacteria sensitive complement killing Here report virulent STm utilizes PgtE evade complementmediated killing iin vivoi wildtype pathogen increase ipgtEi expression PgtE proteolytic function within macrophage macrophagelike iin vitroi growth conditions concomitant physiologic Oantigen truncation environments Furthermore found wildtype STms resistance complementmediated serum neutrophil killing PgtEdependent propose PgtE promotes systemic spread STm acting second line defense complement STm escape macrophageIMPORTANCENontyphoidal iSalmonellai serovars primarily cause gastrointestinal infection also lead bacteremia mechanism completely elucidated show outer membrane protease PgtE enables virulent iSalmonellai evade complementmediated killing iin vivoi thereby promoting bacteremia also demonstrate ipgtEi expression PgtE proteolytic function increased within macrophage macrophagelike growth conditions Upon escaping macrophages PgtE protects complementmediated killing serum neutrophils promoting systemic spread pathogen finding highlight PgtE potential therapeutic target preventing iSalmonellai bacteremia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767554/"
    },
    {
        "pmid": "40767453",
        "title": "Sheehan's syndrome complicated with Graves' disease in a woman with a 20-year history of hypothyroidism.",
        "abstract": "Sheehans syndrome disorder caused ischemic necrosis pituitary gland following postpartum hemorrhage typically resulting pituitary dysfunction affect adrenal thyroid gonadal axes Clinically patient may present dysfunction single axis multiple axes cooccurrence Sheehans syndrome Graves disease extremely rare posing significant diagnostic challenge Herein report case woman early 50 28year history Sheehans syndrome led complete pituitary dysfunction managing hypothyroidism past 20 years However 6month period developed chronic diarrhea showed progressive weight loss laboratory result indicating hyperthyroidism Based imaging laboratory findings along medical history diagnosis Sheehans syndrome complicated Graves disease established evidenced elevated level thyrotropin receptor antibodies Treatment included adrenocorticotropic hormone replacement antithyroid therapy supportive measures Although gastrointestinal symptom weight loss resolved initially patient continued experience persistent hyperthyroidism elevated thyrotropin receptor antibody level 20month followup case highlight need regular endocrine monitoring patient Sheehans syndrome particularly longstanding hypothyroidism promptly identify address potential overlap autoimmune thyroid diseases",
        "mesh_terms": [
            "Humans",
            "Female",
            "Graves Disease",
            "Hypothyroidism",
            "Hypopituitarism",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767453/"
    },
    {
        "pmid": "40767428",
        "title": "Current opinion on the management of diarrhea in the HIV infected individual.",
        "abstract": "Diarrhea one main reason morbidity mortality patient HIV especially low middleincome countries review update approach diagnosis management diarrhea patient HIV Duration symptoms characteristic diarrhea smallbowel largebowel type presence constitutional symptom current CD4 cell count important parameter noted history give important clue diagnosis Multiple pathogen coexist severely immune compromised patients Stool microscopy modified AFB trichrome stains though standard largely replaced multiplex PCR except resource limited settings Computerized tomography scan helpful constitutional symptoms endoscopic biopsy remains gold standard noninvasive test nondiagnostic Diagnostic workup negative subset HIV population could due antiretroviral agent HIV per se Treatment involves replacement fluid  electrolyte etiologyappropriate antimicrobials ART optimized patients often result clinical improvement Managing chronic diarrhea HIV positive patient requires multimodal approach usually successful even resourcelimited setting provided access ART available",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767428/"
    },
    {
        "pmid": "40767317",
        "title": "GLY-200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double-blind placebo-controlled trial.",
        "abstract": "GLY200 investigational oral polymeric drug designed enhance barrier function gastrointestinal mucus noninvasive alternative metabolic surgery study evaluated safety tolerability pharmacodynamic effect GLY200 patient T2D phase 2 placebo PBOcontrolled doubleblind singlecentre inpatient study ClinicalTrialsgov NCT05478525 enrolled patient n  51 aged 3070 year T2D HbA1c ≥60 85 stable metformin ≥750 mgday ≥3 months Patients received 14 day twice day BID 05 10 20 g GLY200 PBO 1111 primary endpoint safety tolerability Additional endpoint included change plasma glucose secondary calorie lipid profile exploratory GLY200 appeared safe well tolerated frequently related TEAEs subject treated GLY200 constipation nausea diarrhoea vomiting mild Improvements fasting postprandial glucose observed 20 g Day 14 postprandial glucose poststandardized meal mean absolute AUCsub03HRsub difference PBO 17833 mgdLhr 95 CI 32716 2950 p  002 Csubmaxsub difference 5088 mgdL 10023 154 p  004 Day 14 mean change baseline fasting serum glucose 20 g group 161 SD 225 versus 121 418 mgdL PBO group GLY200 treatment also resulted numerical reduction food intake modest decrease body weight improvement lipid profile consistent duodenal exclusion mechanism result suggest duodenal exclusion possible oral polymeric drug support development GLY200 treatment T2D obesity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767317/"
    },
    {
        "pmid": "40766846",
        "title": "Helile formula from \"Tai ping sheng hui fang<i>\"</i>: anti-<i>Helicobacter pylori</i> activity, gut microbiota modulation, and inflammatory response regulation.",
        "abstract": "iHelicobacter pylorii HP major gastric pathogen linked chronic gastritis peptic ulcers gastric cancer emergence antibiotic resistance prompted search alternative treatments Helile formula derived ancient Taiping Shenghuifang known treat various degree diarrhea potential treating gastrointestinal disorders However antibacterial efficacy material basis action mechanism helile formula HP remain undetermined chemical constituent analyzed using ultrahighperformance liquid chromatographytandem mass spectrometry UPLCMSMS highperformance liquid chromatography HPLC iin vitroi antiHP activity underlying mechanism investigated series assays including determination minimum inhibitory concentration MIC Nphenyl1naphthylamine NPN uptake assay scanning electron microscopy SEM observe morphological changes cell viability cell adhesion activity assays assessment nitric oxide NO production reverse transcriptionquantitative polymerase chain reaction RTqPCR gene expression analysis iin vivoi antiHP infection study mechanism exploration technique hematoxylin eosin HE staining histological examination enzymelinked immunosorbent assay ELISA cytokine antibody quantification 16S ribosomal DNA 16S rDNA sequencing microbial community profiling metabolomics global metabolite analysis employed Multiple constituent helile formula namely ellagic acid gallic acid chebulagic acid chebulic acid corilagin identified iIn vitroi helile formula increased bacterial outermembrane permeability disrupted HP structure inhibited toxinrelated genes suppressed cell adhesion male Kunming mice helile formula effectively reversed HPinduced inflammation modulated key metabolites adenine panaxytriol 4hydroxyglutamate semialdehyde NalphaAcetylLlysine influenced gut microbiota especially family like iMuribaculaceaei iLactobacillaceaei Adenine particular repaired HPcaused damage GES1 cells reduced HP  mediated cell adhesion inhibited HPinduced interleukin6 IL6 tumor necrosis factoralpha TNFα production finding demonstrated remarkable antiHP efficacy helile formula iin vitroi iin vivoi suggesting helile formula represents highly promising therapeutic candidate management HP infections",
        "mesh_terms": [
            "Helicobacter pylori",
            "Animals",
            "Gastrointestinal Microbiome",
            "Helicobacter Infections",
            "Mice",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Disease Models, Animal",
            "Drugs, Chinese Herbal",
            "Humans",
            "Nitric Oxide",
            "Male",
            "Cell Survival",
            "Inflammation",
            "Tandem Mass Spectrometry",
            "Cytokines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766846/"
    },
    {
        "pmid": "40765987",
        "title": "Na we go shine: women's wellbeing, agency, and health seeking behaviours in southeastern Nigeria.",
        "abstract": "Peerreviewed literature southeastern Nigerian womens health status scant participatory action research project explored mental physical health status issue within sample population childbearing woman Cross River State conducted initial study using formal chieftaincy channel village learned expressed primarily men found concern differed women conducted study attempt hear woman health need context lives Local woman carried facetoface interview language childbearing woman community interviewed 70 woman age 1845 12 villages participant farm grew rice cassava yam feed families majority participant completed elementary school given birth average 6 children 4 survived woman included study walked 68 h per day retrieve drinking water young child baby often accompanied mother journeys Participants reported suffered malaria diarrhea anemia hernia waist pains cough eye problem continuous headaches Traditional healer first choice treatment partly physical financial accessibility partly cultural resonance positive outcomes Despite tremendous social economic political barriers participant generally reported strong sense wellbeing positive outlook lives also interviewed 15 traditional healer enhance statement made female participant regarding healthseeking behaviors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765987/"
    },
    {
        "pmid": "40765232",
        "title": "Prevalence and toxin gene profiles of <i>Clostridium perfringens</i> in diarrheic dogs and cats in Korea: a retrospective analysis.",
        "abstract": "iClostridium perfringensi significant enteropathogen affecting human animals causing gastrointestinal symptom varying severity including diarrhea dog cats Understanding distribution toxinotypes essential improving diagnostic accuracy treatment strategies study aimed determine prevalence toxin gene profile iC perfringensi strain isolated dog cat diarrhea Republic Korea providing insight regarding predominant toxinotypes iC perfringensiassociated diarrhea Fecal specimen dog cat diarrhea analyzed using multiplex realtime polymerase chain reaction detect various iC perfringensi toxin genes isolates categorized established toxinotype group based toxin gene profiles 110 fecal sample from 50 dog 60 cats majority iC perfringensi isolates classified type A small percentage identified type F Type B C D E isolates found Additionally significant portion isolates carried β2 toxin gene associated pathogenicity considered toxinotype classification Type predominant iC perfringensi toxinotype dog cats type F detected cases finding may aid predicting toxinotypes future diarrhea outbreak support development targeted control measures research required clarify clinical relevance toxinotypes iC perfringensiassociated diarrhea",
        "mesh_terms": [
            "Animals",
            "Cats",
            "Dogs",
            "Clostridium perfringens",
            "Cat Diseases",
            "Dog Diseases",
            "Republic of Korea",
            "Diarrhea",
            "Clostridium Infections",
            "Bacterial Toxins",
            "Retrospective Studies",
            "Prevalence",
            "Feces"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765232/"
    },
    {
        "pmid": "40765227",
        "title": "Clinical utility of two-dimensional shear wave elastography in two dogs with presumptive toxic hepatopathy.",
        "abstract": "Shear wave elastography SWE noninvasive ultrasound technique assessing tissue stiffness study examined clinical utility twodimensional SWE 2DSWE two dog diagnosed presumptive toxic hepatopathy first case involved 9yearold Pompitz presented anorexia vomiting diarrhea following garlic onion ingestion Laboratory test revealed anemia elevated liver enzyme levels diabetic ketoacidosis Ultrasonography demonstrated increased hepatic echogenicity elevated SWE values Despite intensive treatment dogs condition deteriorated progressive increase liver enzyme level SWE values resulting euthanasia second case involved 1yearold Maltipoo presented vomiting depression abdominal pain reported history Laboratory finding indicated elevated liver enzyme bile acid levels Ultrasonography revealed increased hepatic echogenicity SWE values Following treatment acute toxic hepatopathy dog exhibited significant improvement within 3 days normalization hepatic echogenicity SWE values liver enzyme levels case demonstrate clinical relevance 2DSWE assessing hepatic damage tracking therapeutic response informing prognosis presumptive toxic hepatopathy",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Chemical and Drug Induced Liver Injury",
            "Dog Diseases",
            "Elasticity Imaging Techniques",
            "Liver"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765227/"
    },
    {
        "pmid": "40761974",
        "title": "Enhancing Childhood-Educator Knowledge and Confidence: Virtual \"Coffee Chat\" Interventions with Medical Professionals.",
        "abstract": "Context Early childhood educator ECEs central development care children often lack adequate access resource expert guidance managing common childhood health issues challenge lead significant stress educator parents address gap pilot intervention involving virtual coffee chat session implemented session aimed provide ECEs evidencebased knowledge practical strategy handle frequent childhood health concerns Objective primary objective study enhance knowledge confidence ECEs addressing common health behavioral issue among child New River Valley USA sessions facilitated pediatrician medical students covered range topic identified highpriority educators goal create sustainable educational model improving child health management childcare settings Methods study used selfdesigned pre postsurvey format measure effectiveness eight virtual coffee chat session conducted two years initial session focused educator New River Valley USA final session expanded across Virginia USA Topics included common illness eg cough diarrhea trauma management obesity behavioral issue selfregulation temper tantrums session consisted brief evidencebased presentation followed interactive discussions Participants recruited local statewide child care organizations survey used assess change confidence knowledge levels Descriptive statistic Wilcoxon Signed Rank test applied analyze data qualitative feedback openended response categorized thematically Results Across eight sessions 30 registration recorded 19 participants attended multiple sessions Pre postsurvey result demonstrated significant improvement knowledge confidence overall pvalue 0001 Six eight topic showed increased postsurvey scores session selfregulation temper tantrums largest cohort N10 yielding significant improvement p00041 highlighting broad impact relevance Feedback participant highlighted value practical evidencebased strategy opportunity engage directly healthcare professionals However variability observed topics diarrhea postsurvey score declined slightly pointing potential area improvement Conclusion Virtual coffee chat session proved effective scalable method improving health management skill ECEs interventions interactive accessible format particularly appreciated participant show promise model ongoing professional development However given studys design sample size finding interpreted preliminary Future effort focus refining content expanding participation exploring longterm impact educator practice child outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40761974/"
    },
    {
        "pmid": "40761965",
        "title": "Acute Adenoviral Gastroenteritis Complicated by Interstitial Edematous Pancreatitis in an Adult Patient: A Rare Clinical Case With a Multidisciplinary Approach.",
        "abstract": "Adenovirus F type 4041 one significant viral etiological agent acute gastroenteritis young children significant growing cause pediatric gastroenteritis worldwide particularly child age five However rare cases may also lead clinically significant illness adults clinical case present describes course acute adenoviral gastroenteritis complicated acute pancreatitis pronounced intoxication syndrome 24yearold woman Ukraine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40761965/"
    },
    {
        "pmid": "40761476",
        "title": "A Case of Drug-Induced Pancytopenia due to Tamoxifen.",
        "abstract": "Tamoxifen TAM wellestablished treatment hormone receptorpositive breast cancer known sideeffect profile includes hot flashes genital bleeding diarrhea 015 notable side effect include liver damage abnormal vaginal discharge depression dizziness headache unknown frequency However blood cell count reduction yet reported side effect Japan 46yearold female patient diagnosed right breast cancer cT1N0M0 patient underwent partial right breast resection sentinel lymph node biopsy Owing positive surgical resection margin mastectomy performed Pathological analysis surgical specimen confirmed invasive ductal carcinoma estrogen receptor ER 95 progesterone receptor PgR 85 HER2 2 fluorescence iin situi hybridization FISH negative macrometastasis one sentinel lymph node Postoperative treatment included chemotherapy dosedense adriamycin cyclophosphamide AC dosedense paclitaxel PTX irradiation TAM initial blood test result starting TAM showed mild anemia Hb 89 gdL Grade 2 followup blood test 5 month initiating TAM revealed significant decrease blood cell count white blood cell WBC 2600μL Grade 2 neutrophil neu 055 × 10³μL Grade 3 Hb 77 gdL Grade 2 platelet PLT 133 × 10⁴μL Considering onset symptom following TAM administration druginduced pancytopenia suspected TAM concomitant medication pregabalin discontinued However blood cell count continued decline necessitating investigation Myelodysplastic syndrome MDS suspected leading multiple bone marrow biopsies However definitive hematological disorder diagnosed patient received transfusion granulocyte colonystimulating factor GCSF injection based blood cell count Approximately 4 month onset neutropenia gradual recovery observed spontaneous remission occurred Given rarity spontaneous recovery MDS TAM considered potential causative agent observed decline blood cell counts report case suspected druginduced cytopenia associated tamoxifen administration",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40761476/"
    },
    {
        "pmid": "40761215",
        "title": "Autoimmune enteropathy in adults: a case report and literature review.",
        "abstract": "Autoimmune enteropathy AIE rare autoimmune disorder characterized primarily villous atrophy small intestinal mucosa article present case adultonset AIE featuring intractable diarrhea severe malnutrition along review existing literature summarize clinical characteristics aiming provide insight diagnosis management AIE 60yearold male admitted due intermittent abdominal pain diarrhea weight loss Laboratory test revealed gliadin immunoglobulin IgA  immunoglobulin G IgG  tissue transglutaminase IgA  IgG  Endoscopy revealed mucous membrane small intestine congested edematous villus atrophied prone bleeding biopsy villus exhibited white mossy appearance Pathologically villus many segment small intestine presented diffuse obvious atrophy lymphocytic infiltration intestinal glands exclusionary diagnosis patient considered AIE effective initial treatment corticosteroid patient exhibited recurrent symptom poor nutritional status eventually died sepsis patient refractory diarrhea intestinal villous atrophy comprehensive diagnosis made based medication history epidemiological factors gluten dietary response serological markers histopathological findings Early intervention corticosteroid combined nutritional support critical vigilance severe adverse event lifethreatening infection essential",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40761215/"
    },
    {
        "pmid": "40760599",
        "title": "Silent complication: chronic diarrhea as a clue to gastrojejunocolic fistula: A case report.",
        "abstract": "Gastrocolic fistula represent abnormal connection stomach large intestine often leading chronic diarrhea malnutrition arise postoperatively particularly complex surgery Billroth II procedure case report describes case 71yearold male history hypertension gastrointestinal surgery experienced significant weight loss postprandial diarrhea Initial investigations including stool culture multiple imaging studies failed reveal fistula definitive diagnosis gastrojejunocolic fistula made third gastroscopy endoscope passed stomach colon Surgical intervention involved adhesiolysis resection fistula followed reconstruction gastrointestinal continuity Postoperative care included nutritional support patient showed significant improvement followup case highlight diagnostic challenge associated gastrojejunocolic fistula emphasizes need high index suspicion patient atypical gastrointestinal symptom complex surgery illustrates timely surgical intervention lead positive outcomes underscore importance ongoing research education regarding management complications study needed understand longterm effect gastrojejunocolic fistula optimize management strategies",
        "mesh_terms": [
            "Humans",
            "Male",
            "Aged",
            "Gastric Fistula",
            "Intestinal Fistula",
            "Diarrhea",
            "Chronic Disease",
            "Postoperative Complications",
            "Colonic Diseases",
            "Gastroscopy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760599/"
    },
    {
        "pmid": "40760469",
        "title": "Pretreatment with an anti-CGRP monoclonal antibody attenuates mild TBI-induced tactile hypersensitivity in mice.",
        "abstract": "Posttraumatic headache PTH develop following mild traumatic brain injury mTBI concussion especially common among activeduty military personnel Veterans athletes high prevalence chronic nature PTH highlight importance studying condition animal model develop new effective treatments Since symptom associated PTH resemble migraine focused neuropeptide calcitonin generelated peptide CGRP potential therapeutic target used mouse model mTBI involving three repeated closed head impact assess therapeutic efficacy monoclonal antibody mAb block CGRP validate model first assessed optimized development periorbital plantar tactile hypersensitivity outbred CD1 mice tested response intraperitoneal injection two migraine triggers CGRP sodium nitroprusside SNP nitric oxide donor Then assessed efficacy antiCGRP mAb using different administration paradigms Early administration antiCGRP mAb induction TBI fully prevent initial transient periorbital tactile hypersensitivity observed following multiple closed head injuries However mAb partially reduce persistent periorbital tactile hypersensitivity subthreshold trigger Administration mAb immediately injury also able partially reduce persistent hypersensitivity Importantly injection antiCGRP mAb 24 h prior injection subthreshold dose CGRP SNP fully prevented periorbital hypersensitivity trigger persistent sensitivity phase result indicate antiCGRP mAb partially fully attenuate cephalic tactile hypersensitivity administered immediately mTBI event contrast stronger rescue seen antiCGRP mAb administered prior CGRP nitric oxide triggers Thus depending timing administration antiCGRP mAb block persistent sensitization headache trigger mTBI online version contains supplementary material available 101186s1019402502108x",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760469/"
    }
]